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Executive summary 
 
The surface water Watch List (WL) under the Water Framework Directive (WFD) is a 
mechanism for obtaining high-quality Union-wide monitoring data on potential water 
pollutants for the purpose of determining the risk they pose and thus whether 
Environmental Quality Standards (EQS) should be set for them at EU level. According to 
the EQS Directive (article 8b)1, this list should be updated every 2 years. 
The main objectives of this report are:  
 To present an overview of the data gathered during the 1st year of monitoring of 
the 1st WL (also called WL dataset in this report), 
 To assess whether this WL dataset is sufficient to determine the risk posed by the 
WL substances, and consequently to determine whether any of these substances 
can be taken out of the WL,  
 To propose new substance(s) to be included in the second WL, using the 
information and results from the latest review of the list of priority substances, as 
well as any other relevant information available at the time of this report. 
This summary first explains the context for the assessment. Then, mirroring the report 
itself, it presents an overview of the WL dataset for the different WL substances, it 
specifies the criteria for taking substances out of the WL and the substances proposed on 
the basis of these criteria, and finally it presents the criteria for including new substances 
in the WL and the new proposed WL candidates.  
 
Context of the assessment: Data scenarios, STE score and PNEC (or EQS) used 
How to use and interpret non-quantified samples is a challenge when dealing with 
datasets in which not all limits of quantification (LOQs) are adequate, which is the case in 
the WL dataset. 
To deal with this issue, 3 data scenarios are considered in this report, as was done 
during the latest review of the priority substances list (see Carvalho et al, 2016). 
Scenario 1 (Sc1) includes only quantified samples, thus clearly overestimating the risk. 
In both Scenario 2 (Sc2) and Scenario 3 (Sc3), non-quantified samples are set to half 
LOQ2. Sc2 comprises all monitoring records, thus leading to non-confirmed exceedances 
when ½LOQ>PNEC, while Sc33 takes into account quantified monitoring samples and 
non-quantified samples only when ½ LOQ ≤ PNEC (or EQS) (thus avoiding these non-
confirmed exceedances)4. According to the sub-group on review of the priority 
substances list (SG-R), Sc3 is the most relevant scenario to assess whether the 
substance poses a risk at EU-level. In addition, comparing the conclusions made on the 
basis of Sc2 and Sc3 gives information on the impact of the non-quantified samples on 
the overall assessment. Therefore these 2 scenarios (Sc2 and Sc3) are used to assess 
the quality of the WL dataset. 
In this report, the preferred indicator for the evaluation of the substances is the STE 
score, which takes into account the Spatial, Temporal and Extent of exceedances of the 
                                           
1 Directive 2008/105/EC, amended by Directive 2013/39/EU. 
2 Under the QA/QC Directive and EQS Directive, MS are required to replace the non-quantified samples by half 
LOQ to assess compliance with the EQS for individual substances, however the amended EQSD mentions 
that "when the calculated mean value of a measurement, when carried out using the best available 
technique not entailing excessive costs, is referred to as “less than limit of quantification”, and the limit of 
quantification of that technique is above the EQS, the result for the substance being measured shall not be 
considered for the purposes of assessing the overall chemical status of that water body". 
3 Sc3 was called Sc2-PNECQC in the monitoring based prioritisation report (Carvalho et al., 2016). 
4 It should be noted that Sc3 could lead to an underestimation of the risk, if the non-quantified samples with 
PNEC<LOQ<2PNEC are actually samples where the concentrations exceeds the PNEC. 
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PNECs. This assessment tool was developed by the JRC for the review of the list of 
priority substances, with the support of the SG-R.5 
Two sets of PNECs are considered in the evaluation of WL substances:  
- PNECs from the 2015 JRC report entitled "Development of the 1st Watch List under the 
Environmental Quality Standards Directive" by Raquel N. Carvalho, Lidia Ceriani, Alessio 
Ippolito and Teresa Lettieri. These will be called the "2015 PNECs". 
- updated PNECs, based on the prioritisation exercise and on additional information 
received from Germany, Switzerland, and Netherlands. These will be called "updated 
PNECs". 
The final assessment, including the recommendation for removal from the watch list, is 
based on the results obtained with the updated PNECs, whenever available.  
 
WL dataset 
The first WL dataset gathers data from 25 EU Member States (MS) with a total number of 
35848 surface water samples in Sc2. The vast majority of these records are river water 
samples (98.3%), with a few measurements for lakes (1.2%) and coastal/transitional 
waters (0.5%).  
For 9 out of 17 substances, the quantification frequency (percentage of quantified 
samples in Sc2) is below 10%, and for two of them (acetamiprid and methiocarb) below 
1%. The quantification frequency for clarithromycin, diclofenac and estrone is above 
50%.  
Some MS had difficulty in always reaching an analytical LOQ below the 2015 PNECs 
and/or updated PNECs for 5 (17-alpha-ethinylestradiol, 17-beta-estradiol, azithromycin, 
imidacloprid, and methiocarb) of the 17 WL substances.  
Around half of the MS provided information on the representativity of the monitoring 
stations and monitoring strategy including the nearby pressures (agricultural, urban, 
industrial, or recreational / bathing water).  
Exceedances of the 2015 PNECs were observed mainly for 17-alpha-ethinylestradiol 
(EE2), imidacloprid, 17-beta-estradiol (E2), diclofenac, azithromycin, clarithromycin, and 
estrone (E1). For the other substances there were very few exceedances.  
The highest STE scores in Sc3 for WL dataset and PNECs from the WL report 2015 were 
obtained for: 17-alpha-ethinylestradiol (0.90), imidacloprid (0.69), 17-beta-estradiol 
(0.65), diclofenac (0.64), estrone (0.54), clarithromycin (0.52), methiocarb (0.45), and 
azithromycin (0.35).  
When using the updated PNEC values with the WL dataset in Sc3, there is on average, a 
small to medium increase of STE scores for diclofenac, methiocarb, azithromycin and 
thiacloprid in comparison with the STE scores with PNECs from the WL report 2015.  
The analyses of the WL dataset are presented in chapters 2 to 6. In addition the main 
findings for each substance are shown in a dedicated summary section, after this 
executive summary.  
 
Review of the 1st WL 
As already mentioned above, substances are included in the WL to gather sufficient, 
high-quality monitoring data to assess the risk they pose at EU level6. Consequently, a 
                                           
5 For more details about the STE score, please see (Carvalho et al., 2016), available at the following link :  
https://circabc.europa.eu/sd/a/7fe29322-946a-4ead-b3b9-e3b156d0c318/Monitoring-
based%20Exercise%20Report_FINAL%20DRAFT_25nov2016(1).pdf 
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substance can be taken out of the WL if enough high-quality monitoring data has been 
collected to allow this risk assessment, otherwise it needs to stay on the list. Whether a 
substance is shown to pose a significant risk at EU-level or not based on the WL 
monitoring data is crucial to decide how to deal with the substance once it has been 
taken off the WL. However, it is not part of the decision to keep or not a substance in the 
list, on which this report focusses.  
The criteria below are intended to identify substances for which there are sufficient, high-
quality, EU-wide monitoring data. Please note, however, that this doesn't preclude the 
possibility of deciding that a substance with monitoring data of a lower quality (not 
meeting all the criteria below) should be prioritised in a future exercise. Additional 
evidence (including other monitoring data, information on use, persistence, etc…) could 
help to provide a sufficient degree of certainty as regards the risk posed by the 
substance. 
In order to judge the collection of high quality monitoring data to assess the EU risk, the 
JRC proposes the criteria below, assuming a monitoring in appropriate matrix. A 
substance can be taken out of the WL if it fulfils all criteria simultaneously: 
1. The ½ LOQ must be below or equal to the PNEC, for at least 90 % of the non-
quantified samples in Sc2 (LOQ-PNEC criterion). 
2. Similarity of STE scores for Sc3 and Sc2 (no more than 15% difference in STE 
scores demonstrating no significant analytical problem with non-quantified 
samples; the difference of the STE scores is calculated as a percentage by the 
formula: |STESc3 – STESc2|/STESc3 * 100) 
Please note that because of the requirement of the EQSD as regards monitoring for the 
WL, the data gathered under the WL mechanism is expected to fulfil the minimum 
requirements in terms of number of MS, sites and samples used during the last 
prioritisation exercise7. This has been checked for each substance, both for scenario 2 
and scenario 3.  
When considering the WL dataset together with the updated PNECs, the substances 
fulfilling the 2 above criteria are: diclofenac, clarithromycin, erythromycin, oxadiazon, tri-
allate, 2,6-di-tert-butyl-4-methylphenol, acetamiprid, clothianidin, thiacloprid, and 2-
ethylhexyl-4-methoxycinnamate.  
For information, the same assessment has been carried out on a dataset combining the 
WL dataset and the dataset used during the review of the priority substances. The 
conclusions obtained with this combined dataset support the conclusions above (more 
details are provided in section 7.1 dedicated to removal of substances from the WL).  
 In addition, it should be noted that: 
- Neonicotinoids and macrolide antibiotics were included as groups in the WL, and all 
substances in each of these groups can be monitored with the same analytical method, 
so it makes sense to keep them jointly in the WL. In addition, ongoing work at EU-level 
(see section 7.1 for more details) may lead to a change in the conditions of approval of 
several of the neonicotinoids, thus possibly leading to substitution effects, and to 
changes in the risk posed by these substances. Consequently, the data collected so far 
under the WL may possibly not reflect the risk posed by the substances in the very near 
future, and it makes sense to keep them in the list to gather sufficient, high quality 
monitoring data to confirm the risk they pose.  
- As regards the sunscreen ingredient 2-ethylhexyl-4-methoxycinnamate, it is unclear 
how far the monitoring sites selected were representative of the relevant pressure 
(samples should be taken preferentially in the summer at bathing sites). It is also worth 
                                                                                                                                    
6 The EQS Directive also highlights the specific cases of diclofenac and the estrogens, which were put on the WL 
to "gather monitoring data for the purpose of facilitating the determination of appropriate measures to 
address the risk posed by those substances." 
7 At least 4 MS, 10 sites and 51 samples. 
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noting that this substance was initially recommended for monitoring in sediment8, but 
that most data received were for water. The few sediment data reported to the JRC were 
not enough to carry out a conclusive analysis for that matrix. Consideration is being 
given to including several substances for monitoring in sediment in a WL update in 2019. 
Therefore we propose to remove the sunscreen ingredient (currently monitored in water) 
from the current WL in 2018, and to consider its reinclusion in 2019 for sediment 
monitoring together with the other candidate substances mentioned below. This will 
ensure the timely and cost-efficient development / validation of analytical methods (in 
particular by optimising the use of sediment samples) and sediment PNECs.  
Overall, based on the above criteria and discussion, the following substances 
are proposed for removal from the list: diclofenac, oxadiazon, 2,6-di-tert-butyl-
4-methylphenol, tri-allate and 2-ethylhexyl-4-methoxycinnamate. 
 
Table 1: Summary information for substances in the 1st WL about PNEC values, fulfilment of 
removal criteria, and JRC's recommendation on whether to include the substance in the 2nd WL 
(based on WL dataset and updated PNECs). The fulfilment of the removal criteria of substances and 
the additional information taken into account for the final decision are described in the chapter 7.1. 
Substance Substance type 
PNEC 
WL 2015 
(µg/l) 
PNEC 
update 
(µg/l) 
JRC's Recommendation 
17-alpha-Ethinylestradiol 
(EE2) 
Synthetic estradiol 
hormone 
0.000035 
(1)
 
  
Inclusion in the 2
nd
 WL  
17-beta-Estradiol (E2) 
Natural female sex 
hormone 
0.0004 
(1)
 
  
Inclusion in the 2
nd
 WL 
Estrone (E1) Hormone 0.0036 
(1)
   Inclusion in the 2
nd
 WL 
Diclofenac 
Non-steroidal anti-
inflammatory drug 
(NSAID) 
0.1 
(1)
 
  
0.05 
(4,6)
 Removal from the WL 
2,6-Di-tert-butyl-4-
methylphenol 
Antioxidant 3.16 
(2)
 
  
Removal from the WL 
2-Ethylhexyl 4-
methoxycinnamate 
Sunscreen ingredient / 
UV filter 
6.0 
(2)
 
200 µg/kg 
(3)
 
(sediment) 
  Removal from the WL
 
 
Erythromycin 
Macrolide antibiotic 
0.2 
(2)
 
 Fulfils both removal criteria but 
recommended for the 2
nd
 WL  
Clarithromycin Macrolide antibiotic 0.13 
(2)
 0.12
(5)
 
Fulfils both removal criteria but 
recommended for the 2
nd
 WL  
Azithromycin Macrolide antibiotic 0.09 
(2)
 0.019
(5)
 Inclusion in the 2
nd
 WL  
Methiocarb 
Carbamate insecticide 
and herbicide 
0.01 
(2)
 0.002
(4,7) 
 
 
Inclusion in the 2
nd
 WL 
Oxadiazon Herbicide 0.088 
(2)
   Removal from the WL  
Triallate Herbicide 0.67 
(2)
 0.41
(4)
 Removal from the WL 
Imidacloprid 
Neonicotinoid 
insecticide 
0.009 
(2)
 0.0083
(4)
 Inclusion in the 2
nd
 WL 
Thiacloprid 
Neonicotinoid 
insecticide 
0.05 
(2)
 0.01
(4)
 
Fulfils both removal criteria but 
recommended for the 2
nd
 WL  
Thiamethoxam 
Neonicotinoid 
insecticide 
0.14 
(2)
 0.042
(5)
 Inclusion in the 2
nd
 WL  
Clothianidin Neonicotinoid 0.13 
(2)
   Fulfils both removal criteria but 
                                           
8 Recital 9 of Commission Implementing Decision 2015/495: "For comparability, all substances should be 
monitored in whole water samples. However, it would be appropriate to monitor 2-ethylhexyl 4-
methoxycinnamate also in suspended particulate matter or sediment, because of its tendency to partition into 
this matrix." 
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insecticide recommended for the 2
nd
 WL 
Acetamiprid 
Neonicotinoid 
insecticide 
0.5 
(2)
 
  Fulfils both removal criteria but 
suggested for the 2
nd
 WL 
PNECs (or EQS) taken from:  
(1) Commission’s priority substances proposal from the year 2012 (EU, 2012).  
(2) (Carvalho et al. 2015).   
(3) Sediment PNEC (Carvalho et al. 2015) 
(4) Monitoring-based prioritisation report (Carvalho et al., 2016) https://circabc.europa.eu/w/browse/52c8d8d3-
906c-48b5-a75e-53013702b20a)  
(5) Oekotoxzentrum Centre Ecotox, 2016  
(6) EQS Datasheet, Environmental Quality Standard, Diclofenac, German Environment Agency (UBA), 2017  
(7) Ctgb (The Netherlands), 2010. SEC Adviesrapport 12707A01, Methiocarb, Afleiding van het MTR-water. 
Scheepmaker JWA. 24478-MTR. October 2010. 
 
Selection of new substances for the 2nd WL 
According to the EQS Directive, the total number of substances/groups of substances in 
the WL can increase by one at each update of the list, up to 14 substances, meaning that 
the 2nd WL can include up to 11 (groups of) substances. Candidate WL substances should 
be selected among substances posing a potential risk for the environment, but for which 
there is not enough good quality monitoring data to confirm this risk. A reliable PNEC and 
an appropriate analytical method (LOQ at least as low as the PNEC) should be available 
for new substances included in the WL. 
The criteria proposed here for identifying new WL substances generally follow the 
approach adopted in the 1st WL report (Carvalho et al., 2015) and  build on the technical 
work carried out for the review of the priority substances list led by the JRC with the 
support of the SG-R. During the review, substances with enough monitoring data to 
assess the risk they posed went through the so-called "monitoring-based approach", 
while others went through the modelling-based approach. Factsheets were drafted for 
substances ranking high through either of these approaches. On the basis of these 
factsheets, 10 substances were short-listed for further consideration.  
For more details on the methodologies, please see the summary available at the 
following link: https://circabc.europa.eu/w/browse/0f6b893e-b0ab-46cb-a631-
c3e1e55c7514 
Consequently, the JRC suggests the following criteria for the selection of new substances 
as potential candidates for the WL:  
Criteria based on the 2014 prioritisation: 
1. Substances for which factsheets were prepared during the prioritisation process 
but not taken forward because there were few or low-quality monitoring data. 
2. Substances short-listed but with uncertainties in the monitoring data, 
3. Substances considered in the modelling based exercise for which:  
a. The monitoring data met the representativity criteria (number of MS, sites 
and samples) in Sc2 but not in Sc3, AND 
b. In Sc2 the STE score was high and the modelled RQ was high. 
4. Substances considered in the prioritisation exercise which went directly to the 
modelling exercise (measured in less than 4 MS in Sc2) with a modelled RQ above 
5, but not further selected because of lack of monitoring data. 
Additional criteria:  
5. Substances identified as potentially relevant in the report “Development of the 
first Watch List” (Carvalho, et al., 2015), but not included in the 1st WL because of 
limitations in the information available at the time (e.g. on analytical methods). 
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6. Substances of emerging concern identified based on research projects and 
scientific articles, in line with the requirement of EQSD article 8b.  
Substances fulfilling these criteria that could be considered for inclusion in the WL 
depending on the availability of a reliable PNEC and appropriate analytical methods, are 
(see section 7.2 for more details):  
- Criterion 1: chromium (VI) (dissolved)  
- Criterion 2: permethrin, esfenvalerate, deltamethrin and bifenthrin,   
- Criterion 3 and 4: diflubenzuron, pyridaben, dimoxystrobin, etofenprox, fenpyroximate, 
metaflumizone, proquinazide, and venlafaxine, 
- Criterion 5: free cyanide (CN-)  
- Criterion 6: the antibiotics amoxicillin and ciprofloxacin. The selection of these 
antibiotics is also in line with the European One Health Action Plan against antimicrobial 
resistance9.  
Taking into account the availability of an appropriate analytical method (LOQ at least as 
low as the PNEC) and of a reliable PNEC, the JRC recommends the inclusion of 
metaflumizone, amoxicillin and cyprofloxacin in the 2nd WL.  
High modelled RQ substances such as the pyrethroids (etofenprox, permethrin, 
esfenvalerate, deltamethrin and bifenthrin) and pyridaben should be considered in the 3rd 
WL, however, based on their physical chemical properties, they should be measured in 
the most relevant matrix, i.e. sediment or biota (the PNEC and analytical methods would 
still need to be investigated). Furthermore venlafaxine and proquinazid should be also 
considered for the 3rd WL if reliable information for the PNEC is found. Free cyanide 
should also be considered when the analytical method recently developed is made 
available. The review of approval of dimoxystrobin is due by January 2019. If the 
approval for this substance is renewed, then it can be considered for inclusion in the 3rd 
WL. No appropriate analytical method has been found for diflubenzuron and 
fenpyroximate.  
Chromium (VI) is not proposed for inclusion in the 2nd WL. The JRC’s assessment of the 
new monitoring data received in January 2018 together with the data from the 2014 
prioritisation doesn’t support the idea that chromium (VI) would be posing a risk in 
freshwaters. However, chromium (VI) could be considered for inclusion in the 3rd watch 
list in transitional and coastal waters, after confirmation of the PNEC via consultation with 
the WG Chemicals and after collection and analysis of any additional existing monitoring 
data for these categories of water.  
Finally, thiram, metconazole and famoxadone could be considered for inclusion in the 3rd 
WL if their approval is renewed and if a reliable PNEC and an appropriate analytical 
method are found. 
Table 11 summarizes the availability of reliable PNECs and appropriate analytical 
methods for the above-mentioned substances.  
 
                                           
9 https://ec.europa.eu/health/amr/sites/amr/files/amr_action_plan_2017_en.pdf 
The Action Plan states: "maximise the use of data from existing monitoring, e.g. Watch List monitoring under 
the Water Framework Directive, to improve knowledge of the occurrence and spread of antimicrobials in the 
environment" 
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Summary of most important findings for the WL substances 
The findings and conclusions on the removal from the WL (or inclusion in the 2nd WL) are 
based on the WL dataset and both sets of PNEC values (from 2015 and updated). In the 
following tables all concentrations are given in µg/l. 
 
17-alpha-Ethinylestradiol (EE2) 
Statistics on samples, concentrations, STE scores and RQs 
Scenario Countries Sites Samples Quant. Samples (%) EQS Median Mean P95 Max 
Sc1 10 54 82 100 
0.000035 
0.00010 0.00023 0.00078 0.0030 
Sc2 25 224 558 14.7 0.00005 0.00055 0.0010 0.0125 
Sc3 14 123 323 25.4 0.000015 0.00007 0.00026 0.0030 
The European median surface water concentration of EE2 is higher than the EQS (0.035 
ng/l) in the data scenarios Sc1 (0.1 ng/l) and Sc2 (0.05 ng/l), but lower in Sc3 (0.015 
ng/l). 
Note that from the 82 quantified samples 75 exceed the EQS of 0.000035 µg/l, and 7 
samples were given as 0.00003 µg/l.  
241 of the 476 non-quantified samples are below the EQS but still very close because the 
lowest reported LOQ was 0.00003 µg/l. 235 of the non-quantified samples are above the 
EQS but are removed in Sc3 because the LOQ is not sufficient.  
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.899 1.910 2.191 7.4 28.6 22.3 
General information on data quality  
In Sc2 558 samples from 25 countries are available (quantification frequency 14.7 %), 
and in Sc3 323 samples from 14 countries. 
A detailed analysis of the LOQs for the non-quantified samples showed that 4 MS 
achieved an LOQ of 0.03 ng/l (for 172 samples) which is below the EQS (0.035 ng/l). 
Other 4 countries reached an LOQ of 0.035 ng/l (for 57 samples), equal to the EQS; 4 
other countries have an LOQ of 0.1 ng/l (for 70 samples). There are however 12 
countries with an LOQ clearly not sufficient for the low EQS of 0.035 ng/l (for 247 
samples). 
Assessment of removal criteria and conclusion as regards removal 
Data quality for EE2 is not satisfactory because 12 MS don’t achieve the low EQS of EE2. 
The ½ LOQ is ≤ EQS for only 50.6 % of the non-quantified samples in Sc2 
(threshold=90%). 
The STE score of Sc2 is much higher than for Sc3 (the difference is above the limit of 
15 %).  
EE2 should remain on the WL. 
 
17-beta-Estradiol (E2) 
Statistics on samples, concentrations, STE scores and RQs 
Scenario Countries Sites Samples Quant. Samples (%) EQS Median Mean P95 Max 
Sc1 11 60 101 100 
0.0004 
0.00021 0.00041 0.00130 0.0030 
Sc2 25 229 597 16.9 0.00017 0.00059 0.00150 0.0125 
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Sc3 18 181 461 21.9 0.00015 0.00020 0.00051 0.0030 
The European median surface water concentration of E2 is in all data scenarios below the 
EQS (0.4 ng/l). 
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.646 1.165 1.090 1.3 3.8 3.3 
General information on data quality  
In Sc2 597 samples from 25 countries are available (quantification frequency 16.9 %), 
and in Sc3 461 samples from 18 countries. For E2 most non-quantified samples have an 
LOQ ≤ the EQS of 0.4 ng/l (360 out of 497 samples). The LOQs range from 0.03 – 25 
ng/l. There are 16 countries which achieve with their analytical method the EQS of E2, 
and 8 countries with higher LOQs.  
Assessment of removal criteria and conclusion as regards removal  
Data quality for E2 is not satisfactory because several MS don’t achieve the EQS. 
However, the ½ LOQ is ≤ EQS for 72.8 % of the non-quantified samples in Sc2, which is 
below the threshold of 90 %. 
The STE scores of Sc2 and Sc3 are different (the difference is > 15 %). 
E2 should remain on the WL. 
 
Estrone (E1) 
Statistics on samples, concentrations, STE scores and RQs 
Scenario Countries Sites Samples Quant. Samples (%) PNEC Median Mean P95 Max 
Sc1 13 141 313 100 
0.0036 
0.00064 0.0015 0.0050 0.031 
Sc2 23 213 574 54.5 0.00050 0.0013 0.0050 0.031 
Sc3 20 198 552 56.7 0.00050 0.0010 0.0035 0.031 
 
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.542 0.796 0.672 0.97 1.39 1.39 
General information on data quality  
In Sc2 574 samples from 23 countries are available (quantification frequency 54.5 %), 
and in Sc3 552 samples from 20 countries. Most of the countries achieve the PNEC of E1; 
there are only 22 samples from 4 countries with an LOQ > PNEC.  
Assessment of removal criteria and conclusion as regards removal  
Data quality for E1 is relatively good; however only one of the two removal criteria is 
fulfilled.  
Most of the countries achieve the PNEC. The ½ LOQ is ≤ PNEC for 91.6 % of the non-
quantified samples in Sc2. 
The STE scores are similar but not identical; the difference is > 15 % (47 %). 
E1 should remain on the WL.  
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Diclofenac 
Statistics on samples, concentrations, STE scores and RQs 
Scenario Countries Sites Samples Quant. Samples (%) PNEC Median Mean P95 Max 
Sc1 21 529 4602 100 
0.1 
0.047 0.093 0.34 2.6 
Sc2 25 608 6698 68.7 0.027 0.067 0.26 2.6 
Sc3 25 608 6697 68.7 0.027 0.067 0.26 2.6 
The median concentration of diclofenac is between 0.027 µg/l (Sc3 and Sc2) and 0.047 
µg/l (Sc1).  
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.645 0.645 0.864 2.6 2.6 3.4 
For diclofenac a lower PNEC of 0.05 µg/l has been derived in the finalised dossier from 
Germany, which results in increased STE scores and RQs. 
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.990 0.990 1.335 5.3 5.3 6.8 
General information on data quality  
In Sc2 6698 samples from 25 countries are available (quantification frequency 68.7 %), 
and in Sc3 6697 samples from 25 countries, so that the data quality is very good. All 
laboratories achieve the PNEC (the ½ LOQ is ≤ PNEC for all but one of the non-quantified 
samples in Sc2). The STE scores of Sc2 and Sc3 are identical. 
Assessment of removal criteria and conclusion as regards removal  
Data quality for diclofenac is good; both removal criteria are fulfilled.  
There is no need to collect additional monitoring data for this substance in the WL.  
Diclofenac can be removed from the WL.  
 
2,6-Di-tert-butyl-4-methylphenol 
Statistics on samples, concentrations, STE scores and RQs 
Scenario Countries Sites Samples Quant. Samples (%) PNEC Median Mean P95 Max 
Sc1 6 22 57 100 
3.16 
0.018 0.512 0.26 14.0 
Sc2 24 245 1035 5.5 0.0050 0.10 0.25 14.0 
Sc3 23 242 1032 5.5 0.0050 0.088 0.25 14.0 
 
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.000 0.167 0.000 0.08 0.08 0.08 
General information on data quality  
In Sc2 1035 samples from 24 countries are available (quantification frequency 5.5 %), 
and in Sc3 1032 samples from 23 countries. Nearly all LOQs are below the PNEC; there 
are 3 samples with an LOQ of 9 µg/l, and 10 samples with an LOQ equal to the PNEC 
(3.16 µg/l). The ½ LOQ is ≤ PNEC for 99.7 % of the non-quantified samples in Sc2. 
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The STE scores of Sc2 and Sc3 are not identical, but the datasets of Sc2 and Sc3 are 
nearly identical. 10 
Assessment of removal criteria and conclusion as regards removal  
Data quality for 2,6-di-tert-butyl-4-methylphenol is good; both removal criteria are 
fulfilled.  
2,6-Di-tert-butyl-4-methylphenol can be removed from the WL.  
 
2-Ethylhexyl 4-methoxycinnamate 
Statistics on samples, concentrations, STE scores and RQs 
2-Ethylhexyl 4-methoxycinnamate is a sunscreen ingredient / UV filter with a water PNEC 
of 6.0 µg/l and a sediment PNEC of 200 µg/kg.  
Scenario Countries Sites Samples Quant. Samples (%) PNEC Median Mean P95 Max 
Sc1 6 19 116 100 
6.0 
0.305 0.420 1.4 1.8 
Sc2 24 201 546 21.2 0.050 0.367 3.0 9.0 
Sc3 23 198 543 21.4 0.050 0.319 3.0 3.0 
 
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.000 0.000 0.000 0.50 0.50 0.23 
General information on data quality  
In Sc2 546 samples from 24 countries are available (quantification frequency 21.2 %), 
and in Sc3 543 samples from 23 countries. Nearly all LOQs are below the PNEC; there 
are 3 samples with an LOQ of 18 µg/l, and 33 samples with an LOQ equal to the PNEC (6 
µg/l). The ½ LOQ is ≤ PNEC for 99.3 % of the non-quantified samples in Sc2.  
The STE scores are identical. 
Sediment analysis 
In sediment 2-ethylhexyl-4-methoxycinnamate was analysed in 4 countries with a total 
number of samples of 37. No nearby pressure information (bathing site) was given. The 
maximum concentration detected for 2-ethylhexyl-4-methoxycinnamate in sediment was 
35 µg/kg, and therefore did not exceed the PNEC of 200 µg/kg.  
Assessment of removal criteria and conclusion as regards removal  
Data quality for 2-ethylhexyl 4-methoxycinnamate in water is good; both removal criteria 
are fulfilled.  
However, the number of samples in sediment is very low, and better nearby pressure 
information (bathing water) would be needed; 2-ethylhexyl 4-methoxycinnamate should 
be monitored in sediment during the summer at bathing sites; therefore, it is proposed 
to remove 2-ethylhexyl 4-methoxycinnamate from the current WL and to consider its 
reinclusion in 2019 for sediment monitoring. 
 
                                           
10 When STESc3=0 and STESc2 is very low (<0.2 or =0) the difference of these scores is assumed to 
be zero (see section 7.1).  
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Erythromycin 
Statistics on samples, concentrations, STE scores and RQs 
Scenario Countries Sites Samples Quant. Samples (%) PNEC Median Mean P95 Max 
Sc1 12 89 211 100 
0.2 
0.026 0.060 0.20 1.1 
Sc2 24 300 2520 8.4 0.0050 0.012 0.028 1.1 
Sc3 19 277 2491 8.5 0.0050 0.012 0.028 1.1 
The median concentration of erythromycin is between 0.005 (Sc3 and Sc2) and 
0.026 µg/l (Sc1).  
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.000 0.000 0.480 0.14 0.14 1.00 
General information on data quality  
In Sc2 2520 samples from 24 countries are available (quantification frequency 8.4 %), 
and in Sc3 2491 samples from 19 countries. Nearly all LOQs are below the PNEC; there 
are only 2 samples with an LOQ equal to the PNEC (0.2 µg/l). The ½ LOQ is ≤ PNEC for 
100 % of the non-quantified samples in Sc2. 
The STE scores are identical. 
Assessment of removal criteria and conclusion as regards removal  
Data quality for erythromycin is good; both removal criteria are fulfilled.  
However the JRC proposes to continue monitoring it together with the other macrolide 
antibiotics.  
 
Clarithromycin 
Statistics on samples, concentrations, STE scores and RQs 
Scenario Countries Sites Samples Quant. Samples (%) PNEC Median Mean P95 Max 
Sc1 17 201 1642 100 
0.13 
0.034 0.073 0.28 1.6 
Sc2 24 324 2792 58.8 0.016 0.047 0.17 1.6 
Sc3 24 324 2792 58.8 0.016 0.047 0.17 1.6 
The median concentration of clarithromycin is between 0.016 (Sc3 and Sc2) and 
0.034 µg/l (Sc1). 
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.515 0.515 0.593 1.34 1.34 2.15 
For clarithromycin a slightly lower PNEC of 0.12 µg/l has been proposed by 
Oekotoxzentrum (CH). 
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.525 0.525 0.593 1.45 1.45 2.33 
General information on data quality  
In Sc2 and Sc3 2792 samples from 24 countries are available (quantification frequency 
58.8 %). The LOQs of all samples are < PNEC; the ½ LOQ is ≤ PNEC for 100 % of the 
non-quantified samples in Sc2.  
The STE scores are identical. 
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Assessment of removal criteria and conclusion as regards removal  
Data quality for clarithromycin is good; both removal criteria are fulfilled.  
However the JRC proposes to continue monitoring it together with the other macrolide 
antibiotics.  
 
Azithromycin 
Statistics on samples, concentrations, STE scores and RQs 
Scenario Countries Sites Samples Quant. Samples (%) PNEC Median Mean P95 Max 
Sc1 14 75 265 100 
0.09 
0.023 0.062 0.25 1.0 
Sc2 24 288 1553 17.1 0.022 0.030 0.055 5.0 
Sc3 19 192 915 29.0 0.022 0.023 0.053 1.0 
The median concentration of azithromycin is between 0.022 (Sc3 and Sc2) and 
0.023 µg/l (Sc1). 
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.348 0.351 0.720 0.59 0.61 2.8 
For azithromycin a lower PNEC of 0.019 µg/l has been proposed by Oekotoxzentrum 
(CH), which changes the STE scores strongly. 
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.879 1.403 1.569 4.5 2.9 13.1 
General information on data quality  
In Sc2 1553 samples from 24 countries are available (quantification frequency 17.1 %), 
and in Sc3 915 samples from 19 countries. The LOQ is for most of the samples below the 
PNEC (0.09 µg/l); only 2 samples have an LOQ of 10 µg/l, and 9 samples and LOQ of 
0.1 µg/l (close to the PNEC). The ½ LOQ is ≤ PNEC for 99.8 % of the non-quantified 
samples in Sc2.  
The STE scores are similar in Sc2 and Sc3 (the difference is < 15 %).  
Assessment of removal criteria and conclusion as regards removal  
Data quality for azithromycin is good; both removal criteria are fulfilled.  
However, a lower PNEC of 0.019 µg/l has been proposed for azithromycin which requires 
lower LOQs in around half of the laboratories. The STE scores for this lower PNEC of 
0.019 µg/l are different (the difference is > 15 %). 
Therefore azithromycin should remain on the WL.  
 
Methiocarb 
Statistics on samples, concentrations, STE scores and RQs 
Scenario Countries Sites Samples Quant. Samples (%) PNEC Median Mean P95 Max 
Sc1 2 4 6 100 
0.01 
0.028 0.040 0.090 0.109 
Sc2 24 369 1834 0.3 0.0050 0.0061 0.010 0.109 
Sc3 7 56 1798 4.7 0.0050 0.0059 0.010 0.109 
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STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.445 0.908 n.a. 1.0 1.0 n.a. 
General information on data quality  
In Sc2 1834 samples from 24 countries are available (quantification frequency 0.3 %), 
and in Sc3 1798 samples from 7 countries. In most countries and samples the LOQ is 
equal to the PNEC (0.01 µg/l). The ½ LOQ is ≤ PNEC for 98 % of the non-quantified 
samples in Sc2. 
The STE scores of Sc2 and Sc3 are different (the difference is > 15 % (104 %)). 
Assessment of removal criteria and conclusion as regards removal  
Data quality for methiocarb is not satisfactory because the STE scores are different.  
Methiocarb should remain on the WL to improve the data quality including better 
information on nearby pressure (pesticide use information). 
 
In addition, a considerably lower PNEC of 0.002 µg/l was proposed by the Netherlands, 
which changes the STE scores substantially.  
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
1.200 1.786 n.a. 0.83 5.0 45.0 
Note that nearly all LOQs are above this PNEC. 
 
Imidacloprid 
Statistics on samples, concentrations, STE scores and RQs 
Scenario Countries Sites Samples Quant. Samples (%) PNEC Median Mean P95 Max 
Sc1 15 123 421 100 
0.009 
0.018 0.031 0.082 1.05 
Sc2 24 376 2385 17.7 0.0050 0.011 0.027 1.05 
Sc3 22 326 1845 22.8 0.0050 0.011 0.033 1.05 
The median concentration of imidacloprid exceeds its PNEC (0.009 µg/l) only in Sc1 
(0.018 µg/l), but not in Sc2 (0.005 µg/l), or Sc3 (0.005 µg/l). 
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.690 1.007 2.005 3.7 3.0 9.1 
A slightly lower PNEC of 0.0083 µg/l was available from the prioritisation exercise, which 
changes the STE scores and RQs only very little. 
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.753 1.033 2.021 4.1 3.2 9.9 
General information on data quality  
In Sc2 2385 samples from 24 countries are available (quantification frequency 17.7 %), 
and in Sc3 1845 samples from 22 countries. The LOQs for imidacloprid range between 
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0.0006 - 0.05 µg/l. Most of the countries have reported for most of their samples an LOQ 
of 0.009 µg/l (123 samples in 8 countries) or 0.01 µg/l (1070 samples in 8 countries) 
which is equal (or nearly equal) to the proposed PNEC of 0.009 µg/l. There are however 
11 laboratories (note that some MS report different LOQs from different laboratories) 
with 687 samples which do not achieve the PNEC. The ½ LOQ is ≤ PNEC for 72.5 % of 
the non-quantified samples in Sc2, which is below the threshold of 90 %. 
The STE scores of Sc2 and Sc3 are different (the difference is > 15 % (37.8 %)). 
Assessment of removal criteria and conclusion as regards removal  
Data quality for imidacloprid is not satisfactory because the STE scores of Sc2 and Sc3 
are different (the difference is > 15 %). 
Imidacloprid should remain on the WL. 
 
Thiacloprid 
Statistics on samples, concentrations, STE scores and RQs 
Scenario Countries Sites Samples Quant. Samples (%) PNEC Median Mean P95 Max 
Sc1 12 50 97 100 
0.05 
0.015 0.026 0.079 0.57 
Sc2 24 374 2243 4.3 0.0050 0.0068 0.010 0.57 
Sc3 23 366 2235 4.3 0.0050 0.0068 0.010 0.57 
 
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.000 0.000 0.469 0.20 0.20 1.58 
General information on data quality  
In Sc2 2243 samples from 24 countries are available (quantification frequency 4.3 %), 
and in Sc3 2235 samples from 23 countries. Nearly all LOQs are below the PNEC; there 
are only 2 samples with an LOQ equal to the PNEC (0.05 µg/l). The ½ LOQ is ≤ PNEC for 
100 % of the non-quantified samples in Sc2. 
The STE scores of Sc2 and Sc3 are identical.  
For thiacloprid a much lower PNEC of 0.01 µg/l has been proposed by Oekotoxzentrum 
(CH), which would increase the STE scores.  
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.240 0.251 1.666 1.0 1.0 7.9 
Assessment of removal criteria and conclusion as regards removal  
Data quality for thiacloprid is good; both removal criteria are fulfilled.  
However the JRC proposes to continue its monitoring as explained in section 7.1.   
The proposed lower PNEC of 0.01 µg/l would require lower LOQs in several MS 
laboratories (559 samples).  
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Thiamethoxam 
Statistics on samples, concentrations, STE scores and RQs 
Scenario Countries Sites Samples Quant. Samples (%) PNEC Median Mean P95 Max 
Sc1 10 67 256 100 
0.14 
0.015 0.032 0.123 0.77 
Sc2 24 418 4020 6.4 0.0050 0.0076 0.013 0.77 
Sc3 23 412 3979 6.4 0.0050 0.0076 0.013 0.77 
 
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.062 0.062 0.227 0.09 0.09 0.88 
General information on data quality  
In Sc2 4020 samples from 24 countries are available (quantification frequency 6.4 %), 
and in Sc3 3979 samples from 23 countries. The LOQs of all samples are < PNEC; the ½ 
LOQ is ≤ PNEC for 100 % of the non-quantified samples in Sc2. 
The STE scores of Sc2 and Sc3 are identical.  
For thiamethoxam a lower PNEC of 0.042 µg/l has been proposed by Oekotoxzentrum 
(CH), which changes the STE scores slightly. 
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.076 0.300 0.391 0.24 0.30 2.9 
Assessment of removal criteria and conclusion as regards removal  
Data quality for thiamethoxam with the higher PNEC of 0.14 µg/l is good; both removal 
criteria are fulfilled. However, the STE scores are not identical with the lower PNEC of 
0.042 µg/l (the difference is > 15 %).  
Thiamethoxam should remain on the WL.  
 
Clothianidin 
Statistics on samples, concentrations, STE scores and RQs 
Scenario Countries Sites Samples Quant. Samples (%) PNEC Median Mean P95 Max 
Sc1 6 47 217 100 
0.13 
0.016 0.044 0.173 0.78 
Sc2 24 343 2254 9.6 0.0050 0.011 0.033 0.78 
Sc3 24 343 2254 9.6 0.0050 0.011 0.033 0.78 
 
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.286 0.286 0.309 0.25 0.25 1.33 
General information on data quality  
In Sc2 and Sc3 2254 samples from 24 countries are available (quantification frequency 
9.6 %). All LOQs are below the PNEC (the ½ LOQ is ≤ PNEC for 100 % of the non-
quantified samples in Sc2), and the STE scores of Sc2 and Sc3 are identical.  
Assessment of removal criteria and conclusion as regards removal  
Data quality for clothianidin is good; both removal criteria are fulfilled. 
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However the JRC proposes to continue its monitoring as explained in section 7.1.   
 
Acetamiprid 
Statistics on samples, concentrations, STE scores and RQs 
Scenario 
Countries Sites 
Samples 
Quant. Samples 
(%) 
PNEC Median Mean P95 Max 
Sc1 7 10 15 100 
0.5 
0.0090 0.014 0.045 0.074 
Sc2 24 372 2221 0.7 0.0050 0.0067 0.010 0.074 
Sc3 24 372 2221 0.7 0.0050 0.0067 0.010 0.074 
 
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.000 0.000 n.a. 0.02 0.02 n.a. 
General information on data quality  
In Sc2 and Sc3 2221 samples from 24 countries are available (quantification frequency 
0.7 %). The LOQs of all samples are < PNEC. The ½ LOQ is ≤ PNEC for 100 % of the 
non-quantified samples in Sc2. 
The STE scores of Sc2 and Sc3 are identical.  
Assessment of removal criteria and conclusion as regards removal  
Data quality for acetamiprid is good; both removal criteria are fulfilled.  
However the JRC proposes to continue its monitoring as explained in section 7.1.   
 
Oxadiazon 
Statistics on samples, concentrations, STE scores and RQs 
Scenario Countries Sites Samples Quant. Samples (%) PNEC Median Mean P95 Max 
Sc1 5 17 77 100 
0.088 
0.010 0.023 0.071 0.31 
Sc2 24 339 1849 4.2 0.0050 0.011 0.040 0.31 
Sc3 23 337 1847 4.2 0.0050 0.011 0.040 0.31 
 
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.100 0.101 0.450 0.45 0.45 0.80 
General information on data quality  
In Sc2 1849 samples from 24 countries are available (quantification frequency 4.2 %), 
and in Sc3 1847 samples from 23 countries. Nearly all LOQs are below the PNEC; there 
are 2 samples with an LOQ of 0.2 µg/l, and 41 samples with an LOQ of 0.09 µg/l. The ½ 
LOQ is ≤ PNEC for 99.9 % of the non-quantified samples in Sc2. 
The STE scores of Sc2 and Sc3 are identical.  
Assessment of removal criteria and conclusion as regards removal  
Data quality for oxadiazon is good; both removal criteria are fulfilled.  
Oxadiazon can be removed from the WL.  
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Tri-allate 
Statistics on samples, concentrations, STE scores and RQs 
Scenario Countries Sites Samples Quant. Samples (%) PNEC Median Mean P95 Max 
Sc1 4 23 138 100 
0.67 
0.022 0.037 0.113 0.270 
Sc2 24 338 2169 6.4 0.0050 0.015 0.035 0.945 
Sc3 23 335 2166 6.4 0.0050 0.014 0.033 0.335 
 
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.000 0.000 0.000 0.05 0.05 0.17 
For tri-allate a lower PNEC of 0.41 µg/l was available from the prioritisation exercise, 
which does not change the STE scores. 
STE score RQ (P95) 
Sc3 Sc2 Sc1 Sc3 Sc2 Sc1 
0.000 0.000 0.000 0.08 0.09 0.28 
General information on data quality  
In Sc2 2169 samples from 24 countries are available (quantification frequency 6.4 %), 
and in Sc3 2166 samples from 23 countries. Nearly all LOQs are below the PNEC; there 
are 3 samples with an LOQ of 1.89 µg/l, and 9 samples with an LOQ equal to the PNEC 
(0.67 µg/l). The ½ LOQ is ≤ PNEC for 99.9 % of the non-quantified samples in Sc2. 
The STE scores of Sc2 and Sc3 are identical.  
Assessment of removal criteria and conclusion as regards removal  
Data quality for tri-allate is good; both removal criteria are fulfilled.  
Tri-allate can be removed from the WL.  
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1. Introduction 
The Water Framework Directive’s (WFD) surface water Watch List (WL) mechanism was 
established in 2013 under the Priority Substances Directive 2008/105/EC (as amended 
by Directive 2013/39/EU). The WL is a mechanism to gather high-quality Union-wide 
monitoring data for the purpose of supporting future prioritisation exercises by 
investigating whether the selected chemicals pose a significant risk across the European 
Union’s river basins.  
The first WL was established by Commission Implementing Decision (EU) 2015/495 in 
March 2015. It includes 10 substances or groups of substances (amounting to 17 
individual substances) which must be monitored by the EU Member States (MS) at least 
once annually at a minimum number of monitoring sites in each country. Substances 
may remain on the WL for up to four years at a stretch, but may be removed sooner, 
even after only one year, if a decision can already be made on the level of risk they pose. 
At that point, they could be identified as not posing a significant risk at EU-level 
(although they could still be relevant at national or river-basin level) or be prioritised for 
inclusion under WFD as priority substances (EU, 2015).  
The first year of WL monitoring began six months after the list was established (therefore 
on 20th September 2015), and MS had to report the results to the European Commission 
(EC) by December 2016.  
The 10 substances/groups of substances included in the first WL are shown in Table 2, 
together with their CAS numbers, substance type, and corresponding Predicted No Effect 
Concentration (PNEC) or Environmental Quality Standard (EQS). The table also presents 
the recent update of PNEC (or EQS) values, including the source of these proposals, for 9 
WL substances.  
The first WL includes 3 groups of substances: a group of two natural hormones, five 
neonicotinoid insecticides, and three macrolide antibiotics. For the group of neonicotinoid 
insecticides (code EEA_33-52-3) and macrolide antibiotics (code EEA_33-51-2) all MS 
provided the analytical results for the individual substances and not for the sum of group 
of substances. 
In this report WL substances are evaluated using STE (Spatial, Temporal and Extent of 
PNEC exceedance) assessment tool (STE is shortly explained in Annex 1) considering two 
sets of PNEC values:  
- PNECs from the 2015 JRC report entitled "Development of the 1st Watch List under the 
Environmental Quality Standards Directive" by Raquel N. Carvalho, Lidia Ceriani, Alessio 
Ippolito and Teresa Lettieri. These will be called the "2015 PNECs" 
- updated/revised PNECs, coming from the last prioritisation exercise and/or the 
additional information received from Switzerland, Germany, and the Netherlands. These 
will be called "updated PNECs". 
Thereafter, following the established practice in chemical risk assessment (Carvalho et 
al., 2016), three data scenarios were considered when the STE model was run (see 
details in Table 3). Scenario 1 (Sc1) includes only quantified samples while Scenario 2 
(Sc2) comprises all monitoring records. In Sc2 the non-quantified samples were set equal 
to half of LOQ as stipulated in Directive 2009/90/EC. The scenario indicated as Sc3 
(quantified monitoring samples plus non-quantified when ½ LOQ ≤ PNEC) actually was 
called Sc2-PNEC-QC in the monitoring based prioritisation report (Carvalho et al., 2016). 
The so-called “PNEC quality criteria” reduces the Sc2 data set to the Sc3 subset by 
removing the non-quantified records which are above the limit of 2*PNEC. However, 
according to the decisions of the SG-R (sub-group on revision of the priority substances 
list), Sc3 was deemed to be the most relevant scenario to consider during the 
prioritisation and the one being the basis for the decisions taken. Following this concept 
the WL substances were also evaluated using Sc3 data subset. 
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Table 2: Watch list substances with CAS and PNEC values. 
Substance Substance type CAS 
PNEC 
WL 2015 
(µg/L) 
PNEC 
update 
(µg/L) 
17-alpha-Ethinylestradiol 
(EE2) 
Synthetic estradiol 
hormone 
57-63-6 0.000035 
(1)  
17-beta-Estradiol (E2) 
Natural female sex 
hormone 
50-28-2 0.0004 
(1)  
Estrone (E1) Hormone 53-16-7 0.0036 
(1) 
 
Diclofenac 
Non-steroidal anti-
inflammatory drug 
(NSAID) 
15307-86-5 0.1 
(1) 
 
0.05 
(4,6)
 
2,6-Di-tert-butyl-4-
methylphenol 
Antioxidant 
128-37-0 3.16 
(2)
 
 
2-Ethylhexyl 4-
methoxycinnamate 
Sunscreen ingredient / 
UV filter 
5466-77-3 
6.0 
(2)
 
200 µg/kg 
(3) 
(sediment) 
 
Erythromycin Macrolide antibiotic 114-07-8 0.2 
(2)
  
Clarithromycin Macrolide antibiotic 81103-11-9 0.13 
(2)
 0.12
(5)
 
Azithromycin Macrolide antibiotic 83905-01-5 0.09 
(2)
 0.019
(5)
 
Methiocarb 
Carbamate insecticide 
and herbicide 
2032-65-7 0.01 
(2)
 0.002
(4,7)
 
Oxadiazon Herbicide 19666-30-9 0.088 
(2)
  
Triallate Herbicide 2303-17-5 0.67 
(2)
 0.41
(4)
 
Imidacloprid 
Neonicotinoid insecticide 105827-78-9 
/138261-41-3 
0.009 
(2)
 0.0083
(4)
 
Thiacloprid Neonicotinoid insecticide 111988-49-9 0.05 
(2)
 0.01
(4)
 
Thiamethoxam Neonicotinoid insecticide 153719-23-4 0.14 
(2)
 0.042
(5)
 
Clothianidin Neonicotinoid insecticide 210880-92-5 0.13 
(2)
  
Acetamiprid 
Neonicotinoid insecticide 135410-20-7 
/160430-64-8 
0.5 
(2)
 
 
PNECs taken from:  
(1) Commission’s priority substances proposal from the year 2012 (EU, 2012).  
(2) (Carvalho et al. 2015).  
(3) Sediment PNEC (Carvalho et al. 2015) 
(4) Monitoring-based prioritisation report (Carvalho et al., 2016) 
https://circabc.europa.eu/w/browse/52c8d8d3-906c-48b5-a75e-53013702b20a)  
(5) Oekotoxzentrum Centre Ecotox, 2016  
(6) EQS Datasheet, Environmental Quality Standard, Diclofenac, German Environment Agency 
(UBA), 2017  
(7) Ctgb (The Netherlands), 2010. SEC Adviesrapport 12707A01, Methiocarb, Afleiding van het MTR-
water. Scheepmaker JWA. 24478-MTR. October 2010. 
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Table 3: Data scenarios used to score substances with the STE method. The scenario indicated as 
Sc3, actually was called Sc2-PNEC-QC in the monitoring based prioritisation exercise (Carvalho et 
al., 2016). 
Data scenario Description 
Scenario 1 (Sc1) Only quantified monitoring samples 
Scenario 2 (Sc2) 
All monitoring samples (quantified and non-quantified).  
In Sc2 the non-quantified samples were set equal to half of LOQ as 
stipulated in Directive 2009/90/EC 
Scenario 3 (Sc3) 
Quantified monitoring samples plus non-quantified when ½ LOQ ≤ 
PNEC (or EQS) 
(worked out from Sc2 by applying PNEC quality criterion to the 
non-quantified samples) 
 
In the last prioritisation exercise a set of minimum representativity criteria were used to 
determine whether sufficient monitoring data were available to carry out an STE analysis: 
at least 51 samples should be available from minimum 10 sites and at least 4 MS. Since 
the WL dataset comprises a considerable amount of measurements from almost all MS, 
expectedly the aforementioned criteria were always fulfilled in Sc2 and Sc3 (for details 
see Annex 3).  
The purpose of this report is to:  
 present an overview of the data gathered during the 1st year of monitoring of the 
1st WL (also called WL dataset in this report), 
 assess whether this WL dataset is sufficient to determine the risk posed by the WL 
substances, and consequently to determine whether any of these substances can 
be taken out of the WL,  
 propose new substance(s) to be included in the second WL, using the 
information and results from the latest review of the list of priority substances, as 
well as any other relevant information available at the time of this report. 
 
Chapters 2 to 6 present the analysis of the 1st year of monitoring data for the 
first WL. More precisely chapter 2 starts with a presentation of the WL dataset including 
general information and basic statistical analyses for the number of sites and samples. 
Chapter 3 continues with the additional analyses for WL dataset on the number of WL 
substances measured per country, months with measurements in each MS, the frequency 
of sampling and the nearby pressure information. Chapter 4 shows findings on the data 
quality. Chapter 5 presents the measured concentrations of WL substances comparing to 
both sets of PNEC values (from 2015 and updated ones). Then, the STE scores of WL 
substances are shown in chapter 6 calculated using the WL dataset.  
Chapter 7 (discussion) shows the review of the 1st WL and proposals for the 
second WL. Section 7.1 presents the criteria for the removal of a substance from the 
WL, and their implementation, leading to the proposed delisting of several of the 
substances currently in the 1st WL. Section 7.2 presents the criteria for adding new 
substances in the second WL, and the substances proposed on the basis of these criteria. 
The report includes also 9 annexes that show all supportive information in graphical or 
tabular form. 
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2. General analysis of WL dataset  
The EU Member States (MS) provided the WL monitoring data (mainly for surface water, 
to a limited extent for sediment) to the Commission by uploading them to the EEA WISE 
system using the new SoE (State of Environment) reporting template. All countries used 
the SoE data template for data submission. 
Most MS submitted data by the December 2016 deadline, but 3 MS - Spain (ES), Greece 
(EL), and Malta (MT) did not submit any monitoring records even by a later cut-off date 
(18 April 2017), put in place to allow timely analysis of the results and timely production 
of this report. However, if these countries report their disaggregated data for the 1st year 
of monitoring together with their data for the 2nd year of monitoring, ie by December 
2018, they will be used in the production of the next WL report. One EFTA country also 
proposed data, but only from one monitoring station and for 9 of WL substances (in total 
4717 samples). These data were excluded from the statistics for first WL in order to 
avoid “skewing” the results.  
In the individual country’s data sets submitted via the SoE data template, all non-
quantified samples (< LOQ) were reported as equal to LOQ, in line with the requirements 
of the data dictionary http://dd.eionet.europa.eu/datasets/latest/WISE-
SoE_WaterQuality. These non-quantified samples are set for the statistics and STE runs 
as half of their LOQ (LOQ/2) according to Directive 2009/90/EC (EU, 2009).  
Five MS submitted monitoring data for sediment and one for suspended particulate 
matter (SPM). A summary of these data is presented in Annex 2. Substances detected in 
sediment were 2-ethylhexyl-4-methoxycinnamate (countries #07, #09 and #29), 
clarithromycin (detected only in the country #06; it was analysed in 2 MS), and 
diclofenac (only once detected in the country #06; analysed in 2 MS). Country #6 
analysed clarithromycin, diclofenac, erythromycin, and triallate in SPM, but only 
clarithromycin was detected. Thus, the sediment and SPM data were not considered in 
the STE (Spatial, Temporal and Extent of PNEC exceedance) assessment since they do 
not fulfil the minimum representativity criteria (sufficient number of countries, sites and 
samples). The maximum concentration detected for 2-ethylhexyl-4-methoxycinnamate in 
sediment was 35 µg/kg (considerably below the PNEC of 200 µg/kg). 
 
2.1 Basic information 
The analyses of first WL dataset are based on the data from 25 EU countries, with a total 
number of 35848 surface water samples in Sc2. The vast majority of these records are 
from river water samples (98.3%) but there are a few measurements for lakes (1.2%) 
and coastal/transitional water (0.5%). After the application of the PNEC quality criterion 
(explained in the chapter 2) the total amount of samples is reduced by 9.4% to 32482 
records in Sc3. 
Figure 1 shows in green colour the 25 countries which reported disaggregated data from 
the 1st year of WL monitoring (i.e. contributed to the WL dataset). The statistics per 
substance, about number of countries that reported measurements in all data scenarios, 
is shown in Annex 3. Only for information, for data in Sc1 one substance (methiocarb) 
did not pass the minimum representativity criterion for the number of countries with 
measurements. 
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Figure 1: Map of countries having provided data for the first WL. 
 
Conclusions:  
Three MS did not report any disaggregated monitoring data for the first year of WL 
monitoring. 
The analyses of first WL dataset are based on the data from 25 EU countries, with a total 
number of 35848 surface water samples for data in Sc2.  
The vast majority of the sampling records in Sc2 of the WL dataset are from river water 
samples (98.3%). 
There are a few measurements for lakes (1.2%) and coastal/transitional water (0.5%) in 
Sc2 of the WL dataset. 
Insufficient sediment data were submitted for statistical analysis to be possible in Sc2 of 
the WL dataset. 
 
2.2 Analysis by the number of sites 
Figure 2 shows the number of monitoring sites (sampling stations) per substance for data 
of Sc2 (see details in Annex 3). Most of the substances were sampled at between 300 
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and 400 locations. The lower number of observation stations (201) is shown by 2-
ethylhexyl-4-methoxycinnamate while diclofenac is the uppermost (608 sites). Thus, a 
sufficient number of sites for statistical analyses is available since when considering 
together the quantified and non-quantified samples for data in Sc2 all substances were 
measured at more than 200 sites. 
 
 
Figure 2: Number of monitoring sites per substance (Sc2).  
 
Figure 3 displays the number of monitoring sites per country for dataset in Sc2 of the WL 
dataset. For most of the countries the number of monitoring sites has a range from 10 to 
50. The country #21 has measured at smallest number of stations (2). The highest 
number of sites was reported by the country #06 (497) and the country #29 (53).  
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Figure 3: Number of sites (in logarithmic scale) per country (Sc2). 
 
For monitoring data of Sc3, corresponding to the 2015 PNECs (see Annex 3.1) the 
statistical analysis of measurements for the WL substances evidenced that the lower 
number of monitoring sites is 123 (17-alpha-ethinylestradiol). For updated PNECs see 
details in Annex 3.2. Only for information, for data in Sc1 one substance (methiocarb) 
did not pass the minimum representativity threshold because it was quantified (or 
detected) above the LOQ only at 4 sites; in addition, acetamiprid was observed at the 
lower number of 10 sites.  
 
Conclusions:  
The reported monitoring data in Sc2 and Sc3 (corresponding to the 2015 PNECs) of the 
WL dataset contain a sufficient number of sites for statistical analyses since all 
substances were measured at more than 100 sites (Sc3). The analysis for Sc3 with the 
updated PNECs is presented in Annex 3.2.  
 
2.3 Analysis by the number of samples 
The total number of samples submitted up to the cut-off date (18 April 2017) was 35848 
for surface water data of Sc2 (all monitoring records).  
Figure 4 shows that for Sc2 the total number of samples per substance is ranging from 
546 for 2-ethylhexyl-4-methoxycinnamate up to 6698 for diclofenac (see details in Annex 
3). For most of the substances the range of the total number of samples is between 
1000-3000.  
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Figure 4: Number of samples per substance (Sc2). 
 
For data of Sc3 (based on the 2015 PNECs) the statistical analysis (see Annex 3.1) 
showed that the lower number of monitoring samples is 226 (17-alpha-ethinylestradiol) 
and highest is 6698 (diclofenac). For updated PNECs see Annex 3.2. However, in Sc1 two 
substances have just a few samples (acetamiprid and methiocarb with 15 and 6 
quantified samples, respectively) and among the other substances 2,6-di-tert-butyl-4-
methylphenol was the lower observed with 57 quantified samples.  
 
Figure 5 shows the total number of water samples per country for data of Sc2. Most of 
the countries have reported less than 1000 samples, with the exception of the countries 
#06 (25221; plus 582 samples for SPM and 290 for sediment), #07 (2279), #26 (2263), 
and #13 (1454). For the period 2014-2016 the amount of samples reported by one MS 
(#06) is about 70.4% of the total number of the collected samples. Seven countries 
(#15, #17, #20, #21, #22, #28, and #31) have reported less than 100 samples.  
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Figure 5: Number of samples (in logarithmic scale) per country (Sc2). 
 
Figure 6 shows the number of samples per year for data of Sc2. Most of the samples 
reported are from the year 2016 (26056; 72.7% from the total number of samples), 
6470 samples (18.1% from the total) are taken in the year 2015, and 3322 samples 
(9.2% from the total) are from the year 2014.  
 
 
Figure 6: Number of samples per year (Sc2). 
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Figure 7 shows the number of samples per month and gives an idea about seasonality of 
the monitoring for data of Sc2 (on the figure January is indicated as 1, February by 2, 
etc.). In fact, most of the samples were taken between February and November. The 
peak of sampling is observed in the months of May and June. 
 
 
Figure 7: Number of samples per month (Sc2; January is indicated as 1, February by 2, etc.). 
 
Conclusions:  
In Sc2 and Sc3 (based on 2015 PNECs) all substances showed a sufficient amount of 
samples for statistical analyses since in Sc3 the minimum number of monitoring samples 
is 226 (17-alpha-ethinylestradiol). The analysis for Sc3 with the updated PNECs is 
presented in Annex 3.2. 
The peak of WL sampling is observed in the months of May and June. 
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3. Additional analysis of WL dataset 
3.1 Number of measured substances per country 
Figure 8 shows the number of measured substances per country (Sc2). Nearly all 
countries reported measurements for all 17 substances of the first WL. The country #27 
did not measure estrone (E1), and country #28 measured only 17-alpha-ethinylestradiol, 
17-beta-estradiol and diclofenac.  
 
 
Figure 8: Number of measured substances per country (Sc2).  
 
3.2 Months with measurements in each country 
Figure 9 shows the months with measurements in each country of Sc2. For example, MS 
#01 has measured in all months from April to December (i.e. 9 months). The total 
number of months with sampling per country is indicated at the lowermost line of the 
figure. One MS (#17) reported samples only for one month. Several MS measured in two 
(#09, #12, #16, and #27), three (#03, #20, and #24) or four (#08, #11, #21, #30 
and #31) months. Five MS (#02, #06, #07, #13, and #19) monitored in 11 or 12 
months. This may not necessarily reflect that all WL substances have been measured in 
that frequency in a given country. 
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Figure 9: Months with measurements per country (Sc2; January is indicated as 1, February by 2, 
etc.). The total number of months with sampling per country is indicated at the lowermost line of 
the figure. 
 
3.3 Ratio of number of samples and amount of sampling sites 
Figure 10 shows per substance the ratio between the total number of samples and the 
total number of sampling sites for data in Sc2. For all substances the ratio is higher than 
2 (maximum equals to 11) showing on average a sufficient frequency of sampling per 
site which supports the applicability of the STE method (in particular the Temporal 
factor). 
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Figure 10: Ratio of number of samples and amount of sampling sites (Sc2). 
 
3.4 Nearby pressure information 
Article 8b of Directive 2013/39/EC states that “Member States shall monitor each 
substance in the watch list at selected representative monitoring stations over at least a 
12-month period. In selecting the representative monitoring stations, the monitoring 
frequency and timing for each substance, Member States shall take into account the use 
patterns and possible occurrence of the substance. The frequency of monitoring shall be 
no less than once per year.” 
Accordingly, the MS have selected the monitoring stations representative of agricultural, 
urban, industrial pressures or a combination of these 3 types (and in addition in some 
cases “bathing water” for the sunscreen ingredient). However, only 12 MS reported the 
pressure information for the WL monitoring stations. 
Some MS have provided additional information on the representativity of the monitoring 
stations and monitoring strategy. One MS stated for example: “The monitoring sites are 
selected in the vicinity of nearby pressures, but outside mixing zones and therefore the 
monitoring data reflect pressures realistically”. Another MS stressed: “The selected 
monitoring stations are affected by either agricultural runoff or discharge from municipal 
wastewater treatment plants (MWTP) or by both”. However, some MS have selected 
monitoring stations with low pressures (e.g. “at the end of the main rivers / catchment 
areas” (#28), or in big catchments) which are obviously not expected to show 
exceedances. Only one MS provided in their sampling strategy detailed information on 
the timing of sample collection.  
Figure 11 displays the number of monitoring sites and the amount of samples under 
different types of relevant anthropogenic nearby pressures for data of Sc2. 
Unfortunately, for most of the sites (75.3%) and samples (79.3%) this information was 
not reported by MS. However, since a huge part of them (for instance 88.8% of the total 
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number of samples that missing pressure information) is from one MS (#06) this allows 
to making a relevant EU assessment. Most of the reported nearby pressures are defined 
as “agricultural” or “urban with WWTP impact”. 
For instance, considering the sunscreen ingredient 2-ethylhexyl-4-methoxycinnamate 
only 3 MS (#08, #22, and #29; all 3 are northern countries) have given the nearby 
pressure information “bathing site” for a total of 28 samples, which makes a correct data 
interpretation difficult.  
The detailed graphical information (box-plots of concentrations) about the nearby 
pressures per substance is provided in Annex 7.1 (data in Sc3 and updated PNECs). 
 
 
(a) 
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(b) 
Figure 11: Number of monitoring sites (a) and the amount of samples (b) under different types of 
anthropogenic pressures (data in Sc2; the vertical axes are in Log scale).  
 
Conclusions: 
Two countries reported measurements not for all 17 substances of the first WL. The 
country #27 did not measure estrone (E1), and country #28 measured only 17-alpha-
ethinylestradiol, 17-beta-estradiol and diclofenac. 
For all substances the ratio between the total number of samples and the number of 
sampling sites is higher than 2 (maximum equals to 11) showing (on average) a 
sufficient frequency of sampling per site which supports the applicability of the Temporal 
factor of the STE method (Sc2).  
For most of the sites (75 %) and samples (79 %) the anthropogenic nearby pressures 
were not reported by MS. However, since a huge part of them (for instance 88.8% of the 
total number of samples that missing pressure information) is from one MS (#06) that 
still allows to making a relevant EU assessment (Sc2). 
In the first year of monitoring for the WL some MS have selected monitoring stations 
with low pressures (e.g. at the end of the main rivers / catchment areas or in big 
catchments) which are obviously not expected to show exceedances. 
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4 Data quality in WL dataset 
Generally, the reporting and data quality in the first WL campaign is better compared to 
the quality of monitoring data collected in the last prioritisation exercise. As a result the 
processing of data has been faster and no outliers have been found in the first WL 
dataset.  
 
4.1 Percentage of quantified samples 
Figure 12 shows for Sc2 the percentage of quantified samples (measured concentration > 
LOQ) as a part from the total number of samples for the WL substances. For information 
the amount of these samples per substance is given at the lowermost line of the figure. 
Clarithromycin, diclofenac and estrone have a quantification frequency above 50%. 
Substances with a low quantification frequency (<10%) are listed in Table 4. Among 
them two substances (acetamiprid and methiocarb) have just a few quantified records 
and a very low percentage of quantification (below 1%).  
All substances, except acetamiprid and methiocarb, have more than 51 quantified 
samples but 4 of them have less than 100 quantified measurements. Diclofenac and 
clarithromycin have a very high amount of quantified samples (4602 and 1642, 
respectively).  
 
 
Figure 12: Percentage of quantified samples as a part from the total number of samples per 
substance (Sc2). The amount of quantified samples per substance is given at the lowermost line of 
the figure. 
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Table 4: Substances with quantification frequency (percentage of quantified samples from the total 
number of samples) below 10% (Sc2). Acetamiprid and methiocarb have just a few quantified 
records and a very low percentage of quantification (below 1%). 
 
Substance 
Quantification frequency (%) 
(the amount of quantified samples 
is given in brackets) 
2,6-Di-tert-butyl-4-methylphenol 5.5 (57) 
Acetamiprid 0.67 (15) 
Methiocarb 0.33 (6) 
Clothianidin 9.6 (217) 
Erythromycin 8.4 (211) 
Thiacloprid 4.3 (97) 
Thiamethoxam 6.4 (256) 
Oxadiazon 4.2 (77) 
Triallate 6.4 (138) 
 
 
4.2 Analysis of LOQs for the non-quantified samples 
Firstly, Figure 13 compares per substance the range of LOQs (all countries together) with 
PNEC values from the WL report 2015 for the non-quantified samples in Sc2. The amount 
of non-quantified samples per substance is given at the lowermost line of the figure. It 
appears that for 17-alpha-ethinylestradiol (EE2) nearly all LOQs are above the PNEC of 
0.000035 µg/L, indicating that it was very difficult for the laboratories to achieve the low 
PNEC of EE2. For 17-beta-estradiol (E2) around half of the LOQs are above the PNEC of 
0.0004 µg/L. For estrone (E1), most of the LOQs are below the PNEC of 0.0036 µg/L. For 
imidacloprid (PNEC 0.009 µg/L) and methiocarb (PNEC 0.01 µg/L) around half of the 
LOQs are above the PNEC of these substances, showing that some MS had problems in 
achieving the PNEC values.  
Thus, the first conclusion for data quality is that the results for the above-mentioned 
substances potentially have to be interpreted with care. All other substances were 
monitored by nearly all laboratories with analytical methods that “fit for purpose” (LOQ 
below PNEC). 
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Figure 13: Range of LOQs for the non-quantified samples (in Sc2) per substance compared to PNEC 
values from the WL report 2015. The amount of non-quantified samples per substance is given at 
the lowermost line of the figure. 
 
On the other hand, Figure 14 shows that for most of the WL substances in Sc2 data, the 
percentage of non-quantified samples with the 0.5*LOQ≤PNEC is more than 90%. The 
amount of these samples is given per each substance at the lowermost line of the figure. 
Indeed, only 3 substances that have very low PNECs showed relatively lower percentages 
of the non-quantified samples with 0.5*LOQ≤PNEC (17-alpha-ethinylestradiol with 
50.6%; 17-beta-Estradiol with 72.8% and imidacloprid with 72.5%). Thus, for them an 
eventual difference between the STE scores for the different data scenarios could be 
anticipated. However, we could conclude, that although some problems in the analytical 
methods for 3 out of 17 substances exist (not sensitive enough to reach always PNEC), 
practically all substances have a sufficient number of samples with a good quality for 
making statistical analyses (the minimum is 241 samples for EE2). 
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Figure 14: Percentage of non-quantified samples with 0.5*LOQ≤PNEC (in Sc2). The amount of 
these samples is given per each substance at the lowermost line of the figure. PNEC values 
correspond to the WL report 2015. 
 
 
Additionally, for the WL substances with a reduced data quality a summary of the LOQ 
analysis regarding the achievement/non-achievement of PNEC value by country is 
presented below (for details see Annexes 4.1-4.5).  
17-alpha-Ethinylestradiol (EE2) 
A more detailed analysis of the LOQs for EE2 (non-quantified samples) showed that 4 MS 
achieved an LOQ of 0.03 ng/L (for 172 samples) which is below the PNEC (0.035 ng/L) 
(Annex 4.1). Other 4 countries reached an LOQ of 0.035 ng/L (for 57 samples), equal to 
the PNEC; 4 other countries have an LOQ of 0.1 ng/L (for 70 samples). There are 
however 12 countries with an LOQ clearly not sufficient for the low PNEC of 0.035 ng/L 
(for 247 samples).  
17-beta-Estradiol (E2) 
Annex 4.2 shows that for E2 most non-quantified samples have an LOQ ≤ the PNEC of 
0.4 ng/L (360 out of 497 samples). The LOQs range from 0.03 – 25 ng/L. There are 16 
countries which achieve with their analytical method the PNEC of E2, and 8 countries 
with higher LOQs.  
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Imidacloprid 
Annex 4.4 shows the detailed analysis of the LOQs for imidacloprid (non-quantified 
samples); the LOQs range between 0.0006 - 0.05 µg/L. Most of the countries have 
reported for most of their samples an LOQ of 0.009 µg/l (123 samples in 8 countries) or 
0.01 µg/l (1070 samples in 8 countries) which is equal (or nearly equal) to the proposed 
PNEC of 0.009 µg/L. There are however 11 laboratories (note that some MS report 
different LOQs from different laboratories) with 687 samples which do not achieve the 
PNEC.  
 
Secondly, for Sc2 of WL dataset, Figure 15 shows a comparison of LOQs with the updated 
PNEC values while Figure 16 presents the percentage of non-quantified samples with 
0.5*LOQ≤PNEC. The check of the WL dataset quality versus the updated PNECs showed 
that lower LOQs would be necessary also for azithromycin and methiocarb (imidacloprid 
is already flagged) to achieve these PNECs in addition to 3 substances identified for the 
PNECs of 2015. 
Finally, we got an equivalent result when compared LOQs to the maximum acceptable 
method detection limit (according to Commission Implementing Decision EU/2015/495) 
as shown in Annex 4.6. 
 
 
 
Figure 15: Range of LOQs for the non-quantified samples per substance compared to updated 
PNEC values (WL dataset in Sc2; only substances with the modified PNECs are shown). The amount 
of non-quantified samples per substance is given at the lowermost line of the figure. 
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Figure 16: Percentage of non-quantified samples with 0.5*LOQ≤PNEC for WL dataset in Sc2 and 
updated PNECs (only substances with the modified PNECs are shown). The amount of these 
samples is given per each substance at the lowermost line of the figure.  
 
4.3 Analytical methods 
Exact methodological details (extraction volume; extraction method, clean-up; analytical 
instrument) on the analytical methods used for the analysis of the WL substances were 
provided by very few MS.  
One MS (#22) which achieved the low PNEC of 0.000035 µg/l for EE2 has given the 
information to have extracted only 400 mL of water by liquid-liquid extraction and to 
have used a GC-MS-MS instrument of the latest generation (the derivatisation followed 
EPA Method 1698 (trimethylsilyl-ether) (Loos, 2015). In addition, country #26 has 
achieved for EE2 an LOQ of 0.00003 µg/l by the use of a SPE-GC-MS-MS method; no 
analytical details were however given. 
Another MS (#19) which achieved the low PNEC of 0.000035 µg/l for EE2 has extracted 1 
L of water by solid-phase extraction (SPE) with Oasis HLB cartridges followed by LC-MS-
MS analysis.  
It is therefore not totally clear why other MS could not reach the low PNEC of EE2. One 
possible solution to overcome the analytical difficulties for measuring E2, EE2 could be 
that MS which could not reach the PNEC values, could ask support to the MS having 
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successfully measured those substances. It would help to really understand if E2 and EE2 
pose a risk at European level.  
 
 
Conclusions (WL dataset and updated PNECs): 
Nine out of 17 substances have a quantification frequency below 10 % for Sc2 and Sc3 
(these substances are listed in Table 4). Among them acetamiprid and methiocarb have a 
very low quantification rate (less than 1%) and just a few quantified records.  
Three substances (clarithromycin, diclofenac and estrone) have a detection frequency 
above 50% (for Sc2 and Sc3).  
Practically all WL substances have in Sc3 and Sc2 a sufficient number of samples with 
good quality for making statistical analyses and STE applications, however, some MS had 
analytical problems to reach always the PNEC values for 5 out of 17 substances (EE2, E2, 
imidacloprid, azithromycin, and methiocarb). 
One possible solution to overcome the analytical difficulties could be that MS that did not 
reach the PNEC values may ask support to the MS having successfully measured those 
substances. This would help to really understand if these substances pose a risk at 
European level. 
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5 Concentrations of WL substances by WL dataset 
This section provides a summary-table of the monitored concentrations of WL substances 
in all data scenarios but visualises the concentrations by box-whisker plots only for Sc3 
(PNECs either from the WL report 2015 or the updated ones). The detailed tabular 
statistics of the monitored concentrations of WL substances are given in Annex 3. In 
addition the information about the seasonal variability of WL substances and their 
concentrations per county is presented in Annex 7.2. 
A box-whisker plot is a convenient way of graphically describing numerical data through 
their quartiles. The limits of the boxes represent the 25th and 75th percentiles while the 
line inside the each box specifies the median of the observed concentrations. Box-plots 
may also have lines extending vertically from the boxes (whiskers) indicating variability 
outside the upper and lower quartiles (spreading of data). The remote values are plotted 
as individual points.  
 
5.1 PNECs from WL report 2015 
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Table 5 gives a summary of the concentration statistics for the WL substances and PNECs 
from WL report 2015.  
It shows that the European median surface water concentration of EE2 is higher than the 
PNEC (0.035 ng/l) in the data scenarios Sc1 (0.1 ng/l) and Sc2 (0.05 ng/l); in Sc3 the 
median (0.015 ng/l) is lower than the PNEC.  
The median concentration of diclofenac is between 0.027 µg/l (Sc3 and Sc2) and 0.047 
µg/l (Sc1), of azithromycin 0.022 (Sc3 and Sc2) and 0.023 µg/l (Sc1), clarithromycin 
0.016 (Sc3 and Sc2) and 0.034 µg/l (Sc1), and erythromycin 0.005 (Sc3 and Sc2) and 
0.026 µg/l (Sc1).  
The median concentration of imidacloprid exceeds its PNEC (0.009 µg/l) only in Sc1 
(0.018 µg/l), but not in Sc2 (0.005 µg/l), or Sc3 (0.005 µg/l). 
Figure 17 shows a box-whisker plot for the concentrations of the WL substances in Sc3 
comparing to their PNEC values according the WL report 2015. The lowermost line of the 
figure indicates the total number of samples per substance.  
The box-whisker plots for data of Sc2 and Sc1 are given in the Annex 3.1. 
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Table 5: Summary statistics of concentrations for the WL substances considering all data scenarios 
and PNECs (or EQS) from WL report 2015 (µg/l). 
Substance Scenario Samples PNEC Median Mean P95 Max 
17-alpha-
Ethinylestradiol 
Sc1 82 
0.000035 
0.00010 0.00023 0.00078 0.0030 
Sc2 558 0.00005 0.00055 0.0010 0.0125 
Sc3 323 0.000015 0.00007 0.00026 0.0030 
17-beta-Estradiol 
Sc1 101 
0.0004 
0.00021 0.00041 0.00130 0.0030 
Sc2 597 0.00017 0.00059 0.00150 0.0125 
Sc3 461 0.00015 0.00020 0.00051 0.0030 
Estrone 
Sc1 313 
0.0036 
0.00064 0.0015 0.0050 0.031 
Sc2 574 0.00050 0.0013 0.0050 0.031 
Sc3 552 0.00050 0.0010 0.0035 0.031 
Diclofenac 
Sc1 4602 
0.1 
0.047 0.093 0.34 2.6 
Sc2 6698 0.027 0.067 0.26 2.6 
Sc3 6697 0.027 0.067 0.26 2.6 
2,6-Di-tert-butyl-4-
methylphenol 
Sc1 57 
3.16 
0.018 0.512 0.26 14.0 
Sc2 1035 0.0050 0.10 0.25 14.0 
Sc3 1032 0.0050 0.088 0.25 14.0 
2-Ethylhexyl-4-
methoxycinnamate 
Sc1 116 
6.0 
0.305 0.420 1.4 1.8 
Sc2 546 0.050 0.367 3.0 9.0 
Sc3 543 0.050 0.319 3.0 3.0 
Erythromycin 
Sc1 211 
0.2 
0.026 0.060 0.20 1.1 
Sc2 2520 0.0050 0.012 0.028 1.1 
Sc3 2520 0.0050 0.012 0.028 1.1 
Clarithromycin 
Sc1 1642 
0.13 
0.034 0.073 0.28 1.6 
Sc2 2792 0.016 0.047 0.17 1.6 
Sc3 2792 0.016 0.047 0.17 1.6 
Azithromycin  
Sc1 265 
0.09 
0.023 0.062 0.25 1.0 
Sc2 1553 0.022 0.030 0.055 5.0 
Sc3 1551 0.022 0.023 0.053 1.0 
Methiocarb 
Sc1 6 
0.01 
0.028 0.040 0.090 0.109 
Sc2 1834 0.0050 0.0061 0.010 0.109 
Sc3 1798 0.0050 0.0059 0.010 0.109 
Imidacloprid 
Sc1 421 
0.009 
0.018 0.031 0.082 1.05 
Sc2 2385 0.0050 0.011 0.027 1.05 
Sc3 1830 0.0050 0.011 0.033 1.05 
Thiacloprid 
Sc1 97 
0.05 
0.015 0.026 0.079 0.57 
Sc2 2243 0.0050 0.0068 0.010 0.57 
Sc3 2243 0.0050 0.0068 0.010 0.57 
Thiamethoxam 
Sc1 256 
0.14 
0.015 0.032 0.123 0.77 
Sc2 4020 0.0050 0.0076 0.013 0.77 
Sc3 4020 0.0050 0.0076 0.013 0.77 
Clothianidin 
Sc1 217 
0.13 
0.016 0.044 0.173 0.78 
Sc2 2254 0.0050 0.011 0.033 0.78 
Sc3 2221 0.0050 0.011 0.033 0.78 
Acetamiprid 
Sc1 15 
0.5 
0.0090 0.014 0.045 0.074 
Sc2 2221 0.0050 0.0067 0.010 0.074 
Sc3 2221 0.0050 0.0067 0.010 0.074 
Oxadiazon 
Sc1 77 
0.088 
0.010 0.023 0.071 0.31 
Sc2 1849 0.0050 0.011 0.040 0.31 
Sc3 1847 0.0050 0.011 0.040 0.31 
Triallate  
Sc1 138 
0.67 
0.022 0.037 0.113 0.270 
Sc2 2169 0.0050 0.015 0.035 0.945 
Sc3 2166 0.0050 0.014 0.033 0.335 
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Figure 17: Box-plot of concentrations (log scale) for WL substances (Sc3) comparing to the PNEC 
values from the WL report 2015. The lowermost line of the figure indicates the total number of 
samples per substance. 
 
 
5.2 Updated PNECs 
Figure 18 shows a box-whisker plot for the concentrations of WL substances in samples 
of Sc3 in comparison to the updated PNEC values. The lowermost line of the figure 
indicates the total number of samples per substance. Attention should be paid on the 
changes for some substances (for instance the number of samples, PNECs, etc.) when 
applying the updated PNECs. 
The box-whisker plots for data of Sc2 and Sc1 are given in the Annex3.2. 
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Figure 18: Box-plot of concentrations (log scale) for WL substances (Sc3) comparing to the 
updated PNEC values (only substances with the modified PNECs are shown). The lowermost line of 
the figure indicates the total number of samples per substance. 
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6 STE scores of WL substances by WL dataset 
 
For the evaluation of the risk of the WL substances the STE assessment tool was run for 
monitoring data in all data scenarios (Sc1, Sc2 and Sc3) and diverse PNEC values (WL 
report 2015 and the updated PNECs). However, following the established practice of the 
sub-group on revision of the priority substances list, Sc3 is considered as the most 
relevant scenario for making assessments. The risk is quantified according to 5 levels of 
the STE scores as follows: very high 2.4-3; high 1.8-2.4; intermediate 1.2-1.8; low 0.6-
1.2; very low 0.0-0.6)11.  
 
6.1 PNECs from 2015 
The tabular comparison of STE scores calculated by the three data scenarios is presented 
in Annex 5.1 together with the additional specific information about the individual STE 
factors in scenario Sc3.  
Figure 19 presents the STE scores for Sc3 and Sc2 with the PNECs from the WL report 
2015. All scores in Sc3 are below 1. The Sc2 leads usually to higher STE results. This is 
explained by the assignment in Sc2 of the artificial concentrations of ½ LOQ to all non-
quantified values, while part of these values are excluded from Sc3 (after the application 
of the PNEC quality criterion) if the analytical method is not able to detect the substance 
close to its PNEC. The biggest deviation between the scores for Sc3 and Sc2 was found 
mostly for substances that were already identified having a reduced data quality (see 
section 5). Expectedly, the results for Sc1 are higher comparing to the other two 
scenarios (Sc1 is not shown in the figure; see details in Annex 5.1).  
 
 
                                           
11 This cut-off threshold was used to reach a list of substances showing very high and high risk score, however 
it doesn't mean that substances with intermediate STE score may not pose a risk at EU-level. 
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Figure 19: Comparison of STE scores obtained for Sc2 and Sc3 of WL dataset (PNECs from WL 
report 2015). 
 
 
6.2 Updated PNECs 
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Figure 20 shows, on average, a small to medium increase of STE scores for diclofenac, 
azithromycin and thiacloprid after the application of the updated PNECs to the WL 
monitoring data in Sc3. The details for the scoring in all data scenarios and updated 
PNECs could be followed in Annex 5.2 in a tabular form.  
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Figure 20: Comparison of STE scores obtained using WL dataset in Sc3 scenario for 
different PNEC values (from WL report 2015 and updated ones). 
 
 
Conclusions: 
For the PNEC values from the WL report 2015, the STE scores in Sc3 are below 1 for all 
WL substances. The usage of data in Sc2 leads usually to higher STE results. The biggest 
deviation between the scores in Sc3 and Sc2 was found mostly for substances that were 
identified having a reduced data quality. 
There is on average, a small to medium increase of STE scores for diclofenac, 
methiocarb, azithromycin and thiacloprid after the application of the updated PNECs (WL 
dataset in Sc3).  
 
 
55 
7 Discussion  
7.1 Review of the 1st WL 
 
This section first proposes a set of criteria to determine whether there is enough, high-
quality EU-wide monitoring data to assess the risk posed by each WL substance. On this 
basis, a list of substances that can be taken out of the WL is then identified.  
 
7.1.1 Criteria for the removal of substances from the WL 
The EQS Directive states: “The Commission shall establish the first watch list by 14 
September 2014 and shall update it every 24 months thereafter. When updating the 
watch list, the Commission shall remove any substance for which a risk-based 
assessment as referred to in Article 16(2) of Directive 2000/60/EC can be concluded 
without additional monitoring data.”  
Respecting the requirements of the EQS Directive, the removal of the substances from 
the WL is determined by the high data quality which is defined by the following criteria 
(proposed by the JRC) and both of them have to be fulfilled: 
1. The ½ LOQ must be below or equal to the PNEC, for at least 90 % of the non-
 quantified samples in Sc2 (LOQ-PNEC criterion). 
2. Similarity of STE scores for Sc3 and Sc2 (no more than 15 % difference in STE 
 scores demonstrating no significant analytical problem with non-quantified 
 samples). 
Note: the difference of the STE scores is calculated as a percentage by the formula 
|STESc3 – STESc2| / STESc3 * 100 
 
Rationale behind the criteria: 
Criteria 1: As mentioned in the summary and in the introduction, scenario 3, which 
gathers non quantified samples with LOQ/2≤PNEC and quantified samples, is considered 
to be the most relevant scenario to assess the risk and to calculate the STE score. 
Criteria 1 ensures that most of the samples in scenario 2 (i.e. in the full dataset) are of 
sufficient quality to be included in scenario 3, and thus to assess the risk posed by the 
substance calculating its STE score. 
Criteria 2: Sc2 differs from Sc3 because Sc2 includes non-quantified samples for which 
LOQ/2>PNEC. As explained previously, these non-quantified samples are replaced by 
LOQ/2 in the calculation of the STE score thus leading to non-confirmed exceedances 
(concentrations above the PNEC). If the STE scores are similar in Sc2 and Sc3, this 
means that the non-quantified samples with a high LOQ (LOQ/2>PNEC), and the related 
"non-confirmed exceedances", have a relatively limited impact on the risk 
assessment/STE score for the substance. In other words, the datasets of Sc2 and Sc3 
have to be similar. This indicates overall reliability in the assessment based on the 
monitoring data. 
 
7.1.2 Implementation of the removal criteria on the WL dataset 
As explained earlier, the above criteria were implemented on the WL dataset with the 
updated PNEC values (see details in Table 7). We found that 10 substances fulfil both 
criteria simultaneously: diclofenac, clarithromycin, erythromycin, oxadiazon, tri-allate, 
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2,6-di-tert-butyl-4-methylphenol, acetamiprid, clothianidin, thiacloprid, and 2-ethylhexyl-
4-methoxycinnamate.12 
These results are confirmed when using the combined dataset and the updated PNEC 
(see details in Annex 6.2). The only difference lies in the fact that thiacloprid does not 
fulfil the above criteria when using the combined dataset, thus pointing to a lower quality 
of the combined dataset for this substance13. 
However to come to the final list of substances to be removed from the WL it should be 
noted and taken into account that: 
- Neonicotinoids and macrolide antibiotics were included as groups in the WL, and all 
substances in each of these groups can be monitored with the same analytical method, 
so it makes sense to keep them jointly in the WL. In addition, ongoing work at EU-level14 
may lead to a change in the conditions of approval of several of the neonicotinoids, thus 
possibly leading to substitution effects, and to changes in the risk posed by these 
substances. Consequently, the data collected so far under the WL may possibly not 
reflect the risk posed by the substances in the very near future, and it makes sense to 
keep them in the list to gather sufficient, high quality monitoring data to confirm the risk 
they pose.  
- As regards the sunscreen ingredient 2-ethylhexyl-4-methoxycinnamate, it is unclear 
how far the monitoring sites selected were representative of the relevant pressure 
(samples should be taken preferentially in the summer at bathing sites). Consequently 
more monitoring data, at the relevant sites and in the relevant period need to be 
gathered before its removal from the list can be confirmed. It is also worth noting that 
this substance was initially recommended for monitoring in sediment15, but that most 
data received were for water. The few sediment data reported to the JRC were not 
enough to carry out a conclusive analysis for that matrix. Consideration is being given to 
include several substances for sediment monitoring in a WL update in 2019. Therefore we 
propose the removal of the sunscreen ingredient (currently monitored in water) from the 
current WL in 2018, and its reinclusion in 2019 for monitoring in sediment together with 
the other candidate substances mentioned below. This will ensure the timely and cost-
efficient development / validation of analytical methods (in particular by optimising the 
use of sediment samples) and sediment PNECs.  
Overall, the following 5 substances are finally proposed to be taken out of the 1st WL, 
based on the removal criteria and discussion: diclofenac, oxadiazon, 2,6-di-tert-butyl-4-
methylphenol, tri-allate and 2-ethylhexyl-4-methoxycinnamate. 
 
                                           
12 Please note that 2 other substances would fulfil the criteria if the 2015 PNEC were taken into account (see 
details in Annex 6.1): azithromycin and thiamethoxam. The decrease in the updated PNEC for these 
substances explains the difference in the assessment (more than 3-fold decrease in the PNECs for each of 
these substances). 
13 Please note that the combined dataset is not relevant to assess the current risk posed by methiocarb. 
Methiocarb was banned as a molluscide in 2014, and consequently only data gathered after that date (e.g. 
from the WL dataset) would reflect the current level of risk. On the contrary, the combined dataset include 
samples dating back to 2006 which could overestimate the current level of risk for methiocarb. 
Consequently it shouldn't be taken into account when assessing whether there is sufficient high quality 
monitoring data to assess the risk for this substance. 
14 A partial ban on imidacloprid, clothianidin, and thiamethoxam was voted in 2013 with 2 conditions: The 
industrials needed to submit confirmatory data for remaining authorised uses and the commission should 
review the available evidence for all uses approved before the 2013 ban for these substances. A vote in the 
Standing Committee should take place in the coming months, on the basis of the EFSA's assessment of the 
data sent by the industrials. In parallel the EFSA is assessing the information gathered in a call launched to 
gather all available evidence, on all uses approved before the 2013 ban, and the report should be available 
in November. 
15 Recital 9 of Commission Implementing Decision 2015/495: "For comparability, all substances should be 
monitored in whole water samples. However, it would be appropriate to monitor 2-ethylhexyl 4-
methoxycinnamate also in suspended particulate matter or sediment, because of its tendency to partition 
into this matrix." 
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Finally it was investigated if the lower updated PNEC values (given in Table 2) are 
achievable with current analytical methods. The analytical methods for the substances of 
the 1st WL were already reported in Loos (2015) and they were validated by Tavazzi et 
al. (2016). Table 6 shows that these lower PNECs should be achievable with good 
analytical instruments.  
Table 6: Analytical achievement of updated PNECs.  
Substance 
PNEC WL 2015 
(µg/l) 
 
Updated PNEC 
(µg/l) 
Updated PNEC achievable with 
analytical methods proposed in 
Commission Implementing Decision 
2015/495  
Clarithromycin 0.13 0.12 
Yes; 
LOQ of Tavazzi et al. (2016) is 
0.0046 µg/l; 
Several publications are given in 
Loos (2015). 
Azithromycin 0.09 0.019 
Yes; 
LOQ of Tavazzi et al. (2016) is 
0.0026 µg/l; 
Several publications are given in 
Loos (2015). 
Methiocarb 0.01 0.002 
Yes;  
LOQ of SPE-LC-MS-MS method 
reported by Masiá et al. (2013) is 
0.001 µg/l;  
LOQ of Tavazzi et al. (2016) is 
0.00002 µg/l. 
Imidacloprid 0.009 0.0083 
Yes; 
LOQ of Tavazzi et al. (2016) is 
0.001 µg/l; 
LOQ of SPE-LC-MS-MS method 
reported by Hladik et al. (2012; 
2014) is 0.0049 µg/l. 
Thiacloprid 0.05 0.01 
Yes; 
LOQ of Tavazzi et al. (2016) is 
0.00005 µg/l; 
LOQ of SPE-LC-MS-MS method 
reported by Hladik et al. (2012; 
2014) is 0.0038 µg/l. 
Thiamethoxam 0.14 0.042 
Yes; 
LOQ of Tavazzi et al. (2016) is 
0.001 µg/l; 
LOQ of SPE-LC-MS-MS method 
reported by Hladik et al. (2012; 
2014) is 0.0039 µg/l. 
 
 
 
 
 
58 
Conclusions: 
Table 7 lists the substances fulfilling all removal criteria, considering the WL dataset and 
updated PNECs. These are the following: diclofenac, clarithromycin, erythromycin, 
oxadiazon, tri-allate, 2,6-di-tert-butyl-4-methylphenol, acetamiprid, clothianidin, 
thiacloprid, and 2-ethylhexyl-4-methoxycinnamate.  
The implementation of the removal criteria to the combined dataset together with 
updated PNECs confirms the above conclusions, except for thiacloprid. 
However, to come to the final list of substances to be removed from the WL, the 
additional reasoning and information should be taken into account for neonicotinoids, 
macrolide antibiotics, and sunscreen ingredient (2-ethylhexyl-4-methoxycinnamate). 
Overall, following the removal criteria and the additional discussion, 5 WL substances are 
proposed to be taken out of the list: diclofenac, oxadiazon, 2,6-di-tert-butyl-4-
methylphenol, tri-allate, and 2-ethylhexyl-4-methoxycinnamate. 
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Table 7: Decision table on potential candidates to be removed from WL considering the WL dataset and updated PNEC values. 
Notes:  
1. The difference of the STE scores is calculated as a percentage by the formula |STESc3 – STESc2|/STESc3 * 100 
2. When STESc3=0 and STESc2 is very low (<0.2) or =0 the difference of these scores is assumed to be zero 
Substance 
Updated 
PNEC 
(µg/L) Type STE (Sc3) STE (Sc2) 
Number 
of 
countries 
(Sc3) 
Number 
of 
samples 
(Sc3) 
RQ 
(P95) 
for Sc3 
Non-
quantified 
samples with 
0.5*LOQ≤PNE
C in Sc2 (% 
from total)  
LOQ-
PNEC 
criterion 
for Sc2 
(>90%) 
Difference 
of STE 
scores (%) 
Similar STE 
scores 
(difference
<15%) 
Potential candidate for 
deselection  
Diclofenac 5.00E-02 Analgesic 9.90E-01 9.90E-01 25 6698 5.26 100.0 yes 0.00 yes 
Yes (fulfils LOQ-PNEC 
criterion; similar STE scores) 
Erythromycin 2.00E-01 Antibiotic 0.00E+00 0.00E+00 24 2520 0.14 100.0 yes 0.00 yes 
Yes (fulfils LOQ-PNEC 
criterion; similar STE scores) 
Clarithromycin 1.20E-01 Antibiotic 5.05E-01 5.05E-01 24 2792 1.45 100.0 yes 0.00 yes 
Yes (fulfils LOQ-PNEC 
criterion; similar STE scores) 
Azithromycin  1.90E-02 Antibiotic 8.79E-01 1.40E+00 19 915 4.49 50.5 no 59.65 no 
No (no LOQ-PNEC criterion; 
dissimilar STE scores) 
2,6-Di-tert-butyl-
4-methylphenol 3.16E+00 Antioxidant 0.00E+00 1.67E-01 23 1032 0.08 99.7 yes 0.00 yes 
Yes (fulfils LOQ-PNEC 
criterion; similar STE scores) 
17-beta-Estradiol 4.00E-04 Estrogen 6.82E-01 1.17E+00 18 462 1.40 72.8 no 70.90 no 
No (no LOQ-PNEC criterion; 
dissimilar STE scores) 
Estrone 3.60E-03 Estrogen 5.42E-01 7.96E-01 20 552 0.97 91.6 yes 46.98 no No (dissimilar STE scores) 
17-alpha-
Ethinylestradiol 3.50E-05 Estrogen 8.99E-01 1.91E+00 14 323 7.35 50.6 no 112.61 no 
No (no LOQ-PNEC criterion; 
dissimilar STE scores) 
Oxadiazon 8.80E-02 Herbicide 1.00E-01 1.01E-01 23 1847 0.45 99.9 yes 0.72 yes 
Yes (fulfils LOQ-PNEC 
criterion; similar STE scores) 
Tri-allate  4.10E-01 Herbicide 0.00E+00 3.70E-04 23 2166 0.08 99.9 yes 0.00 yes 
Yes (fulfils LOQ-PNEC 
criterion; similar STE scores) 
Methiocarb 2.00E-03 
Insecticide / 
Herbicide 1.20E-00 1.79E-00 7 127 0.83 6.6 no 48.77 no 
No (no LOQ-PNEC criterion; 
dissimilar STE scores) 
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Substance 
Updated 
PNEC 
(µg/L) Type STE (Sc3) STE (Sc2) 
Number 
of 
countries 
(Sc3) 
Number 
of 
samples 
(Sc3) 
RQ 
(P95) 
for Sc3 
Non-
quantified 
samples with 
0.5*LOQ≤PNE
C in Sc2 (% 
from total)  
LOQ-
PNEC 
criterion 
for Sc2 
(>90%) 
Difference 
of STE 
scores (%) 
Similar STE 
scores 
(difference
<15%) 
Potential candidate for 
deselection  
Thiacloprid 1.00E-02 
Neonicotino
id 
Insecticide 2.40E-01 2.51E-01 23 2235 1.00 99.6 yes 4.36 yes 
Yes (fulfils LOQ-PNEC 
criterion; similar STE scores) 
Acetamiprid 5.00E-01 
Neonicotino
id 
Insecticide 0.00E+00 0.00E+00 24 2221 0.02 100.0 yes 0.00 yes 
Yes (fulfils LOQ-PNEC 
criterion; similar STE scores) 
Imidacloprid 8.30E-03 
Neonicotino
id 
Insecticide 7.53E-01 1.03E+00 22 1845 4.10 72.5 no 37.05 no 
No (no LOQ-PNEC criterion; 
dissimilar STE scores) 
Thiamethoxam 4.20E-02 
Neonicotino
id 
Insecticide 7.64E-02 3.00E-01 23 3979 0.24 98.9 yes 292.39 no No (dissimilar STE scores) 
Clothianidin 1.30E-01 
Neonicotino
id 
Insecticide 2.86E-01 2.86E-01 24 2254 0.25 100.0 yes 0.00 yes 
Yes (fulfils LOQ-PNEC 
criterion; similar STE scores) 
2-Ethylhexyl-4-
methoxycinnama
te 6.00E+00 Sunscreen 0.00E+00 6.22E-04 23 543 0.50 99.3 yes 0.00 yes 
Yes (fulfils LOQ-PNEC 
criterion; similar STE scores) 
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7.2 Selection of new substances for the 2nd WL 
 
7.2.1 Criteria for including new substances in the 2nd WL 
According to the EQSD, the Commission shall update the WL every 24 months. As a 
reminder, “the substances to be included in the watch list shall be selected from amongst 
those for which the information available indicates that they may pose a significant risk 
at Union level to, or via, the aquatic environment and for which monitoring data are 
insufficient" (EQSD article 8b). A reliable PNEC and an appropriate analytical method 
(LOQ below or equal to the PNEC) should be available for new substances included in the 
WL. 
The criteria proposed here for the identification of new WL substances build on the 
technical work carried out for the review of the priority substances list led by the JRC 
with the support of the SG-R. During the review, substances with enough monitoring 
data to assess the risk they posed went through the so-called "monitoring-based 
approach", while others went through the modelling-based approach. Factsheets were 
drafted for substances ranking high through either of these approaches. On the basis of 
these factsheets, 10 substances were short-listed for further consideration (and in 
particular for EQS derivation).  
For more details on the methodologies, please see the summary available at the 
following link: https://circabc.europa.eu/w/browse/0f6b893e-b0ab-46cb-a631-
c3e1e55c7514 
Respecting the requirements of the EQSD Directive, the JRC is proposing the following 
criteria for identifying potential candidates for inclusion in the 2nd WL:  
Criteria based on the 2014 prioritisation: 
1. Substances for which factsheets were prepared during the ongoing prioritisation 
process but not shortlisted because there were few or low-quality monitoring data. 
2. Substances short-listed but with uncertainties for the monitoring data. 
3. Substances considered in the modelling based exercise (Lettieri et al, 2016) for which:  
a. The monitoring data met the representativity criteria (number of MS, sites and 
 samples) in Sc2 but not in Sc3, and  
b. In Sc2 the STE score was high and the modelled RQ was high. 
4. Substances which went directly to the modelling stream (measured below 4 MS in Sc2 
during the ongoing prioritisation) with modelled RQ above 5 but not further selected 
because of lack of monitoring data. 
Additional criteria:  
5. Substances identified as potentially relevant in the report “Development of the first 
Watch List” (Carvalho, et al., 2015), but not included in the 1st WL because of limitations 
in the information available at the time (e.g. on analytical methods). 
6. Substances of emerging concern identified based on research projects and articles to 
identify substances of emerging concern, in line with the EQSD article 8b.  
Please note that banned substances fulfilling the criteria above will not be taken into 
consideration as potential candidate for the WL following the final recommendation cited 
in the document on the development of the 1st Watch List.16 
Please note also that a further scrutiny of the substances identified with these criteria has 
been carried out. This further scrutiny included consideration of other information such as 
                                           
16 Development of the 1st Watch List under the Environmental Quality Standards Directive - Document for 2nd 
Meeting of WFD CIS Working Group Chemicals, 17-18 March 2014 (DG ENV). 
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the number of MS in which the substance is authorised, a comparison of the RQ and/or 
STE scores between the different substances, to establish a priority for the inclusion in 
the WL, the consideration of the relevant matrix and stability of the substance (see 
details in Annex 9), in addition to the consideration of the availability of a reliable PNEC 
and an appropriate analytical method. These elements are presented below. 
 
7.2.2 Identification of new substances for inclusion in the 2nd WL 
Based on criterion 1, chromium (VI) and teflubenzuron are potential candidates. 
Teflubenzuron was not shortlisted during the previous prioritisation because the 
monitoring data were considered to be insufficient. For chromium (VI) the available 
monitoring data (Sc3) in the 2014 prioritisation exercise were from “whole water” (not 
filtered); monitoring data quality and quantity were very low. Furthermore the risk 
quotient (RQ) based on predicted environmental concentration (PEC, Carvalho et al., 
2015) was 102.9, although this value probably overestimated the risk because it didn’t 
take into account the restrictions recently imposed on the uses of chromium under 
REACH (see Table 10). Consequently this substance was initially proposed for the WL, 
however in January 2018 the JRC received more recent monitoring data for total 
chromium in dissolved fraction from several Member States, as well as additional 
monitoring data for chromium (VI) in dissolved fraction from one Member State. All these 
data were for inland waters (rivers and lakes). Furthermore, the JRC reviewed the 
ecotoxicological data available not only for chromium (VI) but also for chromium (III). 
This led to an update for the PNEC in freshwaters of 2.06 g/l and 1.8g/l for chromium 
(VI) and chromium (III) respectively (see more details in the chromium factsheet, annex 
9). Based on the updated PNEC (2.06 g/l) the RQ for chromium (VI) has been 
approximated considering the total chromium concentrations in dissolved phase (based 
on all monitoring data available, from 2010 onwards, in inland waters). This RQ is 
however below 1 (RQ(P95)=0.49), which doesn’t tend to support the inclusion of 
chromium (VI) in the WL. The same calculation was performed with the PNEC for 
chromium (III) (1.8 g/l), leading to the same conclusion (RQ(P95)=0.56). Finally, the 
JRC derived a PNEC for coastal and transitional waters for chromium (VI). Based on this 
PNEC (0.6 µg/l) and on the monitoring data used in the prioritisation for total chromium 
in dissolved fraction (coastal and transitional waters), the RQ(P(95) is 1.17, which 
warrants further investigation (see chromium factsheet, annex 9). In addition, before any 
definitive conclusion can be made, the PNECs derived by the JRC will need to be 
confirmed, via consultation with the WG Chemicals. 
Based on criterion 2, in the summary document of the prioritisation exercise17, the table 
summarising conclusions from the 6th SG-R meeting, shows the certainty/uncertainty for 
each substance shortlisted as potential PS candidate. Silver, omethoate, selenium and 
the pyrethroids were identified as having a low/medium amount of monitoring data in the 
prioritisation. Silver, omethoate and selenium are not proposed as WL substances. 
According to the latest information available at the moment, dated 201418, silver, 
omethoate and selenium (in water) are RBSPs in a significant number of MS (resp. 7, 6 
and 10 MSs). This tends to support the idea of an EU-wide risk. In addition, more 
monitoring data should become available via routine monitoring in the future, in 
particular for silver and omethoate. What's more, the additional monitoring data recently 
gathered combined with the data previously used in the prioritisation now show more 
than 2000 samples in more than 100 sites and 4 MS for silver in the dissolved fraction, 
so it fulfils the minimum requirements for the number of MS, sites and samples used 
under the previous prioritisation. For selenium, the SG-R deemed that the most relevant 
matrix for monitoring and assessment is biota: a QS biota needs to be developed before 
additional information can be gathered in this matrix. 
                                           
17 https://circabc.europa.eu/w/browse/0f6b893e-b0ab-46cb-a631-c3e1e55c7514 
18 More recent information will be available once the 2nd RBMPs have been fully analysed. 
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The pyrethroids permethrin, deltamethrin, bifenthrin and esfenvalerate were all 
shortlisted and although three of them were selected from the modelling based exercise, 
the criteria for their selection were not only based on the modelled RQ but also on 
realistic scenario for PEC derivation, ratio between PEC RQ and MEC RQ (close to 1) and 
additional monitoring data (see Lettieri et al, 2016). Furthermore permethrin and 
deltamethrin were already identified in the previous exercise. During the 6th SG-R 
meeting, experts were split between inclusion in the priority substances list or in the 
Watch list, provided an adapted analytical method would be developed. Consequently the 
JRC suggests that when an adapted analytical method is made available for these 
substances, they can be considered in a further update of the list.   
Under the criterion 3, the substances from the previous prioritisation with sufficient 
monitoring data in Sc2 but not in Sc3 (data in less than 4 MS) are considered. These 
substances went through the modelling-based exercise. Among these substances, those 
with a high modelled RQ AND a high STE score in Sc2 can be considered for inclusion in 
the 2nd WL (criterion 3). There were 16 substances in this case (for details see page 51 
of the report, Lettieri et al., 2016). From the list the banned substances and the three 
shortlisted substances (deltamethrin, bifenthrin and esfenvalerate) were removed.  Other 
substances fulfilling criterion 3 are shown in Table 8. They are teflubenzuron (already 
selected under criterion 1), and diflubenzuron. 
Considering the criterion 4, the Table 9 shows substances which went directly to the 
modelling stream (measured below 4 MS in Sc2 during the ongoing prioritisation) and 
which modelled RQ is higher than 5. They are pyridaben, dimoxystrobin, etofenprox, 
fenpyroximate and thiram, chlorsulfuron, metconazole, metaflumizone, proquinazide, 
diflubenzuron, and venlafaxine. 
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Table 8: List of substances identified as potential candidates for the WL under criterion 3. These are substances: 
- from the previous prioritisation with sufficient monitoring data in Sc2 but not in Sc3. (These substances went through the modelling-
based exercise) AND 
- with a high modelled RQ and a high STE score in Sc2 can be considered for inclusion in the 2nd WL, AND 
- which are still approved 
Please note the three shortlisted substances (deltamethrin, bifenthrin and esfenvalerate) fulfil these criteria but are not included in this 
table because they already fulfil criteria 2. 
Please note also that because the RQ(MEC95) are based on data of insufficient quality and quantity, these cannot be considered as 
reliable. 
 
 
SUBSTANCE 
 
Type 
 
PEC 
(µg/l) 
 
PNEC  
(µg/l) 
PEC RQ 
 
Hazard STE 
score 
 
RQ(MEC 
P95) 
Monitori
ng No. 
MS in 
sc3 
Monitori
ng No. 
Sites 
Monitori
ng No. 
Samples 
No. 
Samples < 
LOQ 
No. 
Quantified 
samples 
 
Status 
Teflubenzuron PPP 4.62 0.0012 3847 PBT 2.28 41.7 1 1 9 0 9 Approved 
Diflubenzuron PPP, 
Biocide 
13.62 0.004 3406  T 1.22 0.6 2 13 218 0 218 Approved 
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Table 9: List of substances with monitoring data in Sc2 from less than 2 MS, and which modelled RQ is higher than 5 (criteria 4). 
Please note that this table has been extracted directly from the monitoring based report for the 2014 prioritisation. The PNEC for the substances of 
interest have been reviewed, which may lead to differences between the PNEC mentioned here and the PNEC mentioned in the following tables. 
Please note also that because the RQ(MEC95) are based on data of insufficient quality and quantity, these cannot be considered as reliable. 
                                           
19 No samples were quantified. This RQ above one is an artefact resulting from the use of LOQ/2 for non-quantified samples. 
Substance 
 
Type 
PEC 
(µg/l) 
 
PNEC  
(µg/l) 
RQ( PEC) 
Hazard 
STE 
score 
RQ(MEC 
P95) 
Monitori
ng No. 
MS in 
Sc2 
Monitori
ng No. 
Sites 
Monitori
ng No. 
Samples 
No. 
Samples < 
LOQ 
No. 
Quantified 
samples 
 
Status 
Pyridaben PPP 10.40 0.00047 22132 PBT 2.41 53
19
 2 785 5395 5395 0 Approved 
Dimoxystrobin PPP 16.42 0.0032 5196 PT, 
suspected 
C, R 
2.13 8 1 720 6078 5910 168 Approved 
Etofenprox Biocide 
(ECHA) 
Plant 
protection 
product 
8.3 0.0054 1531 B, T 
suspected 
R 
1.52 1.85 3 91 1116 1106 10 Approved 
Fenpyroximate PPP 4.4 0.010 440 PBT 0 1 1 35 1506 1505 1 Approved 
Thiram Industrial 
(ECHA) 
Biocide 
(ECHA) 
Plant 
protection 
product 
61.0
 
0.200 305 T , ED 0 0.25 3 217 3546 3534 12 Approved 
Chlorsulfuron PPP 2.9 0.024 119 P, T , 
suspected 
C 
0.84 1.04 3 1239 15973 15 49 Approved 
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20 No samples were quantified. This RQ above one is an artefact resulting from the use of LOQ/2 for non-quantified samples. 
Metconazole PPP 5.9 0.0582 101 PT, vP, 
suspected 
R 
0 0.43 3 702 5742 5739 3 Approved 
Metaflumizone PPP 0.3 0.01308 22.8 P, B, T n.a. n.a. n.a. n.a. n.a. n.a. n.a. Approved 
Proquinazide PPP 1.3 0.18 7.28 vP, B and 
T 
0 0.06
20
 1 31 1285 1285 0 Approved 
Diflubenzuron PPP, 
biocide 
13.62 0.004 3406 P, B, T 2.09 6.25 4 415 4725 4607 2 Approved 
Venlafaxine Human 
medicine 
0.20 0.038 5.21 P, T 1.36 4.95 1 93 1395 324 1071 Approved 
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Criterion 5 is to consider also substances included in the report “Development of the first 
Watch List” (Carvalho, et al., 2015); in this report the substance free cyanide (CN-) was 
listed however it was not selected because a good analytical method was not available. A 
study carried by Fraunhofer Institute in collaboration with the Stakeholder Consortia 
(Cefic Cyanide Sector Group, CONCAWE, EUROFER and Euromines) succeeded to set up 
the analytical method. Furthermore CN- has been also shortlisted in the first prioritsation 
exercise and an updated draft dossier is available in CIRCABC21. 
Criterion 6 is to consider also substances of emerging concerns, highlighted by research 
projects and scientific articles (in line with the requirements of EQSD article 8b). From 
this source, three antibiotics have been selected because of the potential risk they pose 
to the aquatic environment highlighted by scientific pulbications, and because of the 
emerging concern of antibiotic resistance: Amoxicillin and ciprofloxacin. The selection of 
these antibiotics is also in line with the European One Health Action Plan against 
antimicrobial resistance.22 
Wang et al. (2017) found high ecological hazards of mixture of antibiotics mainly for 
algae. Tetracycline, oxytetracycline, sulfadiazine, and ciprofloxacin pose medium to high 
hazards to algae. 
Quinlan et al. (2011) have reported that significant changes in the stream biotic 
community were observed within 7 days with in-stream tetracycline concentrations as 
low as 0.5 μg/L, including significant changes in antibiotic resistance, bacteria abundance 
and productivity, algae biomass, cyanobacteria, organic biomass, and nematodes. 
The references to additional publications are detailed in the facstheets for these 
substances in Annex 9. 
 
In conclusion, the Table 10 lists the substances identified on the basis of the 6 above 
criteria for further scrutiny. The table includes where relevant for each substance the 
dates by which the approval should be reviewed, and number of MS in which it is 
approved.  
Furthermore in the table are reported the PNEC values, STE score for the substances 
selected from the monitoring based exercise and those from the Table 9. For the 
modelled substances, the PEC, the RQ, hazard properties and number of MS where it is 
authorised are reported. The column to the right includes additional comments.  
Among these substances the JRC wouldn't recommend thiram, famoxadone, 
metconazole, fenpyroximate, dimoxystrobin and chlorsulfuron for inclusion in the 2nd WL 
because of the dates for expiration of their approval between 2018 and 2019, 
respectively. The JRC also doesn't recommend to include teflubenzuron in the WL 
because it is authorised only in 4 MS. 
 
 
                                           
21 Draft Dossier for free cyanide is available on CIRCABC: https://circabc.europa.eu/w/browse/31cc6882-0faf-
4826-a61b-39b81a4c2c5c  
22 The Action Plan states: "maximise the use of data from existing monitoring, e.g. Watch List monitoring under 
the Water Framework Directive, to improve knowledge of the occurrence and spread of antimicrobials in 
the environment" 
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Table 10: List of substances fulfilling either of the 6 above criteria for identification as potential 
candidate for inclusion in the 2nd WL. In bold the STE score and modelled RQ (PEC/PNEC) for 
substances from the monitoring based exercise and modelling based exercise respectively. For free 
cyanide and the antibiotics amoxicillin and tetracycline the RQ is the ratio of Measured 
Environmental Concentration (MEC) and the PNEC since no PEC is available. Additional information 
have been included i.e. monitoring data.  
Substance PNEC 
(µg/l) 
STE score and RQ Monitoring data 
(MSs, number of 
sites and samples) 
Comment 
Chromium (VI) 2.061  
 
RQ (102.94) 
RQ(MEC)=2.43 
STE=1.1 
 
See p. 61 for more 
information on the 
approximation of 
RQ(MEC) using 
monitoring data for total 
chromium. 
 
 
In Sc3 for inland whole 
water (monitoring-based 
prioritisation 2014-2016), 
753 samples were 
available from 4 countries, 
51 % of them quantified.  
 Predicted 
Environmental 
Concentration  
(PEC) has been 
derived before  the 
restricted use 
therefore  it 
overestimates the 
risk .The available 
monitoring data in 
the prioritisation 
exercise were from 
“whole water”; 
Monitoring data 
quality and 
quantity is very 
low.  
 
Metaflumizone 0.06541 PEC 0.3 
(RQ 4.6)  
vP, vB and T (hazard 
properties) 
No monitoring data  
Authorised  as PPP in  13 
MS 1 is in progress  
Approved until 
31/12/2024  
Amoxicillin 
 
  0.078
1
 
RQ (MEC) 1.28  In Sc2 for inland whole 
water (monitoring-based 
prioritisation 2014-2016), 
86 samples from 1 country 
Data quality is not 
good 
Ciprofloxacin 
0.089
4
 
PEC
 
 7  
(RQ 84.2) 
T  (hazard properties) 
In Sc2 data from 3 MS (54 
sites) with 842 samples 
are available.  9% are 
quantified. 
Data quality is not 
good 
Etofenprox 0.00108
1
 PEC 8.3 
(RQ 1531) 
B, T suspected R 
(hazard properties) 
Monitoring data only from 
3 MS with 91 site and 
1316 samples. Only1  
quantified samples 
Etofenprox is authorised in 
18 MS; in 10 MS as a PPP 
(BG, CZ, EL, ES, HU, MT, PL, 
RO, SK, UK), in 4 MS as a 
PPP and as a biocide (AT, 
DE, FR, IT) and in 4 MS as a 
biocide (DK, LU, SE, SI) 
Monitoring data as 
supportive 
information not 
sufficient to bring 
forward in the 
prioritisation 
Expiration of 
approval (as a PPP): 
31/12/2019 
Biocidal active 
substance:  
8-Wood 
Preservatives, 
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Substance PNEC 
(µg/l) 
STE score and RQ Monitoring data 
(MSs, number of 
sites and samples) 
Comment 
expiry date 
01/02/2020 
18- Insecticide, 
acaricides and 
products to control 
other arthropods, 
expiry date 
01/07/2025 
 
Dimoxystrobin 
 
0.03
6 
 
PEC 16.42  
(RQ 519.6) 
PT (hazard properties) 
Monitoring data only from 
1 MS with 720 site and 
6078 samples. 2.8 % 
quantified samples  
Authorised in 16 MS 
Monitoring data as 
supportive 
information not 
sufficient to bring 
forward in the 
prioritisation 
Expiration of 
approval: 
expiration date has 
been extended by 
one year for until 
31/01/2019 
Proquinazid 0.184 PEC  1.3 
(RQ 7.28) 
vP, B and T (hazard 
properties) 
Data from only 1 MS (31 
sites) with 1285 samples 
are available. No 
quantified samples. 
Authorised as PPP in  
24 MS and  1 pending 
Approved until 
31/07/2020  
Venlafaxine 
0.038 
 
PEC 0.20 
(RQ 5.21) 
  P, T(hazard properties) 
Data from 1 MS (93 sites) 
with 1395 samples are 
available in Sc2. 76.8% 
quantified samples 
EOTOX data from 
EPA but the study 
not available. 
Free Cyanide 
 
0.5
9
 
RQ  10-40   (MEC (5-20)
10
 
T (hazard properties) 
No monitoring data  from 
the prioritisation exercise  
 
Pyridaben 0.0047
1
  
 
PEC 10.40 
(RQ 2212)  
PBT
2
 (hazard properties) 
Monitoring data only from 
2 MS with 785 site and 
5395 samples. No 
quantified samples  
Authorised in 11 MS 
 
Monitoring data as 
supportive 
information not 
sufficient to bring 
forward in the 
prioritisation  
Expiration of 
approval: 
30/04/2021 
Fenpyroximate 0.010
1
 PEC 4.4 
(RQ 440) 
PBT
3
 
(hazard properties) 
Monitoring data only from 
3 MS with 91site and 1316 
samples. Only1  quantified 
samples 
Authorised in in 18 MS 
Monitoring data as 
supportive 
information not 
sufficient to bring 
forward in the 
prioritisation 
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Substance PNEC 
(µg/l) 
STE score and RQ Monitoring data 
(MSs, number of 
sites and samples) 
Comment 
 Expiration of 
approval: 
30/04/2019 
Diflubenzuron 0.0008
1
 PEC 13.62 
(RQ 3406) 
STE=1.2 (Sc2) 
T (hazard properties) 
Monitoring data from 4 
MSs with 415 sites and 
4725 samples in Sc2 while 
2 MSs with 13 sites and 
218 samples in Sc3  
Authorised in 20 MS (in 16 
MS as a PPP, in 3 MS as a 
biocide, in 1 MS as a PPP 
and as a biocide) 
 
Monitoring data 
are very few not 
sufficient as 
supportive 
information to 
bring forward in 
the prioritisation 
Expiration of 
approval (as a PPP): 
31/12/2018 
Biocidal active 
substance:  
18- Insecticide, 
acaricides and 
products to control 
other arthropods, 
expiry date 
01/02/2025 
Thiram 0.2
4
 PEC 61 
(RQ 305) 
T (hazard properties
5
) 
Monitoring data only from 
3 MS with 217 site and 
3546 samples.  
 
Authorised in 24 MS 
 
The available data 
although not 
sufficient for STE 
run, is good since 
the LOQ is below 
the PNEC value. 
The MEC RQ is 0.25 
suggesting that the 
modelled RQ is not 
supported by the 
monitoring data so 
far available from 3 
MS.  
Expiration of 
approval: 
30/04/2018  
Biocidal active 
substance: 
Approval status 
under review by 1 
MS (BE) 
Teflubenzuron 0.0012 PEC 4.62 
 (RQ 3847) STE =2.8 (Sc2) 
 
PBT
8
 (hazard properties) 
The number of monitoring 
samples, from 4 MSs in 
Sc2 is 7000 with almost all 
of them below LOQ (range 
0.005-0.05) and none 
below LOD. Only 9 
quantified samples from 1 
MS are available (Sc3).  
Authorised in 4 MS  
Factsheet for this 
substance was 
prepared but it was 
not put forward for 
EQS derivation, 
after SG-R 
comments, because 
the monitoring 
data were 
considered to be 
not sufficient, and 
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Substance PNEC 
(µg/l) 
STE score and RQ Monitoring data 
(MSs, number of 
sites and samples) 
Comment 
therefore as EU-
wide concern for 
freshwater is not 
proven 
Expiration of 
approval: 
30/11/2019 
Chlorsulfuron  0.024
4
  PEC 2.9 
(RQ 119)  
P T suspect C 
(hazard properties) 
Data from 3 MS with 1239 
site and 15973, only 0.31% 
quantified) 
Authorised in 9 MS  
Until 31/12/2019.  
Metconazole 
0.0582  
 
PEC 5.9  
(RQ  101)  
vP T  
suspect R (hazard 
properties) 
Data from 3  MS ( 702 site 
with 5742 samples and 
0.05 %  quantified 
samples) 
Authorised in 24 MS 
Approved until  
30/04/2018 –  
Although the expire 
date is in April 
2018, it is vP and 
should be 
monitored 
Famoxadone 
0.14
1
  
 
PEC 1.8 
(RQ 12.6) 
 
B, T (hazard properties) 
Data from  3 MS  
Authorised as PPP  in   
18 MS 
30/06/2018 
Although the expire 
date is in June 
2018, still good 
candidate since it is 
B as hazard 
property 
 
1 
JRC Derivation 
2 
EFSA Dossier 2010  
3 
P/B: EFSA Dossier 2013; T: CL Inventory
 
4
 Oekotoxzentrum, Eawag/EPFL (CH) 
5 
In 2015 the Sweden stated that “In the light of general systemic toxicity, the available data set does not allow 
concluding that thiram alters function of the endocrine system and consequently causes adverse health effects“. 
Conclusion document online: https://echa.europa.eu/it/information-on-chemicals/evaluation/community-
rolling-action-plan/corap-table/-/dislist/details/0b0236e18070b8fd 
6 
ETOX: Information System Ecotoxicology and Environmental Quality Targets (UBA) 
7 
EU Report 2012 
8 EFSA Dossier 2008 
9 
Draft Dossier for free cyanide is available on CIRCABC: https://circabc.europa.eu/w/browse/31cc6882-0faf-
4826-a61b-39b81a4c2c5c 
10 
MEC source from NORMAN Database http://www.norman-network.net/?q=node/24 and WATERBASE 
Database http://www.eea.europa.eu/data-and-maps/data/waterbase-rivers-6 
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Table 11 shows the final list of recommended substances that are potential candidates for 
inclusion in the 2nd or 3rd WL. The first three substances in the table (metaflumizone, 
amoxicillin and ciprofloxacin) are recommended for inclusion in the 2nd WL. The following 
substances are recommended for consideration for the 3rd WL. The PNECs, available 
analytical methods, and if the lowest LOQ is below the PNEC are shown.  
Separate factsheets have been prepared for each substance (Annex 9). The factsheets 
give information on substance identity, physico-chemical properties, environmental fate, 
environmental exposure (PECs/MECs), analytical methods, P, B, T, C, M, R, ED 
properties, ecotoxicology data, PNEC derivation, risk quotients and STE scores (if 
available).  
The preferred monitoring matrix for the hydrophobic substances (pyrethroid insecticides; 
pyridaben) with high log KOW values is sediment or biota.  
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Table 11: Summary of analytical methods and reliability of the PNECs for the potential WL 
candidate substances.  
 
Substance CAS PNEC 
(µg/l) 
Is the PNEC 
reliable 
Available analytical 
method for analysis in 
water 
LOQ < PNEC  
(in water) 
Metaflumizone 139968-49-3 0.0654 Yes LC-MS-MS Yes (LOQ = 0.025) 
Amoxicillin 26787-78-0 0.078 Yes LC-MS-MS Yes (LOQ = 0.004) 
Ciprofloxacin 85721-33-1 0.089 Yes LC-MS-MS Yes (LOQ = 0.002) 
Chromium (VI) 18540-29-9 2.06 
(inland 
surface 
waters); 
 
0.6 
(transitio
nal and 
coastal 
waters)  
Yes EPA method 218.7; 
Ion chromatography 
followed by post-column 
derivatization of the Cr(VI) 
with diphenylcarbazide 
and detection of the 
colored complex at 530 
nm; 
LC-ICP-MS 
 Yes 
Etofenprox 80844-07-1 0.00108 
2
 Yes GC-ECD-MS or GC-MS ?
23
 
Dimoxystrobin 149961-52-4 0.0316 Yes LC-MS-MS Yes (LOQ = 0.01) 
Proquinazide 189278-12-4 0.18 No GC-MS Yes (LOQ = 0.1) 
Venlafaxine 93413-69-5 0.038 No LC-MS-MS Yes (LOQ = 0.0003) 
Free Cyanide 57-12-5 0.5 Yes CFA-photometric 
detection 
Yes
24
 
Permethrin 52645-53-1 0.00047 Yes HRGC-HRMS Yes (LOQ = 
0.000044) 
Esfenvalerate 66230-04-4 0.0001 Yes GC-NCI-MS Yes (LOQ = PNEC) 
Pyridaben 96489-71-3 0.0047 
2
  Yes LC-MS-MS No (LOQ = 0.005) 
Fenpyroximate 134098-61-6 0.01 
2
 Yes LC-MS-MS No (LOQ = 0.1) 
Diflubenzuron 35367-38-5 0.0008 
1 
Yes LC-MS-MS No (LOQ = 0.04) 
Deltamethrin 52918-63-5 0.00007 Yes GC-ECD/MS or GC-NCI-MS ?
25
 
Bifenthrin 82657-04-3 0.00002 Yes GC-ECD/MS or GC-NCI-MS ?
25
 
 
1 
EU Report 2012 
2
 JRC Derivation 
 
 
 
                                           
23 One publication from China was found giving a multi-compound analytical method for 82 pesticides; the 
general LOD of 0.00006–0.00098 µg/l given is questionable (Zheng et al., 2016). 
24 An LOQ of ca. 0.14-0.30 µg/l was reached. Natural background concentrations between 0.127-0.240 µg/l 
were determined in Germany (Fraunhofer Institute, 2017). 
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Conclusion: 
Taking into account the availability of an appropriate analytical method (LOQ at least as 
low as the PNEC) and of a reliable PNEC, JRC would recommend for the 2nd WL 
metaflumizone, amoxicillin and ciprofloxacin.  
Other substances such as pyrethroids (etofenprox, permethrin, esfenvalerate, 
deltamethrin and bifenthrin) and pyridaben would be interesting to consider in a following 
update of the list (e.g. 3rd WL) to be measured in the most appropriate matrix. 
Furthermore venlafaxine and proquinazid should be also considered if reliable information 
for the PNEC is found. Free cyanide should also be considered when the analytical 
method recently developed is made available. No appropriate analytical method has been 
found for diflubenzuron and fenpyroximate. In addition, the approval of dimoxystrobin as 
a PPP should be reviewed by January 2019. If the approval for this substance is renewed, 
then it can be considered for inclusion in the 3rd WL. Furthermore, upon confirmation of 
the PNEC derived for chromium (VI) and (III) by consulting with the WG Chemicals, the 
JRC will also further investigate a potential risk posed by chromium (VI) in coastal and 
transitional waters, in particular by investigating whether monitoring data more recent 
than those used in the prioritisation are available, in view of a possible inclusion of 
chromium (VI) in the 3rd WL.  Finally, thiram, metconazole and famoxadone could be 
considered for inclusion in the 3rd WL if their approval is renewed and if a reliable PNEC 
and an appropriate analytical method are available. 
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8 Conclusions 
Based on the performed analyses, we could conclude that the first WFD watch list 
program has fulfilled its objective of gathering Union-wide high-quality surface water 
monitoring data for several of the selected substances.  
Nearly all EU Member States have provided monitoring data of mostly good quality. 
Analytical method performance improvements would however be necessary in some MS 
for 17-alpha-ethinylestradiol (EE2), 17-beta-estradiol (E2), imidacloprid, azithromycin, 
and methiocarb (for the updated PNECs).  
Around half of the MS did not give the relevant information on the representativity of the 
monitoring stations and monitoring strategy including the nearby pressures of the 
sampling stations. This information would be necessary for a better interpretation of the 
WL data.  
Sampling site selection and correct timing of sample collection is essential for monitoring 
of plant protection products (PPPs) because exposure of surface waters to pesticides is 
heavily dependent on local conditions (e.g. pesticide application and land use) and 
therefore can be spatially and temporally variable. In addition, antibiotics show an 
increased use during winter and the sunscreen ingredient in the summer. Only one MS 
provided in their sampling strategy detailed information on the timing of sample 
collection.  
JRC has identified 10 substances, based on the criteria defined, as potential candidates to 
be removed from the first WL when considering the WL dataset together with the 
updated PNECs: diclofenac, clarithromycin, erythromycin, oxadiazon, tri-allate, 2,6-di-
tert-butyl-4-methylphenol, acetamiprid, clothianidin, thiacloprid, and 2-ethylhexyl-4-
methoxycinnamate.  
The potential candidates for removal from the WL were confirmed applying the removal 
criteria to the combined dataset together with updated PNECs except for thiacloprid.  
Despite the above, there are reasons for retaining some of the substances in the WL, as 
explained in the main part of the document (section 7.1). 
Consequently only diclofenac, oxadiazon, 2,6-di-tert-butyl-4-methylphenol, tri-allate and 
2-ethylhexyl-4-methoxycinnamate are proposed to be removed from the first WL.  
Based on the criteria identified in section 7.2 above, JRC proposes to select as a new WL 
substances for inclusion in the 2nd WL the following substances from the prioritisation 
monitoring and modelling exercise 2016 with low monitoring data quality and quantity, 
which are: metaflumizone, amoxicillin and ciprofloxacin. Please note that in selecting 
these substances, additional information, such as the date of expiration of their approval 
and the number of MS where they are approved, the available analytical method with 
LOQ < PNEC and the matrix have been taken into account.  
In addition, when an adequate analytical method is available and possibly by measuring 
in the most appropriate matrix (i.e. sediment or biota) the pyrethroid insecticides 
(etofenprox, permethrin, deltamethrin, bifenthrin and esfenvalerate), and pyridaben 
could be proposed as group of substances to be included in the WL for its next update.  
Furthermore venlafaxine and proquinazid should be also considered when reliable 
information for PNEC is made available. Free cyanide should also be considered when the 
analytical method recently developed is made available. Finally, the approval of 
dimoxystrobin as a PPP should be reviewed by January 2019. If the approval for this 
substance is renewed, then it can be considered for inclusion in the 3rd WL. Chromium 
(VI) is not proposed for inclusion in the 2nd WL. The JRC’s assessment of the new 
monitoring data received in January 2018 together with the data from the 2014 
prioritisation doesn’t support the idea that chromium (VI) would be posing a risk in 
freshwaters. However, chromium (VI) could be considered for inclusion in the 3rd watch 
list in transitional and coastal waters, after confirmation of the PNEC via consultation with 
the WG Chemicals and after collection and analysis of any additional existing monitoring 
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data for these categories of water. Finally, thiram, metconazole and famoxadone could 
be considered for inclusion in the 3rd WL if their approval is renewed and if a reliable 
PNEC and an appropriate analytical method are available. 
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List of abbreviations and definitions 
 
CAS  Chemical Abstract Service 
EEA   European Environment Agency 
EE2  17-alpha-Ethinylestradiol 
E1  Estrone 
E2  17-beta-Estradiol 
EFTA  European Free Trade Association 
EQS  Environmental quality standard 
GC-MS  Gas chromatography mass spectrometry 
LC-MS-MS  Liquid chromatography (tandem) triple quadrupole mass spectrometry 
LLE   Liquid liquid extraction 
LOQ  Limit of quantification 
MS  Member State 
PEC  Predicted environmental concentration 
PNEC  Predicted no-effect concentration 
MEC  Measured environmental concentration 
PPP  Plant protection product 
RQ  Risk Quotient 
SG-R  Sub-group on revision (of the priority substance list) 
SoE  State of the Environment 
SPE   Solid-phase extraction 
SPM  Suspended particle matter 
STE  Spatial, Temporal and Extent of PNEC exceedance 
WFD  Water Framework Directive 
WISE  Water Information System for Europe 
 
The European ISO country codes can be found online:  
http://ec.europa.eu/eurostat/statistics-explained/index.php/Glossary:Country_codes 
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Supplementary Information  
 
 
The annexes below present a detailed information (tabular and/or graphical) for the 
different datasets about the data statistics, range of LOQs, quality of data, STE scores, 
STE factors, the removal of substances from WL, the inclusion of new substances to the 
WL and additional information individually for WL substances (nearby pressures, 
seasonality and distribution per country). 
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Annex 1: STE assessment tool 
For the monitoring-based prioritisation exercise, the Joint Research Centre (JRC) of the 
European Commission (EC) developed a chemical risk assessment tool, called “Spatial, 
Temporal and Extent of exceedance” (STE), which accounts the concentration 
exceedances over the Predicted No Effect Concentration (PNEC) considered as an eco-
toxicological threshold of concern (Carvalho et al., 2016). 
The STE method follows the concept of von der Ohe et al. (2011), where substances 
were assessed as potential river basin specific pollutants based on two indicators - the 
spatial frequency of PNEC exceedances, considering the maximal concentrations at 
different monitoring sites, and the extent of the PNEC exceedance, considering the 
absolute risk ratio to evaluate the intensity of local impacts (using 95th percentile of max 
concentration at each monitoring site). 
The STE method introduced modifications on the originally proposed calculations for the 
Spatial and Extent factors - the max concentration was substituted by 95th percentile of 
concentrations when accounting the exceedances at monitoring sites. Moreover, in the 
Spatial factor a correction of the frequency of exceedances at sites was established by 
the percentage of the countries with exceedances. In addition a new temporal factor has 
been included to further explore the inherent variability of the monitoring data and to 
improve the ranking of substances. Moreover, the robustness and sensitivity of the STE 
method were tested, in particular with respect to the quantity and quality of the 
monitoring data, and the statistical independence of the individual STE factors and the 
impact of uncertainty of the PNEC values were verified (Carvalho et al., 2016).  
The STE method calculates for each substance an overall risk assessment score by 
summing the Spatial, Temporal and Extent of PNEC exceedance factors. The range of the 
STE scores is between 0 and 3 (since the individual factors vary from 0 to 1), with a 
score of 0 indicating no concern, while a score of 3 showing an extremely high concern. 
In the prioritisation exercise (that started in 2014) five risk classes (very high, high, 
intermediate, low and very low) were adopted to rank the substances according to the 
obtained STE scores as specified in the table below. 
STE score Risk classification 
≥ 2.4 and ≤3 Very high 
≥ 1.8 and < 2.4 High 
≥ 1.2 and < 1.8 Intermediate 
≥ 0.6 and < 1.2 Low 
≥ 0 and < 0.6 Very low 
 
Then, the substances showing high and very high risks (i.e. STE ≥ 1.8) were short-listed 
and eventually proposed as new candidates for priority substances. 
Advantages of the STE method: 
a) Simplicity 
The method is built on a simple and distinct scheme that calculates Spatial, Temporal 
and Extent factors of exceedances per substance using measurements in different 
environmental compartments (water, biota, sediment, etc.) and identifies when a 
potential risk exists comparing to EQS/PNEC values. 
b) Robustness 
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The STE factors are sound and robust indexes for quantification of spatial, temporal and 
extent of eco-toxicological exceedances. 
The STE factors are confirmed being independent from a statistical point of view by the 
Chi-squared test for statistical independence and low correlations among them. 
The statistical independence of the STE factors allows summing of the spatial, temporal 
and extent factors in a single and representative final score for each substance. 
c) Novelty and Innovation  
An additional term for the exceedances per country was added to the spatial factor. It 
plays an extra controlling role on the spatial propagation of the impact of toxic chemicals 
at continental scale. 
A new temporal factor was introduced in the chemical risk assessment since some 
substances could present sudden peak concentrations or are affected by clear 
seasonality. 
A better quantification of the extent of exceedance factor was developed which 
guarantees that the extent factor increases more gradually and smoothly. 
Shortcomings of the STE method: 
a) Data quality 
Since the outcome of STE method is susceptible to the quality and quantity of monitoring 
data they should be subject to a strict evaluation according to a set of general 
requirements and criteria for quantification limits, representativity and treatment of 
outliers. 
b) Sensitivity 
The method showed a low sensitivity to the number of samples and sites where 
substances are measured (in case they are sufficient statistically). However, before 
applying the STE method a detailed statistical analysis of datasets is always needed in 
order to avoid inconsistent and unrealistic outcome. In particular, it is important to check 
if a sufficient number of measurement stations and records per substance are available 
that for example could be measured occasionally or just once at some sites. Thus, it is 
important to set requirements on data for the minimum number of countries and sites 
with measurements, for the statistically sufficient number of samples, and for a minimal 
number of samples per site. 
Conversely, the STE method is very sensitive to the choice and the uncertainty in the 
EQS/PNEC values which apparently are a very important parameters in the assessment 
of chemicals. 
In conclusion, STE method is a robust and innovative approach to rank substances in the 
chemicals risk assessment. When reliable data are available (measurements and 
EQS/PNEC values) STE could be applied for a variety of environmental compartments or 
receptors including surface and marine waters, sediment, biota, groundwater, and 
drinking water. 
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Annex 2: Sediment and SPM monitoring data 
Monitoring data on sediment were submitted by five countries. Substances detected in 
sediment were 2-ethylhexyl-4-methoxycinnamate (countries #07, #09 and #29), 
clarithromycin (country #06), and diclofenac (only once detected in country #06).  
The maximum concentration detected for 2-ethylhexyl-4-methoxycinnamate in sediment 
was 35 µg/kg, and therefore did not exceed the PNEC of 200 µg/kg. The total number of 
samples was 31.  
 
Annex 2.1 Summary on sediment monitoring data. 
 
Country # of 
samples 
Substances Results 
#06 290 (years 
2014-
2016) 
Clarithromycin 
Diclofenac 
Erythromycin 
Triallate 
Clarithromycin: often detected above the LOQ 
(2 µg/kg); mean: 6.5 µg/kg; max.: 65 µg/kg. 
Diclofenac: Only detected once above the 
LOQ of 10 µg/kg. 
Erythromycin: Not detected above the LOQ of 
10 µg/kg. 
Triallate: Not detected above the LOQ of 10 
µg/kg. 
#07 11 2-Ethylhexyl-4-
methoxycinnamate 
All monitoring data on 2-ethylhexyl-4-
methoxycinnamate in sediment were below 
the LOQ, which was between 2 and 10 µg/kg. 
No information on nearby pressure “bathing 
site” was given.  
(number of samples: 11) 
#09 68 17-alpha-
Ethinylestradiol 
17-beta-Estradiol 
2,6-Ditert-butyl-4-
methylphenol 
2-Ethylhexyl-4-
methoxycinnamate 
Azithromycin 
Clarithromycin  
Diclofenac 
Erythromycin 
Estrone 
Triallate 
All measurements except one (for 2-
ethylhexyl 4-methoxycinnamate) were below 
the LOD.  
2-Ethylhexyl-4-methoxycinnamate was 
detected at one monitoring site at a 
concentration of 8.5 µg/kg dry weight. No 
information on nearby pressure “bathing site” 
was given. 
(number of samples: 4) 
 
#26 18 2,6-Ditert-butyl-4-
methylphenol 
2-Ethylhexyl-4-
methoxycinnamate 
Triallate 
Three substances were measured at 6 
locations. All data were below the LOQ. 
2,6-Ditert-butyl-4-methylphenol: LOQ 0.5 
µg/kg; 
2-Ethylhexyl-4-methoxycinnamate: LOQ 0.2 
µg/kg; 
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Country # of 
samples 
Substances Results 
Triallate: LOQ 0.5 µg/kg. 
#29 16 2-Ethylhexyl-4-
methoxycinnamate 
 
2-Ethylhexyl-4-methoxycinnamate was 
detected 6 times (out of 16 samples) above 
the LOQ of 7 µg/kg. The maximum 
concentration was 35 µg/kg. No information 
on nearby pressure “bathing site” was given.  
A screening study was undertaken in 2014; 
most samples were taken close to 
recreational bathing sites. A more detailed 
study in a small lake with popular bathing 
sites where surface water and sediment were 
sampled before, during and after the bathing 
season. In addition surface water and 
sediment samples were taken upstream and 
downstream a STP effluent point.  
In an earlier screening study, several sites 
were sampled before and during the bathing 
season. Results from that study have been 
reported to JRC previously.  
 
 
In addition, SPM (suspended particle matter) monitoring data were submitted by country 
#6 for clarithromycin, diclofenac, erythromycin, and triallate (years 2014-2016). Only 
clarithromycin was detected above the LOQ (median concentration: 39 µg/kg) (see table 
below). 
 
 
 
Annex 2.2 Summary on SPM monitoring data of country #6 (concentrations in 
µg/kg). 
 
Substance Number of 
samples 
LOQ Min Median Mean Max Comment 
Clarithromycin 11 2 12.0 39.0 45.4 93.0 All samples > 
LOQ 
Diclofenac 11 10 n.a. n.a. n.a. n.a. All samples < 
LOQ 
Erythromycin 11 10 n.a. n.a. n.a. n.a. All samples < 
LOQ 
Triallate 549 10 n.a. n.a. n.a. n.a. All samples < 
LOQ 
 
 
 
87 
Annex 3: Detailed statistics for WL substances by WL dataset 
 
Annex 3.1 PNECs from 2015 
 
Substance 
PNEC 
(µg/L) Scenario Countries Sites Samples 
Samples 
< LOQ 
Quantified 
samples 
(%) Min Mean SD Median P90 P95 Max 
17-alpha-
Ethinylestradiol 3.50E-05 Sc2 25 223 558 476 14.70 1.50E-05 5.53E-04 1.80E-03 5.00E-05 1.00E-03 1.00E-03 1.25E-02 
  
Sc1 10 54 82 0 100.00 3.00E-05 2.28E-04 4.28E-04 1.00E-04 3.59E-04 7.79E-04 3.00E-03 
  
Sc3 14 122 323 241 25.39 1.50E-05 6.99E-05 2.34E-04 1.50E-05 1.51E-04 2.57E-04 3.00E-03 
17-beta-Estradiol 4.00E-04 Sc2 25 228 597 496 16.92 1.50E-05 5.92E-04 1.72E-03 1.70E-04 7.00E-04 1.50E-03 1.25E-02 
  
Sc1 11 60 101 0 100.00 4.28E-05 4.11E-04 4.83E-04 2.10E-04 1.00E-03 1.30E-03 3.00E-03 
  
Sc3 18 180 462 361 21.86 1.50E-05 2.01E-04 2.56E-04 1.50E-04 2.50E-04 5.58E-04 3.00E-03 
2,6-Di-tert-butyl-4-
methylphenol 3.16E+00 Sc2 24 244 1035 978 5.51 1.00E-04 1.00E-01 6.66E-01 5.00E-03 1.05E-01 2.50E-01 1.40E+01 
  
Sc1 6 22 57 0 100.00 6.66E-03 5.12E-01 2.50E+00 1.80E-02 1.00E-01 2.60E-01 1.40E+01 
  
Sc3 23 241 1032 975 5.52 1.00E-04 8.77E-02 6.23E-01 5.00E-03 1.05E-01 2.50E-01 1.40E+01 
2-Ethylhexyl-4-
methoxycinnamate 6.00E+00 Sc2 24 200 546 430 21.25 5.00E-04 3.67E-01 9.72E-01 5.00E-02 7.55E-01 3.00E+00 9.00E+00 
  
Sc1 6 19 116 0 100.00 3.00E-03 4.20E-01 4.05E-01 3.05E-01 1.00E+00 1.40E+00 1.80E+00 
  
Sc3 23 197 543 427 21.36 5.00E-04 3.19E-01 7.32E-01 5.00E-02 7.50E-01 3.00E+00 3.00E+00 
Acetamiprid 5.00E-01 Sc2 24 372 2221 2206 0.68 2.50E-04 6.72E-03 6.17E-03 5.00E-03 1.00E-02 1.00E-02 7.40E-02 
  
Sc1 7 10 15 0 100.00 1.37E-03 1.41E-02 1.89E-02 9.00E-03 2.96E-02 4.46E-02 7.40E-02 
  
Sc3 24 372 2221 2206 0.68 2.50E-04 6.72E-03 6.17E-03 5.00E-03 1.00E-02 1.00E-02 7.40E-02 
Azithromycin  9.00E-02 Sc2 24 288 1553 1288 17.06 1.00E-04 2.98E-02 1.85E-01 2.20E-02 3.29E-02 5.52E-02 5.00E+00 
  
Sc1 14 75 265 0 100.00 2.00E-04 6.16E-02 1.10E-01 2.30E-02 1.50E-01 2.49E-01 1.00E+00 
  
Sc3 24 286 1551 1286 17.09 1.00E-04 2.34E-02 4.96E-02 2.20E-02 3.20E-02 5.30E-02 1.00E+00 
Clarithromycin 1.30E-01 Sc2 24 323 2792 1150 58.81 3.80E-05 4.71E-02 1.08E-01 1.60E-02 9.59E-02 1.74E-01 1.60E+00 
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Substance 
PNEC 
(µg/L) Scenario Countries Sites Samples 
Samples 
< LOQ 
Quantified 
samples 
(%) Min Mean SD Median P90 P95 Max 
  
Sc1 17 201 1642 0 100.00 3.80E-05 7.33E-02 1.35E-01 3.40E-02 1.53E-01 2.80E-01 1.60E+00 
  
Sc3 24 323 2792 1150 58.81 3.80E-05 4.71E-02 1.08E-01 1.60E-02 9.59E-02 1.74E-01 1.60E+00 
Clothianidin 1.30E-01 Sc2 24 343 2254 2037 9.63 5.00E-04 1.09E-02 2.77E-02 5.00E-03 1.10E-02 3.25E-02 7.80E-01 
  
Sc1 6 47 217 0 100.00 7.00E-04 4.35E-02 8.05E-02 1.60E-02 1.00E-01 1.73E-01 7.80E-01 
  
Sc3 24 343 2254 2037 9.63 5.00E-04 1.09E-02 2.77E-02 5.00E-03 1.10E-02 3.25E-02 7.80E-01 
Diclofenac 1.00E-01 Sc2 25 607 6698 2096 68.71 4.25E-04 6.66E-02 1.26E-01 2.74E-02 1.60E-01 2.63E-01 2.60E+00 
  
Sc1 21 529 4602 0 100.00 1.40E-03 9.32E-02 1.45E-01 4.70E-02 2.10E-01 3.40E-01 2.60E+00 
  
Sc3 25 607 6698 2096 68.71 4.25E-04 6.66E-02 1.26E-01 2.74E-02 1.60E-01 2.63E-01 2.60E+00 
Erythromycin 2.00E-01 Sc2 24 299 2520 2309 8.37 5.00E-04 1.15E-02 4.00E-02 5.00E-03 1.40E-02 2.81E-02 1.10E+00 
  
Sc1 12 89 211 0 100.00 1.00E-03 6.01E-02 1.27E-01 2.60E-02 1.00E-01 2.00E-01 1.10E+00 
  
Sc3 24 299 2520 2309 8.37 5.00E-04 1.15E-02 4.00E-02 5.00E-03 1.40E-02 2.81E-02 1.10E+00 
Estrone 3.60E-03 Sc2 23 212 574 261 54.53 1.50E-05 1.29E-03 2.87E-03 5.00E-04 2.58E-03 5.00E-03 3.13E-02 
  
Sc1 13 141 313 0 100.00 3.97E-05 1.50E-03 3.14E-03 6.39E-04 2.99E-03 5.02E-03 3.13E-02 
  
Sc3 20 197 552 239 56.70 1.50E-05 1.01E-03 2.43E-03 5.00E-04 1.70E-03 3.50E-03 3.13E-02 
Imidacloprid 9.00E-03 Sc2 24 376 2385 1964 17.65 3.00E-04 1.08E-02 2.83E-02 5.00E-03 1.70E-02 2.68E-02 1.05E+00 
  
Sc1 15 123 421 0 100.00 1.20E-03 3.12E-02 6.31E-02 1.80E-02 5.80E-02 8.20E-02 1.05E+00 
  
Sc3 22 326 1845 1424 22.82 3.00E-04 1.09E-02 3.21E-02 5.00E-03 2.00E-02 3.40E-02 1.05E+00 
Methiocarb 1.00E-02 Sc2 24 369 1834 1828 0.33 5.00E-04 6.14E-03 4.10E-03 5.00E-03 1.00E-02 1.00E-02 1.09E-01 
  
Sc1 2 4 6 0 100.00 2.00E-02 3.96E-02 3.44E-02 2.79E-02 7.10E-02 9.00E-02 1.09E-01 
  
Sc3 22 356 1798 1792 0.33 5.00E-04 5.90E-03 3.66E-03 5.00E-03 1.00E-02 1.00E-02 1.09E-01 
Oxadiazon 8.80E-02 Sc2 24 339 1849 1772 4.16 5.00E-04 1.10E-02 1.47E-02 5.00E-03 4.00E-02 4.00E-02 3.10E-01 
  
Sc1 5 17 77 0 100.00 1.80E-03 2.28E-02 4.25E-02 1.00E-02 5.00E-02 7.08E-02 3.10E-01 
  
Sc3 23 337 1847 1770 4.17 5.00E-04 1.09E-02 1.44E-02 5.00E-03 4.00E-02 4.00E-02 3.10E-01 
Thiacloprid 5.00E-02 Sc2 24 374 2243 2146 4.32 3.50E-04 6.82E-03 1.35E-02 5.00E-03 1.00E-02 1.00E-02 5.70E-01 
  
Sc1 12 50 97 0 100.00 8.00E-04 2.64E-02 6.07E-02 1.50E-02 4.40E-02 7.90E-02 5.70E-01 
  
Sc3 24 374 2243 2146 4.32 3.50E-04 6.82E-03 1.35E-02 5.00E-03 1.00E-02 1.00E-02 5.70E-01 
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Substance 
PNEC 
(µg/L) Scenario Countries Sites Samples 
Samples 
< LOQ 
Quantified 
samples 
(%) Min Mean SD Median P90 P95 Max 
Thiamethoxam 1.40E-01 Sc2 24 418 4020 3764 6.37 5.00E-04 7.57E-03 1.81E-02 5.00E-03 1.00E-02 1.25E-02 7.70E-01 
  
Sc1 10 67 256 0 100.00 1.20E-03 3.16E-02 6.52E-02 1.50E-02 5.75E-02 1.23E-01 7.70E-01 
  
Sc3 24 418 4020 3764 6.37 5.00E-04 7.57E-03 1.81E-02 5.00E-03 1.00E-02 1.25E-02 7.70E-01 
Tri-allate  6.70E-01 Sc2 24 338 2169 2031 6.36 5.00E-04 1.54E-02 4.50E-02 5.00E-03 2.50E-02 3.50E-02 9.45E-01 
  
Sc1 4 23 138 0 100.00 2.20E-03 3.73E-02 4.40E-02 2.20E-02 8.19E-02 1.13E-01 2.70E-01 
  
Sc3 23 335 2166 2028 6.37 5.00E-04 1.41E-02 2.89E-02 5.00E-03 2.50E-02 3.30E-02 3.35E-01 
The figure below shows for Sc2 of WL dataset a box-whisker plot of all records (quantified and non-quantified) for WL substances in 
comparison to their PNEC values taken from the WL report 2015. The concentrations of the non-quantified samples are set to LOQ/2. The 
lowermost line of the figure also indicates the total number of samples per substance. 
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Next figure shows for Sc1 of WL dataset a box-whisker plot only of the quantified concentrations for WL substances in comparison to their 
PNEC according the WL report 2015. The figure also indicates the number of quantified samples per substance. Attention should be paid 
on the fact that for 2 substances (acetamiprid and methiocarb) the amount of the quantified samples is below the statistical threshold of 
51 applied in the prioritisation monitoring exercise in 2016.  
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Annex 3.2 Updated PNECs 
 
Substance 
PNEC 
(µg/L) Scenario Countries Sites Samples 
Samples 
< LOQ 
Quantified 
samples 
(%) Min Mean SD Median P90 P95 Max 
17-alpha-
Ethinylestradiol 3.50E-05 Sc2 25 223 558 476 14.70 1.50E-05 5.53E-04 1.80E-03 5.00E-05 1.00E-03 1.00E-03 1.25E-02 
  
Sc1 10 54 82 0 100.00 3.00E-05 2.28E-04 4.28E-04 1.00E-04 3.59E-04 7.79E-04 3.00E-03 
  
Sc3 14 122 323 241 25.39 1.50E-05 6.99E-05 2.34E-04 1.50E-05 1.51E-04 2.57E-04 3.00E-03 
17-beta-Estradiol 4.00E-04 Sc2 25 228 597 496 16.92 1.50E-05 5.92E-04 1.72E-03 1.70E-04 7.00E-04 1.50E-03 1.25E-02 
  
Sc1 11 60 101 0 100.00 4.28E-05 4.11E-04 4.83E-04 2.10E-04 1.00E-03 1.30E-03 3.00E-03 
  
Sc3 18 180 462 361 21.86 1.50E-05 2.01E-04 2.56E-04 1.50E-04 2.50E-04 5.58E-04 3.00E-03 
2,6-Di-tert-butyl-4-
methylphenol 3.16E+00 Sc2 24 244 1035 978 5.51 1.00E-04 1.00E-01 6.66E-01 5.00E-03 1.05E-01 2.50E-01 1.40E+01 
  
Sc1 6 22 57 0 100.00 6.66E-03 5.12E-01 2.50E+00 1.80E-02 1.00E-01 2.60E-01 1.40E+01 
  
Sc3 23 241 1032 975 5.52 1.00E-04 8.77E-02 6.23E-01 5.00E-03 1.05E-01 2.50E-01 1.40E+01 
2-Ethylhexyl-4-
methoxycinnamate 6.00E+00 Sc2 24 200 546 430 21.25 5.00E-04 3.67E-01 9.72E-01 5.00E-02 7.55E-01 3.00E+00 9.00E+00 
  
Sc1 6 19 116 0 100.00 3.00E-03 4.20E-01 4.05E-01 3.05E-01 1.00E+00 1.40E+00 1.80E+00 
  
Sc3 23 197 543 427 21.36 5.00E-04 3.19E-01 7.32E-01 5.00E-02 7.50E-01 3.00E+00 3.00E+00 
Acetamiprid 5.00E-01 Sc2 24 372 2221 2206 0.68 2.50E-04 6.72E-03 6.17E-03 5.00E-03 1.00E-02 1.00E-02 7.40E-02 
  
Sc1 7 10 15 0 100.00 1.37E-03 1.41E-02 1.89E-02 9.00E-03 2.96E-02 4.46E-02 7.40E-02 
  
Sc3 24 372 2221 2206 0.68 2.50E-04 6.72E-03 6.17E-03 5.00E-03 1.00E-02 1.00E-02 7.40E-02 
Azithromycin  1.90E-02 Sc2 24 288 1553 1288 17.06 1.00E-04 2.98E-02 1.85E-01 2.20E-02 3.29E-02 5.52E-02 5.00E+00 
  
Sc1 14 75 265 0 100.00 2.00E-04 6.16E-02 1.10E-01 2.30E-02 1.50E-01 2.49E-01 1.00E+00 
  
Sc3 19 192 915 650 28.96 1.00E-04 2.14E-02 6.43E-02 5.00E-03 4.59E-02 8.53E-02 1.00E+00 
Clarithromycin 1.20E-01 Sc2 24 323 2792 1150 58.81 3.80E-05 4.71E-02 1.08E-01 1.60E-02 9.59E-02 1.74E-01 1.60E+00 
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Substance 
PNEC 
(µg/L) Scenario Countries Sites Samples 
Samples 
< LOQ 
Quantified 
samples 
(%) Min Mean SD Median P90 P95 Max 
  
Sc1 17 201 1642 0 100.00 3.80E-05 7.33E-02 1.35E-01 3.40E-02 1.53E-01 2.80E-01 1.60E+00 
  
Sc3 24 323 2792 1150 58.81 3.80E-05 4.71E-02 1.08E-01 1.60E-02 9.59E-02 1.74E-01 1.60E+00 
Clothianidin 1.30E-01 Sc2 24 343 2254 2037 9.63 5.00E-04 1.09E-02 2.77E-02 5.00E-03 1.10E-02 3.25E-02 7.80E-01 
  
Sc1 6 47 217 0 100.00 7.00E-04 4.35E-02 8.05E-02 1.60E-02 1.00E-01 1.73E-01 7.80E-01 
  
Sc3 24 343 2254 2037 9.63 5.00E-04 1.09E-02 2.77E-02 5.00E-03 1.10E-02 3.25E-02 7.80E-01 
Diclofenac 5.00E-02 Sc2 25 607 6698 2096 68.71 4.25E-04 6.66E-02 1.26E-01 2.74E-02 1.60E-01 2.63E-01 2.60E+00 
  
Sc1 21 529 4602 0 100.00 1.40E-03 9.32E-02 1.45E-01 4.70E-02 2.10E-01 3.40E-01 2.60E+00 
  
Sc3 25 607 6698 2096 68.71 4.25E-04 6.66E-02 1.26E-01 2.74E-02 1.60E-01 2.63E-01 2.60E+00 
Erythromycin 2.00E-01 Sc2 24 300 2520 2309 8.37 5.00E-04 1.15E-02 4.00E-02 5.00E-03 1.40E-02 2.81E-02 1.10E+00 
  
Sc1 12 89 211 0 100.00 1.00E-03 6.01E-02 1.27E-01 2.60E-02 1.00E-01 2.00E-01 1.10E+00 
  
Sc3 24 300 2520 2309 8.37 5.00E-04 1.15E-02 4.00E-02 5.00E-03 1.40E-02 2.81E-02 1.10E+00 
Estrone 3.60E-03 Sc2 23 212 574 261 54.53 1.50E-05 1.29E-03 2.87E-03 5.00E-04 2.58E-03 5.00E-03 3.13E-02 
  
Sc1 13 141 313 0 100.00 3.97E-05 1.50E-03 3.14E-03 6.39E-04 2.99E-03 5.02E-03 3.13E-02 
  
Sc3 20 197 552 239 56.70 1.50E-05 1.01E-03 2.43E-03 5.00E-04 1.70E-03 3.50E-03 3.13E-02 
Imidacloprid 8.30E-03 Sc2 24 376 2385 1964 17.65 3.00E-04 1.08E-02 2.83E-02 5.00E-03 1.70E-02 2.68E-02 1.05E+00 
  
Sc1 15 123 421 0 100.00 1.20E-03 3.12E-02 6.31E-02 1.80E-02 5.80E-02 8.20E-02 1.05E+00 
  
Sc3 22 326 1845 1424 22.82 3.00E-04 1.09E-02 3.21E-02 5.00E-03 2.00E-02 3.40E-02 1.05E+00 
Methiocarb 2.00E-03 Sc2 24 369 1834 1828 0.33 5.00E-04 6.14E-03 4.10E-03 5.00E-03 1.00E-02 1.00E-02 1.09E-01 
  
Sc1 2 4 6 0 100.00 2.00E-02 3.96E-02 3.44E-02 2.79E-02 7.10E-02 9.00E-02 1.09E-01 
  
Sc3 7 56 127 121 4.72 5.00E-04 2.76E-03 1.07E-02 1.00E-03 1.50E-03 1.65E-03 1.09E-01 
Oxadiazon 8.80E-02 Sc2 24 339 1849 1772 4.16 5.00E-04 1.10E-02 1.47E-02 5.00E-03 4.00E-02 4.00E-02 3.10E-01 
  
Sc1 5 17 77 0 100.00 1.80E-03 2.28E-02 4.25E-02 1.00E-02 5.00E-02 7.08E-02 3.10E-01 
  
Sc3 23 337 1847 1770 4.17 5.00E-04 1.09E-02 1.44E-02 5.00E-03 4.00E-02 4.00E-02 3.10E-01 
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Substance 
PNEC 
(µg/L) Scenario Countries Sites Samples 
Samples 
< LOQ 
Quantified 
samples 
(%) Min Mean SD Median P90 P95 Max 
Thiacloprid 1.00E-02 Sc2 24 374 2243 2146 4.32 3.50E-04 6.82E-03 1.35E-02 5.00E-03 1.00E-02 1.00E-02 5.70E-01 
  
Sc1 12 50 97 0 100.00 8.00E-04 2.64E-02 6.07E-02 1.50E-02 4.40E-02 7.90E-02 5.70E-01 
  
Sc3 23 366 2235 2138 4.34 3.50E-04 6.79E-03 1.35E-02 5.00E-03 1.00E-02 1.00E-02 5.70E-01 
Thiamethoxam 4.20E-02 Sc2 24 418 4020 3764 6.37 5.00E-04 7.57E-03 1.81E-02 5.00E-03 1.00E-02 1.25E-02 7.70E-01 
  
Sc1 10 67 256 0 100.00 1.20E-03 3.16E-02 6.52E-02 1.50E-02 5.75E-02 1.23E-01 7.70E-01 
  
Sc3 23 412 3979 3723 6.43 5.00E-04 7.18E-03 1.78E-02 5.00E-03 1.00E-02 1.00E-02 7.70E-01 
Tri-allate  4.10E-01 Sc2 24 338 2169 2031 6.36 5.00E-04 1.54E-02 4.50E-02 5.00E-03 2.50E-02 3.50E-02 9.45E-01 
  
Sc1 4 23 138 0 100.00 2.20E-03 3.73E-02 4.40E-02 2.20E-02 8.19E-02 1.13E-01 2.70E-01 
  
Sc3 23 335 2166 2028 6.37 5.00E-04 1.41E-02 2.89E-02 5.00E-03 2.50E-02 3.30E-02 3.35E-01 
 
 
 
 
 
 
The figure below shows for Sc2 of WL dataset a box-whisker plot of all records (quantified and non-quantified) for WL substances in 
comparison to the updated PNECs. The concentrations of the non-quantified samples are set to LOQ/2. The lowermost line of the figure 
also indicates the total number of samples per substance. 
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The next figure presents for Sc1 of WL dataset a box-whisker plot only of the quantified concentrations for WL substances in comparison 
to the updated PNECs. The figure also indicates the number of quantified samples per substance. Attention should be paid on the fact that 
for 2 substances (acetamiprid and methiocarb) the amount of the quantified samples is below the statistical threshold of 51 applied in the 
prioritisation monitoring exercise in 2016. 
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Annex 4: Analysis on LOQs by WL dataset for non-quantified samples of substances with reduced data 
quality (Sc2) 
 
Annex 4.1. EE2 (PNEC = 0.000035 µg/L).  
LOQ (µg/L) # of samples Countries (#) 
0.000030 172 3, 7, 13, 26 
0.000035 57 11, 19, 20, 22 
0.00005 11 6, 7 
0.00006 1 13 
0.0001 70 1, 2, 6, 7, 12, 24 
0.00013 1 7 
0.00025 3 7 
0.0003 11 5, 7 
0.0004 16 16, 27 
0.00094 2 15 
0.001 24 6, 8, 19, 29, 31 
0.002 88 6, 8, 28 
0.003 1 8 
0.01 8 9, 21 
0.02 1 8 
0.025 10 30 
 
Annex 4.2. E2 (PNEC = 0.0004 µg/L). 
LOQ (µg/L) # of samples Countries (#) 
0.00003 16 7, 13 
0.00005 1 7 
0.0001 44 1, 7, 19, 24 
0.00012 8 7 
0.0002 7 7 
0.00025 17 7 
0.0003 163 6, 26 
0.0004 104 2, 3, 7, 9, 11, 12, 16, 19, 20, 22, 27 
0.0005 2 7 
0.00099 2 15 
0.001 88 6, 8, 29 
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0.0012 3 5 
0.002 3 2, 8 
0.003 17 8, 28 
0.01 12 9, 21, 31 
0.025 10 30 
 
Annex 4.3. Estrone (PNEC = 0.0036 µg/L). 
LOQ (µg/L) # of samples Countries (#) 
0.00003 1 7 
0.0001 9 19, 24 
0.0003 33 26 
0.0004 50 2, 7, 11, 12, 16, 19, 20, 22 
0.0005 14 7 
0.00087 2 15 
0.0009 3 5 
0.001 122 6, 8, 29 
0.002 4 2, 8 
0.0025 2 2 
0.003 1 8 
0.01 12 9, 21, 31 
0.025 10 30 
 
 
Annex 4.4. Imidacloprid (PNEC = 0.009 µg/L). 
LOQ (µg/L) # of samples Countries (#) 
0.0006 1 7 
0.001 18 2, 7, 13, 17 
0.0012 7 15 
0.005 47 7, 9, 11, 19 
0.006 11 24 
0.009 123 3, 5, 7, 16, 19, 20, 22, 31 
0.01 1070 2, 6, 7, 9, 12, 19, 29, 30 
0.011 109 26 
0.013 38 1 
0.02 519 6, 7, 19, 21, 29 
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0.025 5 27 
0.04 1 29 
0.05 15 8, 9, 29 
 
Annex 4.5. Methiocarb (PNEC = 0.01 µg/L). 
LOQ (µg/L) # of samples Countries (#) 
0.001 29 13, 17 
0.002 81 29 
0.003 8 7 
0.0033 3 15 
0.005 26 6, 7, 9, 11 
0.007 12 7 
0.008 41 1 
0.009 10 16 
0.01 1176 2, 3, 5, 6, 7, 9, 12, 19, 20, 24, 30, 31 
0.02 406 2, 6, 7, 8, 9, 26 
0.025 16 7, 27 
0.03 4 21 
0.05 16 7 
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Annex 4.6. Data quality check versus the maximum acceptable method detection limit (Decision EU/2015/495) 
 
On the figures shown below PNEC values are considered as equal to the maximum acceptable method detection limit (Commission 
Implementing Decision EU/2015/495). 
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The WL data quality check according to the maximum acceptable method detection limit (Commission Implementing Decision 
EU/2015/495) allows concluding that all Estrogens and Neonicotinoid insecticides have a reduced but adequate data quality to perform a 
relevant assessment. 
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Annex 5: STE results by the WL dataset 
 
Annex 5.1 PNECs from 2015: STE factors, STE scores and RQ(P95) for all data scenarios. 
CAS Substance 
PNEC 
(µg/L) Type Scenario RQ(p95) Fspat Ftemp Fext STE score 
57-63-6 
17-alpha-
Ethinylestradiol 3.50E-05 Estrogen Sc2 2.86E+01 5.66E-01 7.84E-01 5.60E-01 1.91E+00 
    
Sc1 2.23E+01 9.26E-01 9.85E-01 2.80E-01 2.19E+00 
    
Sc3 7.35E+00 2.67E-01 5.21E-01 1.10E-01 8.99E-01 
50-28-2 17-beta-Estradiol 4.00E-04 Estrogen Sc2 3.75E+00 2.01E-01 7.84E-01 1.80E-01 1.17E+00 
    
Sc1 3.26E+00 3.00E-01 7.20E-01 7.00E-02 1.09E+00 
    
Sc3 1.28E+00 5.40E-02 5.58E-01 7.00E-02 6.82E-01 
128-37-0 
2,6-Di-tert-butyl-4-
methylphenol 3.16E+00 Antioxidant Sc2 7.91E-02 6.80E-04 1.67E-01 0.00E+00 1.67E-01 
    
Sc1 8.23E-02 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
    
Sc3 7.91E-02 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
5466-77-3 
2-Ethylhexyl-4-
methoxycinnamate 6.00E+00 Sunscreen Sc2 5.00E-01 6.22E-04 0.00E+00 0.00E+00 6.22E-04 
    
Sc1 2.33E-01 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
    
Sc3 5.00E-01 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
135410-20-7 Acetamiprid 5.00E-01 
Neonicotinoid 
Insecticide Sc2 2.00E-02 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
    
Sc1 8.92E-02 n/a n/a n/a n/a 
    
Sc3 2.00E-02 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
83905-01-5 Azithromycin  9.00E-02 Antibiotic Sc2 6.13E-01 7.81E-03 3.03E-01 4.00E-02 3.51E-01 
    
Sc1 2.77E+00 1.09E-01 5.42E-01 7.00E-02 7.20E-01 
    
Sc3 5.89E-01 4.66E-03 3.03E-01 4.00E-02 3.48E-01 
81103-11-9 Clarithromycin 1.30E-01 Antibiotic Sc2 1.34E+00 2.57E-02 4.19E-01 7.00E-02 5.15E-01 
    
Sc1 2.15E+00 8.19E-02 4.41E-01 7.00E-02 5.93E-01 
    
Sc3 1.34E+00 2.57E-02 4.19E-01 7.00E-02 5.15E-01 
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CAS Substance 
PNEC 
(µg/L) Type Scenario RQ(p95) Fspat Ftemp Fext STE score 
210880-92-5 Clothianidin 1.30E-01 
Neonicotinoid 
Insecticide Sc2 2.50E-01 2.43E-04 2.85E-01 0.00E+00 2.86E-01 
    
Sc1 1.33E+00 2.13E-02 2.48E-01 4.00E-02 3.09E-01 
    
Sc3 2.50E-01 2.43E-04 2.85E-01 0.00E+00 2.86E-01 
15307-86-5 Diclofenac 1.00E-01 Analgesic Sc2 2.63E+00 2.10E-01 3.65E-01 7.00E-02 6.45E-01 
    
Sc1 3.40E+00 3.12E-01 4.42E-01 1.10E-01 8.64E-01 
    
Sc3 2.63E+00 2.10E-01 3.65E-01 7.00E-02 6.45E-01 
114-07-8 Erythromycin 2.00E-01 Antibiotic Sc2 1.41E-01 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
    
Sc1 1.00E+00 1.31E-02 4.27E-01 4.00E-02 4.80E-01 
    
Sc3 1.41E-01 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
53-16-7 Estrone 3.60E-03 Estrogen Sc2 1.39E+00 6.12E-02 6.65E-01 7.00E-02 7.96E-01 
    
Sc1 1.39E+00 6.11E-02 5.71E-01 4.00E-02 6.72E-01 
    
Sc3 9.72E-01 2.12E-02 4.81E-01 4.00E-02 5.42E-01 
138261-41-3 Imidacloprid 9.00E-03 
Neonicotinoid 
Insecticide Sc2 2.98E+00 2.77E-01 6.21E-01 1.10E-01 1.01E+00 
    
Sc1 9.11E+00 8.42E-01 9.83E-01 1.80E-01 2.00E+00 
    
Sc3 3.67E+00 1.87E-01 4.34E-01 1.10E-01 7.31E-01 
2032-65-7 Methiocarb 1.00E-02 Insecticide/Herbicide Sc2 1.00E+00 7.68E-03 8.60E-01 4.00E-02 9.08E-01 
    
Sc1 9.00E+00 n/a n/a n/a n/a 
    
Sc3 1.00E+00 5.11E-04 4.05E-01 4.00E-02 4.45E-01 
19666-30-9 Oxadiazon 8.80E-02 Herbicide Sc2 4.55E-01 9.83E-04 1.00E-01 0.00E+00 1.01E-01 
    
Sc1 8.05E-01 4.71E-02 3.33E-01 7.00E-02 4.50E-01 
    
Sc3 4.55E-01 2.58E-04 1.00E-01 0.00E+00 1.00E-01 
111988-49-9 Thiacloprid 5.00E-02 
Neonicotinoid 
Insecticide Sc2 2.00E-01 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
    
Sc1 1.58E+00 5.33E-02 3.45E-01 7.00E-02 4.69E-01 
    
Sc3 2.00E-01 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
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CAS Substance 
PNEC 
(µg/L) Type Scenario RQ(p95) Fspat Ftemp Fext STE score 
153719-23-4 Thiamethoxam 1.40E-01 
Neonicotinoid 
Insecticide Sc2 8.93E-02 9.97E-05 6.14E-02 0.00E+00 6.15E-02 
    
Sc1 8.75E-01 4.48E-03 2.23E-01 0.00E+00 2.27E-01 
    
Sc3 8.93E-02 9.97E-05 6.14E-02 0.00E+00 6.15E-02 
2303-17-5 Tri-allate  6.70E-01 Herbicide Sc2 5.22E-02 3.70E-04 0.00E+00 0.00E+00 3.70E-04 
    
Sc1 1.69E-01 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
    
Sc3 4.93E-02 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
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The figure shows a comparison of STE scores obtained by WL dataset for scenarios Sc1 and Sc3. In Sc1 no scores were presented for methiocarb and 
acetamiprid since they did not fulfil the representativity criteria for this scenario. PNECs correspond to those in the WL report 2015. 
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The table below gives per substance for Sc3 and PNECs from 2005 information for the site (Fs,site) and country (Fs,country) frequency of 
exceedances in Fspat, the calculation of Ftemp by all sites (Ftemp_1) and excluding sites with a single measurement that exceeds PNEC 
(Ftemp_2), the size of the exceedance extent in Fext, the percentage (from the total number of samples) of samples that exceed PNEC 
and the total amount of samples.  
Substance PNEC (μg/L) (WL 
report 2015) 
Type Fs,site Fs,country Ftemp_1 Ftemp_2 EXCextent Exceeding 
samples (%) 
Number of 
samples (Sc3) 
17-alpha-Ethinylestradiol 3.50E-05 Estrogen 3.74E-01 7.14E-01 7.13E-01 5.21E-01 9.79E+00 22.91 323 
17-beta-Estradiol 4.00E-04 Estrogen 1.17E-01 4.12E-01 7.26E-01 5.58E-01 1.87E+00 6.72 461 
2,6-Di-tert-butyl-4-
methylphenol 
3.16E+00 Antioxidant 4.13E-03 0.00E+00 1.67E-01 1.67E-01 3.09E-01 0.19 1032 
2-Ethylhexyl-4-
methoxycinnamate 
6.00E+00 Sunscreen 0.00E+00 0.00E+00 0.00E+00 0.00E+00 5.00E-01 0.00 543 
Acetamiprid 5.00E-01 Neonicotinoid Insecticide 0.00E+00 0.00E+00 0.00E+00 0.00E+00 2.50E-02 0.00 2221 
Azithromycin  9.00E-02 Antibiotic 5.59E-02 8.33E-02 3.40E-01 3.03E-01 1.13E+00 2.71 1551 
Clarithromycin 1.30E-01 Antibiotic 1.23E-01 2.08E-01 4.19E-01 4.06E-01 2.29E+00 7.02 2792 
Clothianidin 1.30E-01 Neonicotinoid Insecticide 5.83E-03 4.17E-02 2.85E-01 2.85E-01 2.50E-01 0.67 2254 
Diclofenac 1.00E-01 Analgesic 3.49E-01 6.00E-01 3.64E-01 3.29E-01 4.39E+00 16.11 6697 
Erythromycin 2.00E-01 Antibiotic 1.33E-02 0.00E+00 2.68E-01 1.46E-01 4.25E-01 0.44 2520 
Estrone 3.60E-03 Estrogen 7.07E-02 3.00E-01 6.75E-01 4.81E-01 1.30E+00 4.53 552 
Imidacloprid 9.00E-03 Neonicotinoid Insecticide 3.02E-01 5.45E-01 5.53E-01 4.16E-01 6.61E+00 19.29 1830 
Methiocarb 1.00E-02 Insecticide/Herbicide 1.12E-02 4.55E-02 4.05E-01 4.05E-01 1.00E+00 0.33 1798 
Oxadiazon 8.80E-02 Herbicide 5.93E-03 4.35E-02 5.50E-01 1.00E-01 5.00E-01 0.11 1847 
Thiacloprid 5.00E-02 Neonicotinoid Insecticide 1.07E-02 0.00E+00 9.76E-02 9.76E-02 3.60E-01 0.36 2243 
Thiamethoxam 1.40E-01 Neonicotinoid Insecticide 2.39E-03 4.17E-02 6.14E-02 6.14E-02 2.01E-01 0.25 4020 
Triallate  6.70E-01 Herbicide 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1.49E-01 0.00 2166 
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Annex 5.2 WL data and updated PNECs: STE factors, STE scores and RQ(P95) for all scenarios. 
 
CAS Substance 
PNEC 
(µg/L) Type Scenario RQ(p95) Fspat Ftemp Fext STE score 
57-63-6 
17-alpha-
Ethinylestradiol 3.50E-05 Estrogen Sc2 2.86E+01 5.66E-01 7.84E-01 5.60E-01 1.91E+00 
    
Sc1 2.23E+01 9.26E-01 9.85E-01 2.80E-01 2.19E+00 
    
Sc3 7.35E+00 2.67E-01 5.21E-01 1.10E-01 8.99E-01 
50-28-2 17-beta-Estradiol 4.00E-04 Estrogen Sc2 3.75E+00 2.01E-01 7.84E-01 1.80E-01 1.17E+00 
    
Sc1 3.26E+00 3.00E-01 7.20E-01 7.00E-02 1.09E+00 
    
Sc3 1.40E+00 5.40E-02 5.58E-01 7.00E-02 6.82E-01 
128-37-0 
2,6-Di-tert-butyl-4-
methylphenol 3.16E+00 Antioxidant Sc2 7.91E-02 6.80E-04 1.67E-01 0.00E+00 1.67E-01 
    
Sc1 8.23E-02 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
    
Sc3 7.91E-02 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
5466-77-3 
2-Ethylhexyl-4-
methoxycinnamate 6.00E+00 Sunscreen Sc2 5.00E-01 6.22E-04 0.00E+00 0.00E+00 6.22E-04 
    
Sc1 2.33E-01 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
    
Sc3 5.00E-01 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
135410-20-7 Acetamiprid 5.00E-01 
Neonicotinoid 
Insecticide Sc2 2.00E-02 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
    
Sc1 8.92E-02 n/a n/a n/a n/a 
    
Sc3 2.00E-02 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
83905-01-5 Azithromycin  1.90E-02 Antibiotic Sc2 2.91E+00 3.96E-01 8.97E-01 1.10E-01 1.40E+00 
    
Sc1 1.31E+01 5.45E-01 7.45E-01 2.80E-01 1.57E+00 
    
Sc3 4.49E+00 1.45E-01 6.24E-01 1.10E-01 8.79E-01 
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CAS Substance 
PNEC 
(µg/L) Type Scenario RQ(p95) Fspat Ftemp Fext STE score 
81103-11-9 Clarithromycin 1.20E-01 Antibiotic Sc2 1.45E+00 2.83E-02 4.27E-01 7.00E-02 5.25E-01 
    
Sc1 2.33E+00 9.01E-02 4.35E-01 7.00E-02 5.95E-01 
    
Sc3 1.45E+00 2.83E-02 4.27E-01 7.00E-02 5.25E-01 
210880-92-5 Clothianidin 1.30E-01 
Neonicotinoid 
Insecticide Sc2 2.50E-01 2.43E-04 2.85E-01 0.00E+00 2.86E-01 
    
Sc1 1.33E+00 2.13E-02 2.48E-01 4.00E-02 3.09E-01 
    
Sc3 2.50E-01 2.43E-04 2.85E-01 0.00E+00 2.86E-01 
15307-86-5 Diclofenac 5.00E-02 Analgesic Sc2 5.26E+00 4.05E-01 4.75E-01 1.10E-01 9.90E-01 
    
Sc1 6.80E+00 5.75E-01 5.80E-01 1.80E-01 1.34E+00 
    
Sc3 5.26E+00 4.05E-01 4.75E-01 1.10E-01 9.90E-01 
114-07-8 Erythromycin 2.00E-01 Antibiotic Sc2 1.41E-01 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
    
Sc1 1.00E+00 1.31E-02 4.27E-01 4.00E-02 4.80E-01 
    
Sc3 1.41E-01 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
53-16-7 Estrone 3.60E-03 Estrogen Sc2 1.39E+00 6.12E-02 6.65E-01 7.00E-02 7.96E-01 
    
Sc1 1.39E+00 6.11E-02 5.71E-01 4.00E-02 6.72E-01 
    
Sc3 9.72E-01 2.12E-02 4.81E-01 4.00E-02 5.42E-01 
138261-41-3 Imidacloprid 8.30E-03 
Neonicotinoid 
Insecticide Sc2 3.23E+00 3.03E-01 6.19E-01 1.10E-01 1.03E+00 
    
Sc1 9.88E+00 8.57E-01 9.84E-01 1.80E-01 2.02E+00 
    
Sc3 4.10E+00 2.09E-01 4.35E-01 1.10E-01 7.53E-01 
2032-65-7 Methiocarb 2.00E-03 Insecticide/Herbicide Sc2 5.00E+00 7.16E-01 1.00E+00 7.00E-02 1.79E+00 
    
Sc1 4.50E+01 n/a n/a n/a n/a 
    
Sc3 8.25E+01 2.04E-02 1.00E-00 1.80E-01 1.20E+00 
19666-30-9 Oxadiazon 8.80E-02 Herbicide Sc2 4.55E-01 9.83E-04 1.00E-01 0.00E+00 1.01E-01 
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CAS Substance 
PNEC 
(µg/L) Type Scenario RQ(p95) Fspat Ftemp Fext STE score 
    
Sc1 8.05E-01 4.71E-02 3.33E-01 7.00E-02 4.50E-01 
    
Sc3 4.55E-01 2.58E-04 1.00E-01 0.00E+00 1.00E-01 
111988-49-9 Thiacloprid 1.00E-02 
Neonicotinoid 
Insecticide Sc2 1.00E+00 2.12E-02 1.89E-01 4.00E-02 2.51E-01 
    
Sc1 7.90E+00 5.55E-01 9.31E-01 1.80E-01 1.67E+00 
    
Sc3 1.00E+00 1.07E-02 1.89E-01 4.00E-02 2.40E-01 
153719-23-4 Thiamethoxam 4.20E-02 
Neonicotinoid 
Insecticide Sc2 2.98E-01 2.19E-03 2.98E-01 0.00E+00 3.00E-01 
    
Sc1 2.92E+00 5.37E-02 2.67E-01 7.00E-02 3.91E-01 
    
Sc3 2.38E-01 5.28E-04 7.59E-02 0.00E+00 7.64E-02 
2303-17-5 Tri-allate  4.10E-01 Herbicide Sc2 8.54E-02 3.70E-04 0.00E+00 0.00E+00 3.70E-04 
    
Sc1 2.76E-01 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
    
Sc3 8.05E-02 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
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The table below gives per substance for Sc3 and updated PNECs information for the site (Fs,site) and country (Fs,country) frequency of 
exceedances in Fspat, the calculation of Ftemp by all sites (Ftemp_1) and excluding sites with a single measurement that exceeds PNEC 
(Ftemp_2), the size of the exceedance extent in Fext, the percentage (from the total number of samples) of samples that exceed PNEC 
and the total amount of samples.  
 
Substance PNEC (μg/L) Type Fs,site Fs,country Ftemp_1 Ftemp_2 EXCextent 
Exceeding 
samples (%) 
Number of 
samples (Sc3) 
17-alpha-Ethinylestradiol 3.50E-05 Estrogen 3.77E-01 7.14E-01 7.13E-01 5.21E-01 9.83E+00 22.91 323 
17-beta-Estradiol 4.00E-04 Estrogen 1.22E-01 4.44E-01 7.39E-01 5.58E-01 2.16E+00 6.93 462 
2,6-Di-tert-butyl-4-methylphenol 3.16 Antioxidant 4.15E-03 0.00E+00 1.67E-01 1.67E-01 3.16E-01 0.19 1032 
2-Ethylhexyl-4-methoxycinnamate 6 Sunscreen 0.00E+00 0.00E+00 0.00E+00 0.00E+00 5.00E-01 0.00 543 
Acetamiprid 0.5 
Neonicotinoid 
Insecticide 0.00E+00 0.00E+00 0.00E+00 0.00E+00 2.50E-02 0.00 2221 
Azithromycin  0.019 Antibiotic 2.50E-01 5.79E-01 7.69E-01 6.24E-01 8.82E+00 16.07 915 
Clarithromycin 0.12 Antibiotic 1.36E-01 2.08E-01 4.07E-01 3.95E-01 2.48E+00 7.74 2792 
Clothianidin 0.13 
Neonicotinoid 
Insecticide 5.83E-03 4.17E-02 2.85E-01 2.85E-01 2.50E-01 0.67 2254 
Diclofenac 0.05 Analgesic 5.63E-01 7.20E-01 4.75E-01 4.38E-01 8.78E+00 32.40 6698 
Erythromycin 2.00E-01 Antibiotic 1.33E-02 0.00E+00 2.68E-01 1.46E-01 4.25E-01 0.44 2520 
Estrone 0.0036 Estrogen 7.11E-02 3.00E-01 6.75E-01 4.81E-01 1.31E+00 4.53 552 
Imidacloprid 0.0083 
Neonicotinoid 
Insecticide 3.28E-01 6.36E-01 5.65E-01 4.35E-01 7.67E+00 20.33 1845 
Methiocarb 2.00E-03 
Insecticide/ 
Herbicide 
7.14E-02 2.86E-01 1.00E+00 1.00E+00 1.13E+01 4.70 127 
Oxadiazon 0.088 Herbicide 5.93E-03 4.35E-02 5.50E-01 1.00E-01 5.00E-01 0.11 1847 
Thiacloprid 0.01 
Neonicotinoid 
Insecticide 8.20E-02 1.30E-01 2.33E-01 1.89E-01 1.75E+00 2.68 2235 
Thiamethoxam 0.042 
Neonicotinoid 
Insecticide 1.21E-02 4.35E-02 7.59E-02 7.59E-02 5.66E-01 0.96 3979 
Tri-allate  0.41 Herbicide 0.00E+00 0.00E+00 0.00E+00 0.00E+00 2.44E-01 0.00 2166 
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The figure shows a comparison of STE scores obtained by WL dataset for all data scenarios and updated PNECs. Two substances didn’t fulfilled the 
representativity criteria in Sc1 and were not shown on the graph.  
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Annex 6: Information supporting the removing of substances from the WL  
 
Annex 6.1 Application of removal criteria to the WL dataset and PNEC of 2015. 
 
Substance 
PNEC 
(µg/L) 
(WL 
report 
2015) Type STE (Sc3) STE (Sc2) 
Number 
of 
countrie
s (Sc3) 
Number 
of 
samples 
(Sc3) 
RQ 
(P95) 
for 
Sc3 
Non-quantified 
samples with 
0.5*LOQ≤PNEC 
in Sc2 (% from 
total)  
LOQ-PNEC 
criterion 
for Sc2 
(>90%) 
Difference 
of STE 
scores (%) 
Similar STE 
scores 
(difference
<15%) 
Potential 
candidate for 
deselection  
Diclofenac 1.00E-01 Analgesic 6.45E-01 6.45E-01 25 6697 2.63 100.0 yes 0.00 yes 
Yes (fulfils LOQ-
PNEC criterion; 
similar STE scores) 
Clarithromycin 1.30E-01 Antibiotic 5.15E-01 5.15E-01 24 2792 1.34 100.0 yes 0.00 yes 
Yes (fulfils LOQ-
PNEC criterion; 
similar STE scores) 
Azithromycin  9.00E-02 Antibiotic 3.48E-01 3.51E-01 24 1551 0.59 99.8 yes 0.91 yes 
Yes (fulfils LOQ-
PNEC criterion; 
similar STE scores) 
Erythromycin 2.00E-01 Antibiotic 0.00E+00 0.00E+00 24 2520 0.14 100.0 yes 0.00 yes 
Yes (fulfils LOQ-
PNEC criterion; 
similar STE scores) 
2,6-Di-tert-butyl-4-
methylphenol 3.16E+00 Antioxidant 0.00E+00 1.67E-01 23 1032 0.08 99.7 yes 0.00 yes 
Yes (fulfils LOQ-
PNEC criterion; 
similar STE scores) 
17-alpha-
Ethinylestradiol 3.50E-05 Estrogen 8.99E-01 1.91E+00 14 323 7.35 50.6 no 112.61 no 
No (no LOQ-PNEC 
criterion; 
dissimilar STE 
scores) 
17-beta-Estradiol 4.00E-04 Estrogen 6.82E-01 1.17E+00 17 461 1.28 72.8 no 70.90 no 
No (no LOQ-PNEC 
criterion; 
dissimilar STE 
scores) 
Estrone 3.60E-03 Estrogen 5.42E-01 7.96E-01 20 552 0.97 91.6 yes 46.98 no 
No (dissimilar STE 
scores) 
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Substance 
PNEC 
(µg/L) 
(WL 
report 
2015) Type STE (Sc3) STE (Sc2) 
Number 
of 
countrie
s (Sc3) 
Number 
of 
samples 
(Sc3) 
RQ 
(P95) 
for 
Sc3 
Non-quantified 
samples with 
0.5*LOQ≤PNEC 
in Sc2 (% from 
total)  
LOQ-PNEC 
criterion 
for Sc2 
(>90%) 
Difference 
of STE 
scores (%) 
Similar STE 
scores 
(difference
<15%) 
Potential 
candidate for 
deselection  
Oxadiazon 8.80E-02 Herbicide 1.00E-01 1.01E-01 23 1847 0.45 99.9 yes 0.72 yes 
Yes (fulfils LOQ-
PNEC criterion; 
similar STE scores) 
Tri-allate  6.70E-01 Herbicide 0.00E+00 3.70E-04 23 2166 0.05 99.9 yes 0.00 yes 
Yes (fulfils LOQ-
PNEC criterion; 
similar STE scores) 
Methiocarb 1.00E-02 
Insecticide 
/ Herbicide 4.45E-01 9.08E-01 22 1798 1.00 98.0 yes 103.84 no 
No (dissimilar STE 
scores) 
Imidacloprid 9.00E-03 
Neonicotin
oid 
Insecticide 7.31E-01 1.01E+00 22 1830 3.67 72.5 no 37.76 no 
No (no LOQ-PNEC 
criterion; 
dissimilar STE 
scores) 
Clothianidin 1.30E-01 
Neonicotin
oid 
Insecticide 2.86E-01 2.86E-01 24 2254 0.25 100.0 yes 0.00 yes 
Yes (fulfils LOQ-
PNEC criterion; 
similar STE scores) 
Thiamethoxam 1.40E-01 
Neonicotin
oid 
Insecticide 6.15E-02 6.15E-02 24 4020 0.09 100.0 yes 0.00 yes 
Yes (fulfils LOQ-
PNEC criterion; 
similar STE scores) 
Acetamiprid 5.00E-01 
Neonicotin
oid 
Insecticide 0.00E+00 0.00E+00 24 2221 0.02 100.0 yes 0.00 yes 
Yes (fulfils LOQ-
PNEC criterion; 
similar STE scores) 
Thiacloprid 5.00E-02 
Neonicotin
oid 
Insecticide 0.00E+00 0.00E+00 24 2243 0.20 100.0 yes 0.00 yes 
Yes (fulfils LOQ-
PNEC criterion; 
similar STE scores) 
2-Ethylhexyl-4-
methoxycinnamate 6.00E+00 Sunscreen 0.00E+00 6.22E-04 23 543 0.50 99.3 yes 0.00 yes 
Yes (fulfils LOQ-
PNEC criterion; 
similar STE scores) 
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Annex 6.2 Application of removal criteria to the combined dataset and updated PNECs 
 
The short-list of substances, identified as potential candidates to be removed from the WL using WL dataset and the updated PNECs, is 
confirmed applying the removal criteria to the combined dataset together with updated PNECs except for thiacloprid. For all other 
substances the STE scores found by both datasets are identical which confirms the similarity of the assessment of these substances. 
 
Substance 
PNEC 
(µg/L) Type 
STE 
(Sc3) 
STE 
(Sc2) 
Number 
of 
countries 
(Sc3) 
Number 
of 
samples 
(Sc3) 
RQ 
(P95) 
for 
Sc3 
Non-quantified 
samples with 
0.5*LOQ≤PNEC 
in Sc2 (% from 
total)  
LOQ-PNEC 
criterion for 
Sc2 (>90%) 
Difference 
of STE 
scores (%) 
Similar STE 
scores 
(difference<15%) 
Potential candidate 
for deselection  
Diclofenac 5.00E-02 Analgesic 1.215 1.215 26 17748 9.21 100.0 yes 0.00 yes 
Yes (fulfils LOQ-PNEC 
criterion; similar STE 
scores) 
Clarithromycin 1.20E-01 Antibiotic 0.406 0.406 25 7443 1.08 100.0 yes 0.00 yes 
Yes (fulfils LOQ-PNEC 
criterion; similar STE 
scores) 
Azithromycin  1.90E-02 Antibiotic 1.219 1.537 20 1217 8.95 44.8 no 26.06 no 
No (no LOQ-PNEC 
criterion; dissimilar 
STE scores) 
Erythromycin 2.00E-01 Antibiotic 0.000 0.000 25 6313 0.25 100.0 yes 0.00 yes 
Yes (fulfils LOQ-PNEC 
criterion; similar STE 
scores) 
2,6-Di-tert-
butyl-4-
methylphenol 3.16E+00 Antioxidant 0.000 0.080 23 1293 0.08 99.8 yes 0.00 yes 
Yes (fulfils LOQ-PNEC 
criterion; similar STE 
scores) 
17-alpha-
Ethinylestradiol 3.50E-05 Estrogen 0.862 1.704 14 469 5.85 58.7 no 97.78 no 
No (no LOQ-PNEC 
criterion; dissimilar 
STE scores) 
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Substance 
PNEC 
(µg/L) Type 
STE 
(Sc3) 
STE 
(Sc2) 
Number 
of 
countries 
(Sc3) 
Number 
of 
samples 
(Sc3) 
RQ 
(P95) 
for 
Sc3 
Non-quantified 
samples with 
0.5*LOQ≤PNEC 
in Sc2 (% from 
total)  
LOQ-PNEC 
criterion for 
Sc2 (>90%) 
Difference 
of STE 
scores (%) 
Similar STE 
scores 
(difference<15%) 
Potential candidate 
for deselection  
17-beta-
Estradiol 4.00E-04 Estrogen 0.829 1.403 20 716 2.50 35.4 no 69.13 no 
No (no LOQ-PNEC 
criterion; dissimilar 
STE scores) 
Estrone 3.60E-03 Estrogen 0.521 0.645 23 1314 1.39 95.5 yes 23.85 no 
No (dissimilar STE 
scores) 
Oxadiazon 8.80E-02 Herbicide 0.277 0.268 23 50148 0.28 99.6 yes 3.13 yes 
Yes (fulfils LOQ-PNEC 
criterion; similar STE 
scores) 
Tri-allate  4.10E-01 Herbicide 0.000 0.000 23 20725 0.06 100.0 yes 0.00 yes 
Yes (fulfils LOQ-PNEC 
criterion; similar STE 
scores) 
Methiocarb 2.00E-03 
Insecticide/
Herbicide 1.227 2.094 10 2781 7.00 10.0 no 70.71 no 
No (no LOQ-PNEC 
criterion; dissimilar 
STE scores) 
Imidacloprid 8.30E-03 
Neonicotin
oid 
Insecticide 1.299 1.729 22 24745 27.71 27.6 no 33.15 no 
No (no LOQ-PNEC 
criterion; dissimilar 
STE scores) 
Clothianidin 1.30E-01 
Neonicotin
oid 
Insecticide 0.188 0.188 24 5952 0.19 100.0 yes 0.00 yes 
Yes (fulfils LOQ-PNEC 
criterion; similar STE 
scores) 
Thiamethoxam 4.20E-02 
Neonicotin
oid 
Insecticide 0.376 0.436 24 9041 0.36 99.5 yes 15.75 no 
No (dissimilar STE 
scores) 
Acetamiprid 5.00E-01 
Neonicotin
oid 
Insecticide 0.000 0.000 24 7121 0.02 100.0 yes 0.00 yes 
Yes (fulfils LOQ-PNEC 
criterion; similar STE 
scores) 
Thiacloprid 1.00E-02 
Neonicotin
oid 
Insecticide 0.237 0.403 23 8533 1.00 98.9 yes 70.27 no 
No (dissimilar STE 
scores) 
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Substance 
PNEC 
(µg/L) Type 
STE 
(Sc3) 
STE 
(Sc2) 
Number 
of 
countries 
(Sc3) 
Number 
of 
samples 
(Sc3) 
RQ 
(P95) 
for 
Sc3 
Non-quantified 
samples with 
0.5*LOQ≤PNEC 
in Sc2 (% from 
total)  
LOQ-PNEC 
criterion for 
Sc2 (>90%) 
Difference 
of STE 
scores (%) 
Similar STE 
scores 
(difference<15%) 
Potential candidate 
for deselection  
2-Ethylhexyl-4-
methoxycinnam
ate 6.00E+00 Sunscreen 0.000 0.001 23 543 0.50 99.3 yes 0.00 yes 
Yes (fulfils LOQ-PNEC 
criterion; similar STE 
scores) 
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Annex 7: Additional information for WL substances 
Annex 7.1 WL dataset in Sc2 and updated PNECs: Nearby pressures 
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Annex 7.2 WL dataset in Sc2 and updated PNECs: Seasonality and 
Concentrations per country 
17-alpha-Ethinylestradiol 
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17-beta-Estradiol 
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2,6-Di-tert-butyl-4-methylphenol 
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2-Ethylhexyl-4-methoxycinnamate 
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Acetamiprid 
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Azithromycin  
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Clarithromycin 
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Clothianidin 
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Diclofenac 
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Erythromycin 
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Estrone 
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Imidacloprid 
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Methiocarb 
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Oxadiazon 
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Thiacloprid 
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Thiamethoxam 
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Tri-allate  
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Annex 8: Evaluation of WL susbtances by the combined dataset 
 
In addition to the WL dataset, the WL substances have been evaluated by a so-called 
“combined dataset”, which is a combination of measurements from the monitoring 
prioritisation exercise (Carvalho et al., 2016) and the first year of WL monitoring. 
WL dataset is unique and very useful since it includes a good quality data from all MS. 
However, the information provided by WL dataset is timely (only one year) and spatially 
(a few selected sampling stations) restricted. For this reason the WL substances also 
were evaluated additionally combining the WL dataset and the dataset used in the 
monitoring prioritisation exercise. The later does not necessarily include samples from all 
MS but has the advantage to cover a wider time period (2006-2014). Of course, the 
eventual duplicates were eliminated from the combined dataset.  
The report is showing the results for the WL and combined datasets separately, so the 
experts could see the assessment of WL substances taking into account different spatial 
and temporal perspectives.  
The combined dataset contains more data and covers a longer time period (2006-2016); 
it includes measurements from 26 countries and a total number of 232486 samples in 
Sc2 for the WL substances. After the application of the PNEC quality criterion to the 
records in Sc2 the total amount of samples is reduced by 28.6% to 166073 samples in 
Sc3 (related to the updated PNECs). The average percentage of quantification frequency 
is 20% (range 0.9%-73.2%) for data of Sc3. 
All WL substances showed in Sc3 (related to the updated PNECs) a good quality of non-
quantified samples except for 5 substances (EE2, E2, azithromycin, imidacloprid and 
methiocarb) that have a reduced quality of data but a sufficient amount of samples for 
making statistical analyses and to run the STE tool. These substances are identical to 
those already identified in the WL dataset.  
The highest STE scores obtained by the combined dataset in Sc3 and updated PNECs 
were for: imidacloprid (1.30), methiocarb (1.23), azithromycin (1.22), diclofenac (1.22), 
17-alpha-ethinylestradiol (0.86), 17-beta-estradiol (0.83), estrone (0.52), and 
clarithromycin (0.41).  
The combined dataset in Sc3 and the updated PNECs give, in particular for the 
substances with higher scoring, slightly elevated scores in comparison to the WL dataset 
since the higher concentrations measured earlier than 2014-2015 (for details see Annex 
8.2). Also worth to mention that the intermediate scored substances, including diclofenac 
and EE2 (with STE scores about 0.9), have relatively high risk quotients (above 5). 
 
Annex 8.1 Concentrations of WL substances by the combined dataset 
Next table gives a summary of the concentration statistics for the WL substances from 
the combined data set (all data scenarios) and updated PNECs.  
In this case, the median of EE2 is exceeded PNEC only in Sc1. However, additional PNEC 
exceedances are observed for E2 (Sc1 and Sc2), diclofenac (Sc1), azithromycin (all 
scenarios), and methiocarb (Sc1 and Sc2). 
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Table: Summary statistics of concentrations for the WL substances (µg/l) considering the 
combined data set (all data scenarios) and updated PNECs. In bold the PNEC exceedance of the 
median concentration. 
 
Substance Scenario Samples PNEC Median Mean P95 Max 
17-alpha-
Ethinylestradiol 
Sc1 86 
0.000035 
0.00011 0.00024 0.00087 0.0030 
Sc2 738 0.000021 0.00045 0.0010 0.0125 
Sc3 469 0.000015 0.000053 0.00021 0.0030 
17-beta-Estradiol 
Sc1 140 
0.0004 
0.00041 0.0011 0.0051 0.015 
Sc2 1767 0.00050 0.00054 0.0010 0.015 
Sc3 716 0.00015 0.00031 0.0010 0.015 
Estrone 
Sc1 374 
0.0036 
0.00085 0.0040 0.030 0.099 
Sc2 1358 0.0025 0.0029 0.00566 0.099 
Sc3 1314 0.0025 0.0024 0.0050 0.099 
Diclofenac 
Sc1 12988 
0.05 
0.069 0.15 0.56 7.1 
Sc2 17748 0.040 0.11 0.46 7.1 
Sc3 17748 0.040 0.11 0.46 7.1 
2,6-Di-tert-butyl-4-
methylphenol 
Sc1 91 
3.16 
0.047 1.22 4.9 49.0 
Sc2 1296 0.015 0.161 0.250 49.0 
Sc3 1293 0.015 0.151 0.250 49.0 
2-Ethylhexyl-4-
methoxycinnamate 
Sc1 116 
6.0 
0.305 0.420 1.4 1.8 
Sc2 546 0.050 0.367 3.0 9.0 
Sc3 543 0.050 0.319 3.0 3.0 
Erythromycin 
Sc1 1144 
0.2 
0.030 0.050 0.150 1.1 
Sc2 6313 0.010 0.017 0.050 1.1 
Sc3 6313 0.010 0.017 0.050 1.1 
Clarithromycin 
Sc1 3585 
0.12 
0.033 0.063 0.21 1.6 
Sc2 7443 0.015 0.036 0.13 1.6 
Sc3 7443 0.015 0.036 0.13 1.6 
Azithromycin  
Sc1 410 
0.019 
0.050 0.088 0.31 1.0 
Sc2 2212 0.025 0.034 0.10 5.0 
Sc3 2210 0.025 0.030 0.10 1.0 
Methiocarb 
Sc1 377 
0.002 
0.010 0.031 0.098 0.96 
Sc2 24375 0.010 0.011 0.025 0.96 
Sc3 2781 0.001 0.006 0.010 0.96 
Imidacloprid 
Sc1 8689 
0.0083 
0.034 0.564 0.840 450.0 
Sc2 66827 0.010 0.086 0.070 450.0 
Sc3 24745 0.005 0.201 0.230 450.0 
Thiacloprid 
Sc1 452 
0.01 
0.013 0.032 0.118 0.81 
Sc2 8623 0.005 0.008 0.010 0.81 
Sc3 8533 0.005 0.008 0.010 0.81 
Thiamethoxam 
Sc1 538 
0.042 
0.028 0.062 0.190 3.18 
Sc2 9082 0.005 0.011 0.017 3.18 
Sc3 9082 0.005 0.011 0.017 3.18 
Clothianidin 
Sc1 315 
0.13 
0.014 0.037 0.140 0.78 
Sc2 5952 0.010 0.012 0.025 0.78 
Sc3 5952 0.010 0.012 0.025 0.78 
Acetamiprid 
Sc1 65 
0.5 
0.020 0.022 0.046 0.074 
Sc2 7121 0.005 0.007 0.010 0.15 
Sc3 7121 0.005 0.007 0.010 0.15 
Oxadiazon 
Sc1 3071 
0.088 
0.020 3.5 26.0 270.0 
Sc2 50357 0.010 0.282 0.025 270.0 
Sc3 50148 0.010 0.225 0.025 270.0 
Triallate  
Sc1 209 
0.41 
0.018 0.035 0.125 0.27 
Sc2 20728 0.020 0.016 0.025 0.95 
Sc3 20725 0.020 0.016 0.025 0.34 
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The following figure shows a box-whisker plot for the concentrations of samples for Sc3 
of the combined dataset for each substance in comparison to the updated PNEC values. 
The lowermost line of the figure indicates the total number of samples per substance. 
Attention should be paid to the increased number of samples in the combined dataset.  
 
 
 
Figure: Box-plot of concentrations for combined dataset in Sc3 comparing to the updated PNEC 
values. The lowermost line of the figure indicates the total number of samples per substance. 
 
The box-whisker plots of concentrations of WL substances for Sc2 and Sc1 scenarios of 
the combined data are given in the Annex 8.3. This annex also presents analyses for the 
quality of monitoring samples in the combined dataset.  
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Conclusions: 
The European median surface water concentration of EE2 is exceeding its PNEC (0.035 
ng/L) only in Sc1 (0.11 ng/L). For E2 the PNEC (0.40 ng/L) exceedance is found for the 
median concentration in Sc1 (0.41ng/L) and Sc2 (0.050 ng/L) but not in Sc3. 
The median concentration of imidacloprid (0.018 µg/L) exceeds its PNEC (0.009 µg/L) in 
Sc1 (0.018 µg/L) and Sc2 (0.010 µg/L) but not in Sc3. 
For diclofenac the median concentration exceeds its PNEC (0.05 µg/L) only in Sc1 (0.069 
µg/L). 
For azithromycin the median concentration exceeds its PNEC (0.019 µg/L) in all 
scenarios, Sc1 (0.050 µg/L) and both Sc3 and Sc2 (0.025 µg/L) respectively. 
The median concentration of methiocarb exceeds its PNEC concentration (0.002 µg/L) 
only in Sc1 and Sc2 (for both 0.010 µg/L). 
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Annex 8.2 Detailed statistics for WL substances by the combined dataset (Sc3 is based on the updated PNECs). 
 
Substance 
PNEC 
(µg/L) Scenario Countries Sites Samples 
Samples 
< LOQ 
Quantified 
samples 
(%) Min Mean SD Median P90 P95 Max 
17-alpha-
Ethinylestradiol 3.50E-05 Sc2 25 272 738 652 11.65 5.00E-06 4.50E-04 1.58E-03 2.13E-05 1.00E-03 1.00E-03 1.25E-02 
  
Sc1 10 57 86 0 100 3.00E-05 2.37E-04 4.25E-04 1.05E-04 3.75E-04 8.70E-04 3.00E-03 
  
Sc3 14 162 469 383 18.34 5.00E-06 5.34E-05 2.01E-04 1.50E-05 9.30E-05 2.05E-04 3.00E-03 
17-beta-Estradiol 4.00E-04 Sc2 25 459 1767 1627 7.92 5.00E-06 5.41E-04 1.21E-03 5.00E-04 5.00E-04 1.00E-03 1.50E-02 
  
Sc1 13 90 140 0 100 4.28E-05 1.13E-03 2.22E-03 4.10E-04 2.02E-03 5.12E-03 1.50E-02 
  
Sc3 20 262 716 576 19.55 5.00E-06 3.09E-04 1.06E-03 1.50E-04 4.00E-04 1.00E-03 1.50E-02 
2,6-Di-tert-butyl-4-
methylphenol 3.16E+00 Sc2 24 261 1296 1205 7.02 1.00E-04 1.61E-01 1.51E+00 1.50E-02 1.25E-01 2.50E-01 4.90E+01 
  
Sc1 7 35 91 0 100 6.66E-03 1.22E+00 5.51E+00 4.70E-02 1.80E+00 4.87E+00 4.90E+01 
  
Sc3 23 258 1293 1202 7.04 1.00E-04 1.51E-01 1.49E+00 1.50E-02 1.25E-01 2.50E-01 4.90E+01 
2-Ethylhexyl-4-
methoxycinnamate 6.00E+00 Sc2 24 201 546 430 21.25 5.00E-04 3.67E-01 9.72E-01 5.00E-02 7.55E-01 3.00E+00 9.00E+00 
  
Sc1 6 19 116 0 100 3.00E-03 4.20E-01 4.05E-01 3.05E-01 1.00E+00 1.40E+00 1.80E+00 
  
Sc3 23 198 543 427 21.36 5.00E-04 3.19E-01 7.32E-01 5.00E-02 7.50E-01 3.00E+00 3.00E+00 
Acetamiprid 5.00E-01 Sc2 24 750 7121 7056 0.91 2.50E-04 6.54E-03 5.00E-03 5.00E-03 1.00E-02 1.00E-02 1.50E-01 
  
Sc1 8 31 65 0 100 1.37E-03 2.17E-02 1.53E-02 2.00E-02 4.02E-02 4.60E-02 7.40E-02 
  
Sc3 24 750 7121 7056 0.91 2.50E-04 6.54E-03 5.00E-03 5.00E-03 1.00E-02 1.00E-02 1.50E-01 
Azithromycin  1.90E-02 Sc2 25 336 2212 1802 18.54 1.00E-04 3.44E-02 1.61E-01 2.50E-02 5.00E-02 1.00E-01 5.00E+00 
  
Sc1 17 105 410 0 100 2.00E-04 8.83E-02 1.20E-01 5.00E-02 2.20E-01 3.11E-01 1.00E+00 
  
Sc3 20 230 1217 807 33.69 1.00E-04 3.32E-02 8.00E-02 5.00E-03 9.00E-02 1.70E-01 1.00E+00 
Clarithromycin 1.20E-01 Sc2 25 733 7443 3858 48.17 3.80E-05 3.63E-02 7.73E-02 1.50E-02 7.50E-02 1.30E-01 1.60E+00 
  
Sc1 18 483 3585 0 100 3.80E-05 6.28E-02 1.05E-01 3.30E-02 1.30E-01 2.10E-01 1.60E+00 
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Substance 
PNEC 
(µg/L) Scenario Countries Sites Samples 
Samples 
< LOQ 
Quantified 
samples 
(%) Min Mean SD Median P90 P95 Max 
  
Sc3 25 733 7443 3858 48.17 3.80E-05 3.63E-02 7.73E-02 1.50E-02 7.50E-02 1.30E-01 1.60E+00 
Clothianidin 1.30E-01 Sc2 24 607 5952 5637 5.29 5.00E-04 1.18E-02 1.90E-02 1.00E-02 2.50E-02 2.50E-02 7.80E-01 
  
Sc1 7 91 315 0 100 7.00E-04 3.72E-02 7.05E-02 1.40E-02 8.92E-02 1.40E-01 7.80E-01 
  
Sc3 24 607 5952 5637 5.29 5.00E-04 1.18E-02 1.90E-02 1.00E-02 2.50E-02 2.50E-02 7.80E-01 
Diclofenac 5.00E-02 Sc2 26 1340 17748 4760 73.18 2.50E-04 1.10E-01 2.07E-01 4.00E-02 2.80E-01 4.61E-01 7.10E+00 
  
Sc1 24 1149 12988 0 100 5.30E-04 1.47E-01 2.31E-01 6.90E-02 3.50E-01 5.60E-01 7.10E+00 
  
Sc3 26 1340 17748 4760 73.18 2.50E-04 1.10E-01 2.07E-01 4.00E-02 2.80E-01 4.61E-01 7.10E+00 
Erythromycin 2.00E-01 Sc2 25 601 6313 5169 18.12 5.00E-04 1.72E-02 3.58E-02 1.00E-02 3.00E-02 5.00E-02 1.10E+00 
  
Sc1 13 263 1144 0 100 1.00E-03 4.99E-02 7.43E-02 3.00E-02 1.00E-01 1.50E-01 1.10E+00 
  
Sc3 25 601 6284 5140 18.20 5.00E-04 1.72E-02 3.58E-02 1.00E-02 3.00E-02 5.00E-02 1.10E+00 
Estrone 3.60E-03 Sc2 24 452 1358 984 27.54 1.50E-05 2.88E-03 6.24E-03 2.50E-03 2.54E-03 5.66E-03 9.90E-02 
  
Sc1 16 182 374 0 100 3.97E-05 3.98E-03 1.02E-02 8.47E-04 5.16E-03 3.00E-02 9.90E-02 
  
Sc3 23 436 1314 940 28.46 1.50E-05 2.41E-03 5.57E-03 2.50E-03 2.50E-03 5.00E-03 9.90E-02 
Imidacloprid 8.30E-03 Sc2 24 4925 66827 58138 13.00 3.00E-04 8.63E-02 3.29E+00 1.00E-02 3.00E-02 7.00E-02 4.50E+02 
  
Sc1 15 1758 8689 0 100 1.20E-03 5.64E-01 9.10E+00 3.40E-02 3.70E-01 8.40E-01 4.50E+02 
  
Sc3 22 2761 24745 16056 35.11 3.00E-04 2.01E-01 5.40E+00 5.00E-03 8.00E-02 2.30E-01 4.50E+02 
Methiocarb 2.00E-03 Sc2 24 2746 24375 23998 1.55 5.00E-04 1.14E-02 1.46E-02 1.00E-02 2.50E-02 2.50E-02 9.60E-01 
  
Sc1 7 222 377 0 100 3.00E-03 3.11E-02 7.84E-02 1.00E-02 6.00E-02 9.76E-02 9.60E-01 
  
Sc3 10 554 2781 2404 13.56 5.00E-04 5.07E-03 3.06E-02 5.00E-03 8.00E-03 1.40E-02 9.60E-01 
Oxadiazon 8.80E-02 Sc2 24 4108 50357 47286 6.10 5.00E-04 2.82E-01 4.44E+00 1.00E-02 2.50E-02 2.50E-02 2.70E+02 
  
Sc1 9 916 3071 0 100 1.80E-03 3.48E+00 1.71E+01 2.00E-02 2.70E-01 2.60E+01 2.70E+02 
  
Sc3 23 4106 50148 47077 6.12 5.00E-04 2.25E-01 4.31E+00 1.00E-02 2.50E-02 2.50E-02 2.70E+02 
Thiacloprid 1.00E-02 Sc2 24 1085 8623 8171 5.24 3.50E-04 8.37E-03 1.73E-02 5.00E-03 1.00E-02 1.00E-02 8.13E-01 
  
Sc1 14 147 452 0 100 8.00E-04 3.20E-02 6.92E-02 1.30E-02 6.49E-02 1.18E-01 8.13E-01 
  
Sc3 23 1037 8533 8081 5.30 3.50E-04 8.09E-03 1.71E-02 5.00E-03 1.00E-02 1.00E-02 8.13E-01 
Thiamethoxam 4.20E-02 Sc2 24 961 9082 8544 5.92 5.00E-04 1.08E-02 5.02E-02 5.00E-03 1.50E-02 1.69E-02 3.18E+00 
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Substance 
PNEC 
(µg/L) Scenario Countries Sites Samples 
Samples 
< LOQ 
Quantified 
samples 
(%) Min Mean SD Median P90 P95 Max 
  
Sc1 12 165 538 0 100 1.20E-03 6.17E-02 1.98E-01 2.80E-02 1.23E-01 1.90E-01 3.18E+00 
  
Sc3 24 955 9041 8503 5.95 5.00E-04 1.06E-02 5.02E-02 5.00E-03 1.50E-02 1.50E-02 3.18E+00 
Tri-allate  4.10E-01 Sc2 24 2253 20728 20519 1.01 5.00E-04 1.60E-02 1.82E-02 2.00E-02 2.50E-02 2.50E-02 9.45E-01 
  
Sc1 6 65 209 0 100 2.20E-03 3.45E-02 4.43E-02 1.80E-02 7.78E-02 1.25E-01 2.70E-01 
  
Sc3 23 2250 20725 20516 1.01 5.00E-04 1.58E-02 1.44E-02 2.00E-02 2.50E-02 2.50E-02 3.35E-01 
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The figures in this annex give information for the quality of the combined monitoring 
dataset and presents the box-plots of concentrations together with the updated PNECs 
for the WL substances.  
 
 
 
 
Figure: Percentage of quantified samples as a part from the total number of samples per substance 
for data in Sc2 of combined dataset. The amount of quantified samples per substance is given at 
the lowermost line of the figure. All WL substances have more than 51 quantified samples but 3 
substances (17-alpha-Ethinylestradiol, 2,6-di-tert-butyl-4-methylphenol and acetamiprid) have less 
than 100. 
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Figure: Range of LOQs for the non-quantified samples in the combined dataset per substance 
compared to the updated PNEC values. The amount of non-quantified samples per substance is 
given at the lowermost line of the figure. 
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Figure: Percentage of non-quantified samples with 0.5*LOQ ≤ updated PNECs in Sc2 of combined 
dataset. The amount of these samples is given per each substance at the lowermost line of the 
figure. All WL substances showed a good quality of non-quantified samples in the combined dataset 
(except 17-alpha-Ethinylestradiol, 17-beta-Estradiol, Azithromycin, Imidacloprid and Methiocarb 
that have a reduced quality of data). 
 
 
Conclusions (combined dataset and updated PNECs): 
All WL substances have in Sc3 and Sc2 more than 51 quantified samples but 3 substances (17-
alpha-Ethinylestradiol, 2,6-di-tert-butyl-4-methylphenol and acetamiprid) have less than 100 
quantifed samples. 
All WL substances showed in Sc3 and Sc2 a good quality of non-quantified samples in the 
combined dataset except 17-alpha-ethinylestradiol, 17-beta-estradiol, azithromycin, imidacloprid 
and methiocarb) that have a reduced quality of data but a sufficient amount of samples for making 
statistical analyses and to running the STE assessment tool. 
 
 
154 
The next two figures show for Sc2 and Sc1 of combined dataset the box-whisker plots for 
WL substances in comparison to the updated PNEC values. The concentrations of the 
non-quantified samples are set to LOQ/2. The lowermost line of the figure also indicates 
the total number of samples per substance. 
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Annex 8.3 STE scores of WL substances by the combined dataset 
 
The detailed information about the STE scores calculated by the combined dataset and 
the updated PNECs for all data scenarios are presented in tabular form in Annex 8.4 This 
annex also shows the detailed specific information about the individual STE factors in Sc3 
scenario. 
The next figure displaces a graphical comparison of the STE scores for the combined 
monitoring dataset in Sc2 and Sc3 scenarios considering the updated PNECs (2-
Ethylhexyl-4-methoxycinnamate is reported only in the WL). All scores of WL substances 
in Sc3 are below 1.4 and 4 substances (imidacloprid, methiocarb, azithromycin and 
diclofenac) showed intermediate range scores.  
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Figure: Comparison of STE scores obtained by combined dataset for Sc2 and Sc3 scenarios (2-
ethylhexyl-4-methoxycinnamate is reported only in the WL dataset) considering the updated PNEC 
values. 
 
 
The graphical comparison of the STE scores for the combined monitoring data in Sc1 and 
Sc3 scenarios and updated PNECs could be seen in Annex 8.4. Interestingly, in Sc1 three 
WL substances (imidacloprid, methiocarb and 17-alpha-ethinylestradiol) have very high 
or high STE scores (STE>2.2; for Sc2 these substances also obtained higher scores). The 
reason for the deviation between the scores in Sc3 and Sc1 could be the lower/reduced 
quality of the data for these substances, made available to the JRC in the prioritisation 
exercise.  
Lastly, on the next figure could be seen the difference of STE scores for scenario Sc3 
obtained when applying the updated PNECs either to the first WL dataset or to the 
combined one. The combined dataset gives, in particular for the substances with higher 
scores, slightly elevated results (since the higher concentrations measured earlier than 
2014-2015; for details see Annex 8.3) but none of WL substances has high or very high 
STE score The lowermost line of the figure shows for information the RQ(P95) for the Sc3 
of the combined dataset. Worth to mention that the intermediate scored substances by 
WL dataset, including diclofenac and EE2 (with STE scores about 0.9), have relatively 
high RQs (more than 5). 
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Figure: Comparison of STE scores obtained by different datasets (the first WL and the 
combined dataset) for data in Sc3 considering the updated PNEC values. The lowermost 
line shows the RQ(P95) for the Sc3 of the combined dataset.  
 
 
 
 
Conclusions: 
The combined dataset in Sc3 (first WL and prioritisation exercise) and updated PNECs 
showed STE scores below 1.4 and 4 substances (imidacloprid, methiocarb, azithromycin 
and diclofenac) have intermediate range scores. 
The combined dataset in Sc3 and the updated PNECs give slightly elevated scores in 
comparison to the WL dataset since the higher concentrations measured earlier than 
2014-2015. The intermediate scored substances by the WL dataset, including diclofenac 
and EE2 (with STE scores about 0.9), have relatively high RQs (more than 5).  
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Annex 8.4 Detailed STE results by the combined dataset and updated PNECs: STE factors, STE scores and RQ(P95) (all data 
scenarios). 
 
CAS Substance 
PNEC 
(µg/L) Type Scenario RQ(p95) Fspat Ftemp Fext STE score 
57-63-6 
17-alpha-
Ethinylestradiol 3.50E-05 Estrogen Sc2 2.86E+01 5.03E-01 7.91E-01 4.10E-01 1.70E+00 
    
Sc1 2.49E+01 9.30E-01 9.86E-01 2.80E-01 2.20E+00 
    
Sc3 5.85E+00 2.16E-01 5.36E-01 1.10E-01 8.62E-01 
50-28-2 17-beta-Estradiol 4.00E-04 Estrogen Sc2 2.50E+00 3.28E-01 9.64E-01 1.10E-01 1.40E+00 
    
Sc1 1.28E+01 4.79E-01 8.60E-01 1.80E-01 1.52E+00 
    
Sc3 2.50E+00 8.76E-02 6.72E-01 7.00E-02 8.29E-01 
128-37-0 
2,6-Di-tert-butyl-4-
methylphenol 3.16E+00 Antioxidant Sc2 7.91E-02 7.98E-04 7.89E-02 0.00E+00 7.97E-02 
    
Sc1 1.54E+00 2.04E-02 4.33E-01 7.00E-02 5.24E-01 
    
Sc3 7.91E-02 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
5466-77-3 
2-Ethylhexyl-4-
methoxycinnamate 6.00E+00 Sunscreen Sc2 5.00E-01 6.22E-04 0.00E+00 0.00E+00 6.22E-04 
    
Sc1 2.33E-01 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
    
Sc3 5.00E-01 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
135410-20-7 Acetamiprid 5.00E-01 
Neonicotinoid 
Insecticide Sc2 2.00E-02 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
    
Sc1 9.20E-02 0 0 0 0 
    
Sc3 2.00E-02 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
83905-01-5 Azithromycin  1.90E-02 Antibiotic Sc2 5.26E+00 4.45E-01 9.12E-01 1.80E-01 1.54E+00 
    
Sc1 1.64E+01 5.61E-01 8.99E-01 2.80E-01 1.74E+00 
    
Sc3 8.95E+00 2.06E-01 8.33E-01 1.80E-01 1.22E+00 
81103-11-9 Clarithromycin 1.20E-01 Antibiotic Sc2 1.08E+00 2.40E-02 3.42E-01 4.00E-02 4.06E-01 
    
Sc1 1.75E+00 7.57E-02 3.94E-01 7.00E-02 5.40E-01 
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CAS Substance 
PNEC 
(µg/L) Type Scenario RQ(p95) Fspat Ftemp Fext STE score 
    
Sc3 1.08E+00 2.40E-02 3.42E-01 4.00E-02 4.06E-01 
210880-92-5 Clothianidin 1.30E-01 
Neonicotinoid 
Insecticide Sc2 1.92E-01 1.37E-04 1.88E-01 0.00E+00 1.88E-01 
    
Sc1 1.08E+00 1.57E-02 2.90E-01 4.00E-02 3.46E-01 
    
Sc3 1.92E-01 1.37E-04 1.88E-01 0.00E+00 1.88E-01 
15307-86-5 Diclofenac 5.00E-02 Analgesic Sc2 9.21E+00 4.43E-01 5.92E-01 1.80E-01 1.22E+00 
    
Sc1 1.12E+01 6.03E-01 6.76E-01 1.80E-01 1.46E+00 
    
Sc3 9.21E+00 4.43E-01 5.92E-01 1.80E-01 1.22E+00 
114-07-8 Erythromycin 2.00E-01 Antibiotic Sc2 2.50E-01 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
    
Sc1 7.50E-01 1.29E-02 3.15E-01 4.00E-02 3.68E-01 
    
Sc3 2.50E-01 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
53-16-7 Estrone 3.60E-03 Estrogen Sc2 1.57E+00 6.69E-02 4.68E-01 1.10E-01 6.45E-01 
    
Sc1 8.33E+00 1.75E-01 9.24E-01 1.80E-01 1.28E+00 
    
Sc3 1.39E+00 3.91E-02 3.72E-01 1.10E-01 5.21E-01 
138261-41-3 Imidacloprid 8.30E-03 
Neonicotinoid 
Insecticide Sc2 8.43E+00 6.12E-01 8.37E-01 2.80E-01 1.73E+00 
    
Sc1 1.01E+02 8.86E-01 9.60E-01 5.60E-01 2.41E+00 
    
Sc3 2.77E+01 3.66E-01 5.23E-01 4.10E-01 1.30E+00 
2032-65-7 Methiocarb 2.00E-03 
Insecticide/ 
Herbicide Sc2 1.25E+01 8.39E-01 9.75E-01 2.80E-01 2.09E+00 
    
Sc1 4.88E+01 1 1 0.28 2.28 
    
Sc3 7.00E+00 2.75E-01 6.71E-01 2.80E-01 1.23E-00 
19666-30-9 Oxadiazon 8.80E-02 Herbicide Sc2 2.84E-01 4.29E-03 2.64E-01 0.00E+00 2.68E-01 
    
Sc1 2.95E+02 8.78E-02 5.38E-01 2.80E-01 9.06E-01 
    
Sc3 2.84E-01 2.71E-03 2.74E-01 0.00E+00 2.77E-01 
111988-49-9 Thiacloprid 1.00E-02 
Neonicotinoid 
Insecticide Sc2 1.00E+00 4.01E-02 2.93E-01 7.00E-02 4.03E-01 
    
Sc1 1.18E+01 5.93E-01 7.34E-01 1.80E-01 1.51E+00 
    
Sc3 1.00E+00 1.54E-02 1.81E-01 4.00E-02 2.37E-01 
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CAS Substance 
PNEC 
(µg/L) Type Scenario RQ(p95) Fspat Ftemp Fext STE score 
153719-23-4 Thiamethoxam 4.20E-02 
Neonicotinoid 
Insecticide Sc2 4.04E-01 7.02E-03 3.89E-01 4.00E-02 4.36E-01 
    
Sc1 4.52E+00 1.62E-01 5.97E-01 1.10E-01 8.69E-01 
    
Sc3 3.57E-01 4.19E-03 3.32E-01 4.00E-02 3.76E-01 
2303-17-5 Tri-allate  4.10E-01 Herbicide Sc2 6.10E-02 5.55E-05 0.00E+00 0.00E+00 5.55E-05 
    
Sc1 3.05E-01 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
    
Sc3 6.10E-02 0.00E+00 0.00E+00 0.00E+00 0.00E+00 
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The next figure shows a comparison of STE scores obtained by combined dataset (first WL and last monitoring prioritisation) for scenarios Sc1, Sc2 and 
Sc3 considering the updated PNECs. 
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The table below gives per substance for Sc3 information for the site (Fs,site) and country (Fs,country) frequency of exceedances in Fspat, 
the calculation of Ftemp by all sites (Ftemp_1) and excluding sites with a single measurement that exceeds PNEC (Ftemp_2), the size of 
the exceedance extent in Fext, the percentage (from the total number of samples) of samples that exceed PNEC and the total amount of 
samples. 
 
Substance PNEC (μg/L) Type Fs,site Fs,country Ftemp_1 Ftemp_2 EXCextent 
Exceeding 
samples (%) 
Number of 
samples (Sc3) 
17-alpha-Ethinylestradiol 3.50E-05 Estrogen 3.02E-01 7.14E-01 7.20E-01 5.36E-01 9.83E+00 16.63 469 
17-beta-Estradiol 4.00E-04 Estrogen 1.95E-01 4.50E-01 8.58E-01 6.72E-01 4.50E+00 9.78 716 
2,6-Di-tert-butyl-4-methylphenol 3.16 Antioxidant 7.75E-03 0.00E+00 7.89E-02 7.89E-02 5.00E-01 0.46 1293 
2-Ethylhexyl-4-methoxycinnamate 6 Sunscreen 0.00E+00 0.00E+00 0.00E+00 0.00E+00 5.00E-01 0.00 543 
Acetamiprid 0.5 Neonicotinoid Insecticide 0.00E+00 0.00E+00 0.00E+00 0.00E+00 2.31E-02 0.00 7121 
Azithromycin  0.019 Antibiotic 3.17E-01 6.50E-01 8.33E-01 7.53E-01 1.53E+01 23.34 1217 
Clarithromycin 0.12 Antibiotic 1.20E-01 2.00E-01 3.42E-01 3.35E-01 1.89E+00 5.27 7443 
Clothianidin 0.13 Neonicotinoid Insecticide 3.29E-03 4.17E-02 1.88E-01 1.88E-01 1.92E-01 0.29 5952 
Diclofenac 0.05 Analgesic 6.06E-01 7.31E-01 5.92E-01 5.70E-01 1.34E+01 44.39 17748 
Erythromycin 0.2 Antibiotic 2.50E-02 0.00E+00 2.51E-01 2.18E-01 6.30E-01 0.51 6313 
Estrone 0.0036 Estrogen 1.12E-01 3.48E-01 5.19E-01 3.72E-01 5.47E+00 6.09 1314 
Imidacloprid 0.0083 Neonicotinoid Insecticide 5.75E-01 6.36E-01 6.01E-01 5.23E-01 5.78E+01 33.38 24745 
Methiocarb 0.002 Insecticide/ Herbicide 3.94E-01 7.00E-01 8.49E-01 1.53E-01 1.00E+00 13.56 2781 
Oxadiazon 0.088 Herbicide 3.12E-02 8.70E-02 2.74E-01 2.63E-01 6.04E-01 0.94 50148 
Thiacloprid 0.01 Neonicotinoid Insecticide 8.87E-02 1.74E-01 2.11E-01 1.81E-01 1.86E+00 2.89 8533 
Thiamethoxam 0.042 Neonicotinoid Insecticide 5.03E-02 8.33E-02 3.32E-01 3.00E-01 1.01E+00 1.78 9041 
Tri-allate  0.41 Herbicide 0.00E+00 0.00E+00 0.00E+00 0.00E+00 1.22E-01 0.00 20725 
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Annex 9: Factsheets 
 
Amoxicillin (CAS N. 26787-78-0) 
Substance identity 
EC name  
EC number  
CAS number 26787-78-0 
Molecular formula C16H19N3O5S 
Molecular weight 365.4 g/mol 
Structure 
  
SMILES  
 
Physico-chemical properties 
Endpoint Value Source 
Vapour Pressure (Pa)   
Water solubility (mg/L) 3430 https://www.drugbank.ca/drugs/DB01060 
Log Kow 0.87 Moarefian et al., 2014 
 
Environmental fate 
Endpoint Value Source 
Sorption potential Koc     
Partition coefficient solid-water in 
sediment Kpsed (L/kg) 
  
Biodegradability 
Amoxicillin has a hydrolysis half-life 
in water at pH 7 of ca. 20 days. 
Braschi, et al., 2013 
Bioaccumulation (BCF)   
 
Environmental exposure assessment 
Predicted Environmental Concentration 
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 Description Source 
Tonnes/year 0.006-0.011 Denmark 
Uses Beta-lactam antibiotic  
Spatial usage (by MS) 
  
Use in fish farms in 2012-
2016. 
Denmark 
Widely used in the UK for 
both human and animal 
health. Available data note it 
is one of the most commonly 
used antibiotics for human 
health used in the UK. 
Various products approved 
for veterinary use on a range 
of animals including cats, 
dogs, sheep, pigs, chickens, 
turkeys, ducks and cattle. 
UK 
Banned uses   
ERC code   
PECfw (µg/L) 0.0068 (Besse and Garric, 2008) 
PECsed (mg/kg dw)   
PECbiota (mg/kg)   
 
 
Measured Environmental Concentrations  
MS 
Source of monitoring 
data 
MEC values (µg/l) 
In Sc2 (inland whole water) data 
from only 1 MS (4 sites) with 86 
samples are available. No 
quantified samples. 
Sc3 was not developed since data 
scarcity. 
Data quality is not good. 
Dataset of monitoring 
prioritisation 2014 
MEC(P95)= 0.01 (Sc2) 
  
Spain 
Hospital wastewater, and 
urban WWTP effluent in 
Girona (Gros et al., 2013) 
0.218-0.258 
Europe (90 samples from 18 WWTP effluents < 0.025 
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countries) Loos et al. (2013) 
France 
Seine River (Dinh et al., 
2011) 
0.068 
Canada 
Wascana Creek, Qu'Appelle 
River (Waiser et al., 2011) 
0.080 (max) 
Italy 
River Po 
(Zuccato et al., 2010) 
<0.002 
Italy 
River Arno 
(Zuccato et al., 2010) 
0.006 (mean); 
0.010 (max) 
UK (Wales) 
River Taff and Ely 
(Kazprzyk-Horden et al., 
2008) 
0.117 (median); 
0.622 (max) 
UK (Wales) 
River Taff (Kazprzyk-
Horden et al., 2007) 
<0.010 – 0.245 
Italy 
WWTP effluents 
(Castiglioni et al., 2005) 
0.015 – 0.120 
Italy 
Different WWTP effluents 
(Andreozzi et al., 2004) 
0.0018 – 0.120 
CZ 
No findings in 650 water 
samples from 52 sites 
(LOQ: 0.02 - 0.1 μg/l) 
< 0.1 
UK 
Monitored at approximately 
80 sites (approx. 1700 
samples). 
Not detected in any of 
the samples. 
 
 
Analytical Methods    
 
Method LOQ (µg/l) Description / Reference 
SPE-LC-MS-MS 0.010 (Kazprzyk-Horden et al., 2007) 
SPE-LC-MS-MS 0.004 Extraction of 100 ml water; positive 
ionisation; mass transitions 366 > 349, 114 
(Gros et al. (2013) 
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P, B, T, C, M, R, ED properties  
 
Substance Persistent (P) 
Bioaccumulative 
(B) Toxic (T) 
Carcinogenic (C) 
Mutagenic (M) 
Reproduction toxicity 
(R) 
Endocrine 
Disruptive 
(ED) 
Comment 
Amoxicillin - - 
 
- - 
 
Amoxicillin has a hydrolysis half-life in water at pH 7 of ca. 20 days (Braschi, et al., 
2013).  
In water, amoxicillin is rapidly degraded by biotic and abiotic factors, yielding different 
intermediate products; these are suspected of being more resistant to degradation, and 
potentially more toxic, than the parent compound (Elizalde-Velázquez, 2016). 
Amoxicillin may bioaccumulate in fish muscle tissues, with the possibility of the 
occurrence of these drugs in food, leading to a passive consumption of this antibiotic 
resulting in undesirable effects on consumer health such as immunoallergic responses. 
However, the main problem related with the presence of this antimicrobial compounds in 
fish tissues is the possibility of inducing bacterial resistance genes (Elizalde-Velázquez, 
2016).  
 
Hazard assessment 
Ecotoxicology data 
Species Time-scale Endpoint Toxicity  
(µg/L) 
Algae 
Pseudokirchneriella 
subcapitata 
72 h Growth 
inhibition 
EC10 >1500000 
Pseudokirchneriella 
subcapitata 
7 d Growth 
inhibition 
NOEC 250000 
Synechococcus 
leopolensis 
96 h Cell 
proliferation 
NOEC 0.78 
Isochrysis galban 96 h Growth 
inhibition 
NOEC 250000 
Phaeodactylum 
tricornutum 
96 h Growth 
inhibition 
NOEC 250000 
Plants 
Lemna gibba 7 d EC10 >1000 
Invertebrates 
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Brachionus calyciflorus - 
Average lifespan, 
net reproductive 
rate, 
generational 
time 
LOEC (NOEC) 50 (25) 
Brachionus calyciflorus Gross 
reproductive rate 
NOEC 50 
Brachionus calyciflorus Average lifespan NOEC 50 
Brachionus calyciflorus Gross 
reproductive 
rate, net 
reproductive 
rate, rate of 
population 
increase 
LOEC (NOEC) 50 (25) 
Arbacia lixula 72 h 
Development 
EC10 1276000 
Parcentrotus lividus 48 h 
Development 
EC10 108000 
 
 
Mammalian toxicology data 
 
PNEC derivation 
PNEC Endpoint 
Endpoint value 
(µg/L) 
AF 
PNEC 
value 
(µg/L) 
PNECfw 
96 h, cell proliferation 
Synechococcus 
leopolensis 
0.78 10      0.078 
PNECsed     
PNECbiota,sec 
pois 
    
PNECbiota, hh     
PNECdw, hh     
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Risk Quotient (MEC or PEC/PNEC) 
RQ Value 
RQfw (MEC(P(95))/PNEC) 1.28 (Sc2)
a 
  
a RQ is not reliable due to the low quality of MEC value  
 
STE score  
 
n/a (since data scarcity)  
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Bifenthrin (CAS N. 82657-04-3) 
Substance identity 
EC name  
EC number  
CAS number 82657-04-3 
Molecular formula C23H22ClF3O2 
Molecular weight 422.87 g/mol 
Structure 
  
Bifenthrin is a mixture of 2 optical isomers, (Z)-(1R)-cis-acid and 
(Z)-(1S)-cis-acid (enantiomers) 
SMILES  
 
Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa)   
Water solubility (mg/L) < 0.001 
http://npic.orst.edu/factsheets/archive/biftech.html 
EFSA, 2011 
Log Kow 
6.0 
6.6 
https://pubchem.ncbi.nlm.nih.gov/compound/bifenthrin 
EFSA, 2011 
 
Environmental fate 
Endpoint Value Source 
Sorption potential Koc   236610 EFSA, 2011 
Partition coefficient solid-water in 
sediment Kpsed (L/kg) 
  
Biodegradability Not readily biodegradable EFSA, 2011 
Bioaccumulation (BCF) 1703 EFSA, 2011 
 
Pyrethroid insecticides are strongly hydrophobic. As such, the water-soluble fraction of 
pyrethroids introduced into an aquatic system will be short-lived and quickly reduced. 
Subsequently, much of the fate and transport of pyrethroids in aquatic systems is 
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governed by particulate adsorption. Pyrethroid transport within aquatic systems occurs 
through movement of pyrethroid absorbed fine particulates. Although the half-lives of 
most pyrethroid insecticides are in the order of days to weeks in the water column, 
pyrethroids adsorbed to particulates are considerably more persistent, with reported half-
lives on sediments of 150 to 200 days. Pyrethroids in stream water are most frequently 
associated with suspended solids and particulates, with only 0.4% to 1.0% of added 
pyrethroids present in the freely dissolved phase (Palmquist et al., 2012). 
Pyrethroids are most commonly introduced into aquatic systems via runoff from sprayed 
fields, lawns, parking lots, etc., during rainstorm events, and, to a lesser extent though 
spray drift (Palmquist et al., 2012).  
Due to their high hydrophobicity, pyrethroids readily associate with sediment particles 
after entering aquatic systems and are one of the major threats to benthic invertebrates 
in urban waterways (Chen et al., 2015; Ding et al., 2010; Kuivila et al., 2012).  
Their high hydrophobicity, along with pseudo-persistence due to continuous input, 
indicates that pyrethroids will accumulate in sediment, pose long-term exposure concerns 
to benthic invertebrates and ultimately cause significant risk to benthic communities and 
aquatic ecosystems. The current study has provided evidence that pyrethroids are not 
only commonly detected in the aquatic environment, but also can cause toxic effects to 
benthic invertebrates, and calls for better development of accurate sediment quality 
criteria and effective ecological risk assessment methods for this emerging class of 
insecticides (Li et al., 2017).  
 
Environmental exposure assessment 
Predicted Environmental Concentration 
 Description Source 
Tonnes/year   
Uses 
Bifenthrin is approved as PPP 
in the EU (12 MS: AT, BE, CY, 
DE, ES, FI, FR, GB, IT, LU, NL, 
PO). The approval is in 
progress for AT and CZ 
 
http://ec.europa.eu/food/plant/pesticides/eu-pesticides-
database/public/?event=activesubstance.detail&language=EN
&selectedID=1026 
 
https://echa.europa.eu/it/information-on-
chemicals/pic/import-
notifications?p_p_id=importnotifications_WAR_echapicportle
t&p_p_lifecycle=0&p_p_col_id=column-
1&p_p_col_pos=1&p_p_col_count=2&_importnotifications_
WAR_echapicportlet_highlightedsearch=true&_importnotifica
tions_WAR_echapicportlet_highlightedname=Bifenthrin&_im
portnotifications_WAR_echapicportlet_highlightedcasnumber
=82657-04-3 
 
Only uses as insecticide may 
be authorised.  
http://eur-lex.europa.eu/legal-
content/EN/TXT/HTML/?uri=CELEX:32012R0582&from=EN 
Spatial usage 
(by MS) 
  
Northern Ireland: used in 
agriculture 
UK 
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Banned uses   
ERC code   
PECfw (mg/L)   
PECsed (mg/kg 
dw) 
  
PECbiota 
(mg/kg) 
  
 
 
Measured Environmental Concentration  
MS 
Source of 
monitoring data 
MEC values 
In Sc2 (inland whole water) data 
from 3 MS (1132 sites) with 7572 
samples are available. Only 0.03% 
quantified samples. 
Sc3 was not developed since data 
scarcity. 
Data quality is not good. 
Dataset of 
monitoring 
prioritisation 2014 
MEC(P95)= 0.025 µg/l 
(Sc2) 
UK 
Monitored at 
approx. 500 sites 
as part of national 
catchment sensitive 
farming (CSF) & 
watch list 
programmes and 
WFD national 
surveillance 
programme.   
Not detected in any 
samples. 
 
California's Stream Pollution Trends program assesses long-term water quality trends, 
using 100 base-of-the-watershed sampling sites. A significant increasing trend for 
pyrethroid pesticide concentrations in sediment samples was observed throughout the 
state, likely associated with an increasing trend of pyrethroid use in urban watersheds. 
There were no significant increasing or decreasing trends for pyrethroids in agriculturally 
dominated or open space watersheds. Bifenthrin was the most commonly detected 
pyrethroid and was measured in 69% of the samples (n=410) over the five year study. 
The remaining pyrethroids, including cyfluthrin, cyhalothrin, cypermethrin, deltamethrin, 
esfenvalerate/fenvalerate, fenpropathrin, and permethrin, were detected in 19% to 39% 
of the samples (Siegler et al., 2015).  
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Currently used agricultural pesticides were monitored in sediments in California’s Central 
Valley. The pyrethroid bifenthrin in particular, as well as lambda-cyhalothrin, 
cypermethrin, esfenvalerate, permethrin, and the organophosphate chlorpyrifos, were 
primarily responsible for the observed sediment toxicity in these agricultural sediments 
(Weston et al., 2013).  
Corcellas et al. (2015) described for the first time pyrethroid pesticide bioaccumulation in 
edible river fish collected in 4 different Iberian rivers, and conclude that pyrethroid levels 
are safe for human consumption taken into account the current regulations.  
Pyrethroids have mainly been analysed in sediment (Amweg et al., 2005; Delgado-
Moreno et al., 2011; Hintzen et al., 2009; Li et al., 2017; Siegler et al., 2015; Weston et 
al., 2011; 2013), and only a few times in water (Delgado-Moreno et al., 2011; Feo et al., 
2010; Weston and Lydy, 2010), or biota (Brodeur et al., 2017; Corcellas et al., 2015).  
Tang et al. (2018) give a world-wide overview on pyrethroid pesticide residues in the 
global environment.  
 
Analytical Methods    
 
Method LOQ (µg/l) Description / Reference 
GC-MS 0.001 In surface water (EFSA, 2008 and EFSA, 
2011). 
GC-NCI-MS 0.00004 Extraction by ultrasound-assisted 
emulsification-extraction of a water-
immiscible solvent (chloroform) in 20 mL 
water (Feo et al., 2010). 
GC-ECD/MS 0.00006–0.00098 
(LOD) 
SPE (Zheng et al., 2016). 
n.a. 0.005 Finland 
 
 
P, B, T, C, M, R, ED properties  
 
Substance Persistent (P) 
Bioaccumulative 
(B) Toxic (T) 
Carcinogenic (C) 
Mutagenic (M) 
Reproduction toxicity 
(R) 
Endocrine 
Disruptive 
(ED) 
Comment 
Bifenthrin P, B and T  ED  
 
Hazard assessment 
Ecotoxicology data 
Species Time-scale Endpoint Toxicity  
(µg/L) 
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Invertebrates 
Daphnia magna 21 d NOEC 0.00095 
Daphnia magna 21 d   NOEC 0.0013 
Corbicula 21 d NOEC 2.58 
Mysidopsis bahia 28 d NOEC 0.0012 
Chironomus riparius 28 d NOEC 0.32 
Fish 
Pimephales promelas 21 d NOEC 1.86 
Pimephales promelas 368 d NOEC 0.04 
 
 
Mammalian toxicology data 
 
PNEC derivation 
 
PNEC Endpoint (µg/l) 
Endpoint value 
(µg/l) 
AF 
PNEC 
value 
(µg/l) 
PNECfw 
NOEC, 21 d 
(Daphnia magna) 
0.00095 50 0.00002  
PNECsed      
PNECbiota,sec 
pois 
    
PNECbiota, hh     
PNECdw, hh     
 
 
 
Risk Quotient (MEC or PEC/PNEC) 
RQ Value 
RQfw (for MEC(P(95)) and 1250 (Sc2) 
175 
PNEC=0.00002 µg/l) 
RQfw (for PEC=0.054 µg/l  and PNEC= 
0.00002 µg/l) 
2700 
RQfw (for PEC=0.0049 µg/l  and PNEC= 
0.00002 µg/l) 
245 
 
Note: PEC values are taken from Lettieri, T., Chirico, N., Carvalho, R.N., Napierska, D., 
Loos, R., Sanseverino, I., Marinov, D., Ceriani, L., Umlauf, G. 2016. Modelling-based 
strategy for the prioritisation exercise under the Water Framework Directive,  
https://circabc.europa.eu/w/browse/85b46283-9353-4e67-bf56-e4d18b32cbaf). 
 
 
STE score  
 
3 (Sc2) 
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Chromium trioxide and other Cr(VI) compounds (CAS N. 1333-82-0; 18540-29-
9) 
Substance identity 
EC name  
EC number  
CAS number 1333-82-0; 18540-29-9 (Chromium(VI)) 
Molecular formula CrO3; Cr(VI) 
Molecular weight 99.99; Cr(VI): 51.9 
Structure 
 
SMILES [Cr](=O)(=O)=O 
 
Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 
Not available (inorganic ionic 
compound) 
EU-RAR, 2005
1
 
Water solubility (mg/L) 1667 mg/L EU-RAR, 2005
1
 
Log Kow 
Not available (inorganic ionic 
compound) 
EU-RAR, 2005
1
 
 
Environmental fate 
Endpoint Value Source 
Sorption potential Koc   Not available EU-RAR, 2005
1
 
Partition coefficient solid-water in 
sediment Kpsed (L/kg) 
1000 EU-RAR, 2005
1
 
Biodegradability N.a. EU-RAR, 2005
1
 
Bioaccumulation (BCF) 2.8 EU-RAR, 2005
1
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Chromium is a relatively common element and occurs in the earth's crust at an average 
concentration of 200 mg/kg. In soils one finds in general contents of 10 to 90 mg/kg. 
Trivalent chromium is an essential trace element for humans and animals. 
Hexavalent chromium compounds cause allergic and asthmatic reactions and are 
considered carcinogenic. 
Chromium occurs in waters in trivalent and hexavalent form. Under aerobic 
conditions chromium (VI) is stable. Under anaerobic conditions, it is reduced to 
Chromium (III). Under oxidizing conditions a transformation from chromium (III) to 
chromium (VI) is also possible. The distribution between chromium (III) and 
chromium (VI) of the total chromium concentration in flowing waters is not 
constant, chromium (VI) has a share of 30-70%. 
Due to the formation of poorly soluble chromium (III) compounds and adsorption 
of chromium in suspended solids, a large part of the chromium is particulate 
bound. 
There is a wide range of background values ("ambient background concentrations") 
within Europe. For the dissolved concentration of chromium in uncontaminated waters, 
values of <0.1 μg/L to 0.5 μg/L are given. The FOREGS study gives for European waters 
for >0.45 μm filtered concentration a median value (n = 806) of 0.38 μg/L. 
(Internationale Kommission zum Schutz des Rheins, 2009). 
 
Environmental exposure assessment 
Predicted Environmental Concentration 
 Description Source 
Tonnes/year 114 (2010) in CZ CZ 
Uses 
Manufacture of substances and of preparations, 
formulation of preparations and materials, 
industrial use resulting in inclusion into or onto 
a matrix, use as laboratory reagent. Chromium 
trioxide meets the criteria for inclusion in Annex 
XIV to Regulation (EC) N. 1906/2006
3
.
 
In 2015 
the latest application date were expected for 
chromium trioxide is 21 March 2016, and the 
sunset date is 21 September 2017
4
, but 
exemptions have been granted for certain uses. 
ECHA, 2013
2
  
Regulation (EC) N. 
1906/2006
3 
COMMISSION REGULATION 
(EU) No 348/2013
4 
 
Electroplating. CZ 
Main source is leather tanning industry and 
other industries using chromium. 
DK 
Spatial usage (by MS) Not known - 
Banned uses 
Cement and cement-containing mixtures shall 
not be placed on the market, or used, if they 
contain, when hydrated, more than 2 mg/kg 
(0,0002%) soluble chromium VI of the total dry 
weight of the cement. 
Leather articles coming into contact with the 
skin shall not be placed on the market where 
ECHA, List of substances 
restricted under REACH
5
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they contain chromium VI in concentrations 
equal to or greater than 3 mg/kg (0,0003 % by 
weight) of the total dry weight of the leather.  
Articles containing leather parts coming into 
contact with the skin shall not be placed on the 
market where any of those leather parts 
contains chromium VI in concentrations equal 
to or greater than 3 mg/kg (0,0003 % by weight) 
of the total dry weight of that leather part. 
ERC code - - 
PECfw (mg/L)   
PECsed (mg/kg dw)   
PECbiota (mg/kg) 0.98 (N.R.) 
Calculation based on 
Equation L (Section 3.4.3) 
N.R. Not required based on BCF value not reaching the trigger value required for biota assessment 
 
 
Measured Environmental Concentrations  
Chromium is analysed in most countries as total chromium (VI+III). In the prioritisation 
exercise 2014, Cr(VI) data were only available for non-filtered water samples (whole 
water fraction) from 4 countries.  
In 2018, one MS (England) submitted Cr(VI) data for dissolved water samples, and 9 MS 
total chromium (VI+III) data. 
The use of monitored concentrations for chromium total in dissolved fraction, and the use 
of monitored concentration for Cr(VI) in whole water, below, gives an overestimation of 
the risk posed by Chromium VI in dissolved fraction. 
MS Source of monitoring data MEC values 
Cr(VI) in Sc3 (inland whole 
water) in 4 countries 
415 samples (93% 
quantified) 
(Dataset of monitoring 
prioritisation 2014) 
6 µg/l (P95) 
 
Cr(total) in Sc3 (inland 
dissolved fraction) in 24 
countries 
134937 samples (22.8% 
quantified) 
(Dataset of monitoring 
prioritisation 2014 + data 
submitted in 2018; years 
2010-2018) 
1.0 µg/l (P95) 
0.25 µg/l (median) 
 
Cr(total) in Sc3 (coastal and 
transitional water) in 6 
countries 
370 samples (23% 
quantified) 
(Dataset of monitoring 
prioritisation 2014) 
0.7 µg/l (P95) 
0.5 µg/l (median) 
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Cr(total) in CZ 
Waste water; measured in 
industrial waste water; not in 
surface water. Year 2015. 
0.02-497 µg/l 
Cr(VI) in England 
(probably dissolved phase) 
Approx. 170 sites monitored 
quarterly in water body’s 
deemed at risk from Cr(VI) 
via permitted discharges.  
Results mostly show 
below LOD however 1 
site exceeds AA EQS, and 
2 others record values 
above this limit. 
Cr(VI) in dissolved water 
phase in England 
Number of samples: 5724; 
quantified samples (> LOQ): 
1716; LOQ (µg/L): 0.1-0.6. 
Number of samples in Sc3: 
5724. 
0.05 µg/l (median) 
0.30 µg/l (P95) 
 
 
Analytical Methods    
Method LOQ (µg/l) Description / Reference 
EPA method 218.7 
(2011) 
0.0044 to 0.015 
(LOD) 
Samples are preserved with a combined 
buffer/dechlorinating reagent which complexes 
free chlorine and increases the pH to a value 
greater than eight. A measured volume (usually 1 
mL) of the sample is introduced into an ion 
chromatograph. CrO42- is separated from other 
matrix components on an anion exchange 
column. CrO42- is derivatized with 1,5-
diphenylcarbazide in a post-column reactor and is 
detected spectrophotometrically at a wavelength 
of 530 nm. Cr(VI) is qualitatively identified via 
retention time, and the concentration of CrO42- in 
the sample is calculated using the integrated 
peak area and the external standard technique. 
Results are reported in units of μg/L of Cr(VI) 
(EPA method 218.7; 2011). 
Ion 
chromatography 
LOD: 0.050 
LOQ: 0.16 
Cr(VI) determination in water samples with ion 
chromatography followed by post-column 
derivatization of the Cr(VI) with 
diphenylcarbazide and detection of the colored 
complex at 530 nm. 
(Mamais et al., 2016). 
LC-ICP-MS 0.001 to 0.01 
(LOD) 
Perkin Elmer Application note; Vonderheide et al, 
2004. 
ISO method 
23913:2006 
Flow analysis (FIA 
2-200 (LOD) ISO 23913:2006 specifies flow injection analysis 
(FIA) and continuous flow analysis (CFA) 
methods for the determination of chromium(VI) 
in various types of water. The method applies to 
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and CFA) and 
spectrometric 
detection 
the following mass concentration ranges: for FIA 
(20 to 200 micrograms per litre and 200 to 2 000 
micrograms per litre for surface water, leachates 
and waste water) and for CFA (2 to 20 
micrograms per litre and 20 to 200 micrograms 
per litre for drinking water, ground water, surface 
water, leachates and waste water). The range of 
application may be changed by varying the 
operating conditions. Seawater may be analysed 
by these methods with changes in sensitivity and 
after adaptation of the reagent and calibration 
solutions to the salinity of the samples. 
Ion 
chromatography 
1 Ionic chromatography to separate Cr6+ and 
interfering compounds. Measure by spectrometry 
(540nm) after derivation post column by 1.5-
diphenylcarbazide solution 
(Belgium-Wallonia). 
 
Hazard properties  
 
Substance Persistent(P) 
Bioaccumulative (B) 
Toxic (T) 
Carcinogenic (C) Mutagenic 
(M) Reproduction toxicity 
(R) 
Endocrine 
Disruptive (ED) 
Chromium  
(VI)  
P and  T M and R  
 
Not investigated   
 
The evidence clearly indicates that highly water-soluble Cr(VI) compounds can produce 
significant  mutagenic activity in vitro and in vivo1. The Cr (VI) compounds under 
consideration are therefore regarded as in vivo somatic cell mutagens1. In addition, 
toxicokinetic and dominant lethal data suggest that water-soluble Cr (VI) has the 
potential to be an in vivo germ cell mutagen1. Chrome plating workers exposed to 
chromium (VI) trioxide in aqueous solution have shown a clear excess in mortality from 
lung cancer1. Therefore chromium (VI) trioxide should be regarded as a human 
carcinogen1. Adverse effects on fertility have been found in studies in mice following 
repeated oral exposure1. In addition, adverse effects on the testes have been seen 
following repeated oral exposure in the rat (EU-RAR, 20051). The substance is not readily 
biodegradable (P). It shows a low potential to bioaccumulate in aquatic organism1. 
 
Hazard assessment 
Ecotoxicology data 
Chromium (VI) 
The PNEC previously used for chromium (VI) in the 2014 prioritisation report has been 
updated by JRC after a literature search and the evaluation of new chronic toxicity data. 
The assessment performed in the European Risk Assessment Report (EU 2005), by the 
Environment Agency in 2007 (UK EA 2007) and in the UBA Dossier 2015 have been 
taken into consideration, with the inclusion of additional chronic data assessed to be 
adequate and relevant. On this basis, the JRC has derived a new PNEC of 2.06 µg/L for 
chromium (VI). 
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In addition to the previous chronic quality standard derivation (EU 2005), 31 freshwater 
and 2 marine water chronic toxicity values have been found from 17 studies published 
after 2005. A literature evaluation of these studies has been performed by using the LET 
tool in-house developed by the JRC, and based on the work of Kase et al. (2015), and 
three of them were deemed to be not reliable. Freshwater and marine water datasets 
have been treated separately, in accordance with the EQS Technical Guidance Document 
(EC 2011). 
An overall dataset of 73 freshwater chronic toxicity values are available for 35 species of 
8 different taxonomic groups, i.e. 7 algae species, 2 cnidarian species, 5 crustaceans, 11 
fish species, 4 higher aquatic plants, 2 insects, 2 molluscs, and 2 amphibians.  
After selecting the most sensitive geometric mean endpoints per species, a probabilistic 
approach has been undertaken with 35 freshwater chronic data points, giving an HC5 
value of 0.006 mg/L. An AF of 3 has been applied to the HC5 value giving a chronic 
freshwater QS of 2.06 µg/L.  
Regarding the marine water chronic toxicity dataset, only a deterministic approach could 
be applied, since data are available for 15 species of 5 taxonomic groups. The lowest 
value has been observed for the polychaete worm Nereis arenaceodentata with a 2-week 
NOEC of 0.006 mg/L. In accordance with the EQS Technical Guidance Document (EC 
2011), an AF of 10 has been applied, giving a chronic marine water QS of 0.6 µg/L. 
 
 
CHRONIC EFFECTS Master Reference 
Algae 
(mg/L) 
Freshwater 
Chlorella pyrenoidosa / 96 h / 
Biomass  NOEC : 0.1 mg/L  
EU, 2005; UK EA, 2007; Meisch 
and Schmitt-Beckmann 1979  
Chlorella sp. (wild) / 96 h / 
Biomass  
NOEC : 0.1 mg/L  
EU, 2005; UK EA, 2007; Meisch 
and Schmitt-Beckmann 1979  
Chlorella vulgaris / 96 h / Growth 
inhibition   
LOEC : 0.0026 mg/L  
Ouyang et al. 2012  
(Klimisch 2; supporting 
information)* 
Chlorella vulgaris / 96 h / 
Percentage of inhibition  
NOEC : 2.6 mg/L  
Qian et al. 2013  
(Klimisch 2)* 
Microcystis aeruginosa / 8 d / 
Biomass  NOEC : 0.002 mg/L  
EU, 2005; UK EA, 2007; 
Bringmann and Kühn 1978 
(Klimisch 3) 
Microcystis aeruginosa / 7 d / 
Chlorophyll  
EC50 : 0.211 mg/L  
ECOTOX DB; UK EA, 2007; 
Halling-Sorensen 2000 
Microcystis aeruginosa / 96 h / 
Growth rate  
NOEC : 0.35 mg/L  
EU, 2005; UK EA, 2007; Slooff 
and Canton 1983 
Scenedesmus pannonicus / 96 h 
/ Biomass  
NOEC : 0.11 mg/L  
EU, 2005; UK EA, 2007; Slooff 
and Canton 1983 
Scenedesmus subspicatus / 72 h 
/ Biomass  
EC10 : 0.032 mg/L  
EU, 2005; UK EA, 2007; Kühn 
and Pattard 1990 
Scenedesmus subspicatus / 72 h 
/ Growth  
EC10 : 0.64 mg/L  
EU, 2005; Kühn and Pattard 
1990 
Pseudokircheneriella subcapitata 
/ 72 h / Growth rate  
EC10 : 0.11 mg/L  
EU, 2005; UK EA, 2007; Nyholm 
1991 
Pseudokircheneriella subcapitata 
/ 72 h / Growth rate  
EU, 2005; UK EA, 2007; 
Christensen and Nyholm 1984 
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CHRONIC EFFECTS Master Reference 
EC10 : 0.01 mg/L  
Marine 
water 
Gracilaria tenuistipitata / 96 h / 
Population growth  
NOEC : 0.04 mg/L  
ECOTOX DB; UK EA, 2007; 
Haglund et al. 1996 
Gracilaria tenuistipitata / 96 h / 
Population growth 
NOEC : 0.26 mg/L  
ECOTOX DB; UK EA, 2007; 
Haglund et al. 1996 
Thalassiosira pesudonana / 15 d 
/ Growth inhibition  
NOEC : 0.1 mg/L  
EU, 2005; UK EA, 2007; Frey et 
al. 1983 
Higher 
aquatic 
plants 
(mg/L) 
Freshwater 
Lemna gibba / 8 d / Growth 
biomass  NOEC : 0.1 mg/L  
EU, 2005; UK EA, 2007; Staves 
and Knaus 1985 
Lemna minor / 7 d / Growth  
NOEC : 0.11 mg/L  
EU, 2005; UK EA, 2007; Slooff 
and Canton 1983 
Lemna minor / 7 d / Growth rate 
dry weight  
EC10 : 0.047 mg/L  
Naumann et al. 2007  
(Klimisch 2)* 
Lemna minor / 7 d / Growth rate 
fresh weight  
EC10 : 0.036 mg/L  
Naumann et al. 2007  
(Klimisch 2)* 
Lemna minor / 7 d / Growth rate 
frond number 
EC10 : 0.047 mg/L  
Naumann et al. 2007  
(Klimisch 2)* 
Spirodela polyrhiza / 8 d / 
Growth   
NOEC : 0.1 mg/L  
EU, 2005; UK EA, 2007; Staves 
and Knaus 1985 
Spirodela punctata / 8 d / 
Growth  
NOEC : 0.5 mg/L  
EU, 2005; UK EA, 2007; Staves 
and Knaus 1985 
Invertebrate
s (mg/L) 
Freshwater 
Hydra littoralis / 11 d / 
Reproduction  Threshold : 0.035 
mg/L  
EU, 2005; UK EA, 2007; 
Dannerberg 1984 
Hydra oligactis / 21 d / Growth 
rate   
NOEC : 1.1 mg/L  
EU, 2005; UK EA, 2007; Slooff 
and Canton 1983 
Ceriodaphnia dubia / 7 d / 
Reproductiom  
NOEC : 0.015 mg/L  
Baral et al. 2016  
(Klimisch 3)* 
Ceriodaphnia dubia / 7 d / 
Reproduction  
NOEC : 0.0045 mg/L  
Rodgher and Espindola 2008 
(Klimisch 2)* 
Ceriodaphnia dubia / 7 d / 
Reproduction  
NOEC : 0.0047 mg/L  
EU, 2005; UK EA, 2007; De 
Graeve et al. 1992 
Ceriodaphnia dubia / 7 d / 
Reproduction  
IC50 : 0.013 mg/L  
EU, 2005; UK EA, 2007; De 
Graeve et al. 1994 
Ceriodaphnia dubia / 7 d / 
Survival  NOEC : 0.0084 mg/L  
EU, 2005; UK EA, 2007; De 
Graeve et al. 1993 
Daphnia carinata / 14 d / 
Reproduction NOEC : 0.05 mg/L  
EU, 2005; UK EA, 2007; Hickey 
1989 
Daphnia magna / 21 d / Growth   
NOEC : 0.06 mg/L  
EU, 2005; UK EA, 2007; Van 
Leeuwen et al. 1987 
Daphnia magna / 63 d / Growth  
NOEC : 0.0035 mg/L  
UK EA, 2007; Gorbi et al. 2002 
Daphnia magna / 21 d / Mortality 
NOEC : 0.018 mg/L  
EU, 2005; UK EA, 2007; Kühn et 
al. 1989 
Daphnia magna / 21 d / Mortality 
NOEC : 0.035 mg/L  
EU, 2005; UK EA, 2007; Slooff 
and Canton 1983 
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Daphnia magna / 21 d / 
Reproduction NOEC : 0.018 mg/L  
EU, 2005; UK EA, 2007; Kühn et 
al. 1989 
Daphnia magna / 21 d / 
Reproduction NOEC : 0.035 mg/L  
EU, 2005; UK EA, 2007; Slooff 
and Canton 1983 
Daphnia magna / 14 d / 
Reproduction NOEC : 0.025 mg/L  
EU, 2005; UK EA, 2007; Hickey 
1989 
Daphnia magna / 63 d / 
Reproduction NOEC : 0.0035 
mg/L  
UK EA, 2007; Gorbi et al. 2002 
Daphnia magna / 14 d / 
Reproduction NOEC : 0.0005 
mg/L  
EU, 2005; UK EA, 2007; 
Elnabarawy et al. 1987 
Daphnia magna / 21 d / Survival   
NOEC : 0.2 mg/L  
EU, 2005; Van Leeuwen et al. 
1987 
Daphnia magna / 63 d / Survival  
NOEC : 0.0035 mg/L  
UK EA, 2007; Gorbi et al. 2002 
Daphnia magna / 14 d / Survival  
NOEC : 0.015 mg/L  
EU, 2005; UK EA, 2007; 
Elnabarawy et al. 1986 
Daphnia magna / 28 d / 
Survival/reproduction  
NOEC : <0.010 mg/L  
EU, 2005; UK EA, 2007; 
Trabalka and Gehrs 1977 
Daphnia magna / 21 d / Yield  
NOEC : 0.35 mg/L  
EU, 2005; Van Leeuwen et al. 
1987 
Hyalella azteca / 28  d / Biomass  
NOEC : 0.0092 mg/L  
Wang et al. 2017  
(Klimisch 2)* 
Hyalella azteca / 28  d / Biomass  
NOEC : 0.042 mg/L  
Hyalella azteca / 28  d / Dry 
weight  
NOEC : 0.019 mg/L  
Hyalella azteca / 28  d / Dry 
weight  
NOEC : 0.021 mg/L  
Hyalella azteca / 28  d / Survival  
NOEC : 0.036 mg/L  
Hyalella azteca / 28  d / Survival 
/  
NOEC : 0.021 mg/L  
Pseudosida ramosa / 21 d / Total 
numbe of eggs and live 
neaonates  
NOEC : 0.003 mg/L  
Freitas and Rocha 2014 
(Klimisch 2)* 
Lampsilis siliquoidea / 28  d / 
Biomass NOEC : 0.019 mg/L  
Wang et al. 2017  
(Klimisch 2)* 
Lampsilis siliquoidea / 28  d / 
Biomass NOEC : 0.01 mg/L  
Lampsilis siliquoidea / 28  d / 
Dry weight  
NOEC : 0.019 mg/L  
Lampsilis siliquoidea / 28  d / 
Dry weight  
NOEC : 0.01 mg/L  
Lampsilis siliquoidea / 28  d / 
Survival NOEC : 0.019 mg/L  
Lampsilis siliquoidea / 28  d / 
Survival NOEC : 0.01 mg/L  
Lymnaea stagnalis / 7 d / 
Hatchability  NOEC : 0.35 mg/L  
EU, 2005; Slooff and Canton 
1983 
Lymnaea stagnalis / 40 d / 
Mortality NOEC : 3.5 mg/L  
EU, 2005; Slooff and Canton 
1983 
185 
CHRONIC EFFECTS Master Reference 
Lymnaea stagnalis / 40 d / 
Reproduction budles  
NOEC : 0.11 mg/L  
EU, 2005; UK EA, 2007; Slooff 
and Canton 1983 
Culex pipiens / 25 d / 
Survival/growth 1st instar  
NOEC : 1.1 mg/L  
EU, 2005; UK EA, 2007; Slooff 
and Canton 1983 
Culex quinquefasciatus / 10 d / 
Relative growth inhibition  
NOEC : 0.1 mg/L  
Sorensen et al. 2006  
(Klimisch 2)* 
Ground 
water 
Budderoo cyclopoid / 28 d / 
Mortality  EC10 : 0.08 mg/L  
Hose et al. 2016  
(Klimisch 2, supporting 
information)* 
Somersby cyclopoid / 28 d / 
Mortality  EC10 : 0.02 mg/L  
Hose et al. 2016  
(Klimisch 2, supporting 
information)* 
Somersby harpacticoid / 28 d / 
Mortality  
EC10 : 0.002 mg/L  
Hose et al. 2016  
(Klimisch 2, supporting 
information)* 
Marine 
water 
Acartia tonsa / 5 d / 
Development  NOEC : 1 mg/L  
ECOTOX DB; UK EA, 2007; 
Andersen et al. 2001 
Americamysis bahia / 7 d / 
Growth   NOEC : 0.6 mg/L  
ECOTOX DB; UK EA, 2007; Jop 
1989 
Americamysis bahia / 7 d / 
Reproduction  
NOEC : 0.32 mg/L  
ECOTOX DB; UK EA, 2007; 
Goodfellow and Rue 1989 
Cyprinodon variagates / 7 d / 
Growth larvae  
NOEC : 3.2 mg/L  
ECOTOX DB; UK EA, 2007; 
McCulloch and Rue 1989 
Cyprinodon variagates / 7 d / 
Growth larvae  
NOEC : 2.5 mg/L  
ECOTOX DB; UK EA, 2007; Jop 
1989 
Mysidopsis bahia / 38 d / 
Reproduction brood size  
NOEC : 0.088 mg/L  
EU, 2005; UK EA, 2007; Lussier 
et al. 1985 
Neomysis integer / 14 d / 
Mortality  NOEC : 0.156 mg/L  
EU, 2005; UK EA, 2007; Van der 
Meer et al. 1988 
Oncorhynchus kisutch / 11 d / 
Mortality 
NOEC : 17.8 mg/L  
ECOTOX DB; UK EA, 2007; 
Holland et al. 1960 
Palaemon elegans / 38 d / 
Mortality  NOEC : 1.56 mg/L  
EU, 2005; UK EA, 2007; Van der 
Meer et al. 1988 
Petrolisthes laevigatus / 7 d / 
Mortality NOEC : 20 mg/L  
Urrutia et al. 2008  
(Klimisch 2)* 
Praunus flexuosus / 23 d / 
Mortality NOEC : 1 mg/L  
EU, 2005; UK EA, 2007; Van der 
Meer et al. 1988 
Rhithropanopeus harrisii / 19 d / 
Survival hatch 1st crab  
NOEC : 0.36 mg/L  
EU, 2005; UK EA, 2007; 
Bookhout et al. 1984 
Rhithropanopeus harrisii / 19 d / 
Survival to 1st crab stage  
NOEC : 0.36 mg/L  
EU, 2005; UK EA, 2007; 
Bookhout et al. 1984 
Tisbe battagliai / 8 d / 
Reproduction /NOEC : 0.32 mg/L  
ECOTOX DB; UK EA, 2007; 
Hutchinson et al. 1994 
Nereis arenaceodentata / 14 d / 
Mortality  
NOEC : 0.006 mg/L  
EU, 2005; UK EA, 2007; Mearns 
et al. 1976 
Nereis arenaceodentata / 2 
generation / Reproduction F1 
generation  
NOEC : 0.017 mg/L  
EU, 2005; UK EA, 2007; Oshida 
and Word 1982 
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Nereis arenaceodentata / 2 
generation / Reproduction 
reduction in no. Of progeny 2nd 
generation 
NOEC : 0.0125 mg/L  
EU, 2005; UK EA, 2007; Oshida 
et al. 1981 
Fish (mg/L) Freshwater 
Catostomus commersoni / 60 d / 
Growth eggs/fry  
NOEC : 0.29 mg/L  
EU, 2005; UK EA, 2007; Sauter 
et al. 1976 
Channa punctatus / 60 d / Body 
weight gain  
NOEC : 2 mg/L  
Mishra and Mohanty 2009  
(Klimisch 2)* 
Channa punctatus / 31 d / 
Growth and development of 
ovary  
LOEC : 4 mg/L  
Mishra and Mohanty 2008  
(Klimisch 3)* 
Esox lucius / 20 d / Mortality 
eggs/fry  NOEC : 0.538 mg/L  
EU, 2005; UK EA, 2007; Sauter 
et al. 1976 
Icatalurus punctatus / 30 d / 
Growth eggs/fry  
NOEC : 0.15 mg/L  
EU, 2005; UK EA, 2007; Sauter 
et al. 1976 
Odontesthes bonariensis / 16 d / 
Growth  
NOEC : 0.5 mg/L  
Carriquiriborde and Ronco 2007 
(Klimisch 2)* 
Oncorhynchus mykiss / 8 mo / 
Growth alevin-juvenile  
NOEC : 0.1 mg/L  
EU, 2005; UK EA, 2007; Benoit 
1976 
Oncorhynchus mykiss / 60 d / 
Growth eggs/fry  
NOEC : 0.051 mg/L  
EU, 2005; UK EA, 2007; Sauter 
et al. 1976 
Oncorhynchus mykiss / 244 d / 
Mortality eyed eggs 
NOEC : 0.02 mg/L  
EU, 2005; UK EA, 2007; Van Der 
Putte et al. 1982 
Oncorhyncus tshawytscha / 7 d / 
Fertilization  
NOEC (highest value tested) : 
0.266 mg/L  
Farag et al. 2006  
(Klimisch 3)* 
Oryzias latipes / 40 d / Mortality 
embryo larvae  
NOEC : 3.5 mg/L  
EU, 2005; UK EA, 2007; Slooff 
and Canton 1983 
Pimephales promelas / 60 d / 
Growth egg/larvae  
NOEC : 1 mg/L  
EU, 2005; UK EA, 2007; 
Pickering 1980 
Pimephales promelas / 30 d / 
Growth larvae  
NOEC : 0.05 mg/L  
EU, 2005; UK EA, 2007; 
Broderius and Smith 1979  
Pimephales promelas / 7 d / 
Growth larvae  
NOEC : 1.1 mg/L  
EU, 2005; UK EA, 2007; De 
Graeve et al. 1993 
Pimephales promelas / 412 d / 
Growth larval  
NOEC : 3.95 mg/L  
EU, 2005; UK EA, 2007; 
Pickering 1980 
Pimephales promelas / 60 d / 
Survival 4-week juvenile  
NOEC : 1 mg/L  
EU, 2005; UK EA, 2007; 
Pickering 1980 
Poecilia reticulata / 28 d / 
Mortality 3-4 weeks 
NOEC : 3.5 mg/L  
EU, 2005; UK EA, 2007; Slooff 
and Canton 1983 
Salvelinus fontinalis / 8 mo / 
Growth  NOEC : 0.01 mg/L  
EU, 2005; UK EA, 2007; Benoit 
1976 
Salvelinus namaycush / 60 d / EU, 2005; UK EA, 2007; Sauter 
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Growth eggs/fry  
NOEC : 0.105 mg/L  
et al. 1976 
Marine 
water 
Fundulus heteroclitus / 30 d / 
Weight  NOEC : 1.5 mg/L  
Roling et al. 2006  
(Klimisch 1)* 
Other 
organisms: 
Amphibians 
(mg/L) 
Freshwater 
Duttaphrynus melanostictus / 21 
d / Mortality  
LC50 : 1 mg/L  
Fernando et al. 2016  
(Klimisch 2, supporting 
information) 
Hypsiboas pulchellis / 280 h / 
Embryo growth inhibition  
NOEC : 1 mg/L  
Natale et al. 2006  
(Klimisch 2)* 
Hypsiboas pulchellis / 280 h / 
Tadpoles growth inhibition  
NOEC : 3 mg/L  
Natale et al. 2006  
(Klimisch 2)* 
Xenopus laevis / 100 d / 
Mortality tadpole  
NOEC : 0.35 mg/L  
EU, 2005; UK EA, 2007; Slooff 
and Canton 1983 
* The reliability of the study was evaluated by using the LET tool in-house developed by the JRC, 
and based on the work of Kase et al. (2015) 
 
 
 
Chromium (III) 
In addition a new PNEC of 1.8 µg/L has been derived by JRC for chromium (III) after a 
literature search and the evaluation of new chronic ecotoxicological data. 
In addition to the chronic toxicity values reported in the European Assessment report of 
2005 (EU 2005), four toxicological data have been retrieved (2 from the ECHA’s 
dissemination website, and 2 from recent publications), giving a final dataset of 9 
freshwater and 2 marine water chronic toxicity values. 
The available dataset could not enable the derivation of an SSD curve, since only data 
from 7 species of three taxonomic groups have been found. Therefore, the deterministic 
approach has been carried out in the present assessment. 
The 30-day time-to-hatch NOEC 0.018 mg/L for the fish Danio rerio (Study report 1990, 
ECHA DB 2018b) has been determined to be the lowest chronic freshwater value in the 
new dataset. Because data are available from each trophic level of the base set, an AF of 
10 has been applied (EC 2011), giving a QS of 1.8 µg/L.  
The only value available for the marine water is the 7-day mortality NOEC 40 mg/L of the 
crustacean Petrolisthes laevigatus (Urrutia et al. 2008). Based on these data, it has been 
yet deemed to be insufficient to derive QS for marine water bodies.  
 
Species 
Taxonomic 
group 
Duration 
Effect 
measured 
Endpoint 
Effect 
concentration 
(mg/L) 
Reference 
Freshwater 
Chlorella 
pyrenoidosa 
Algae 5 d Cell 
number 
NOEC 0.1 EU 2005 ; 
Meisch and 
Schmitt-
Beckmann 
1979 
Scenedesmus 
subspicatus 
Algae 72 h Growth 
rate 
NOEC 0.004 ECHA 
dissemination 
website 2018a
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Species 
Taxonomic 
group 
Duration 
Effect 
measured 
Endpoint 
Effect 
concentration 
(mg/L) 
Reference 
; Study report 
2010 
(supporting 
information, 
value not 
related to 
dissolved Cr 
form) 
Ceriodaphnia 
dubia 
Crustaceans 7 d Reproducti
om 
NOEC 1.253 Baral et al. 
2016 
(Klimisch 3)* 
Daphnia magna Crustaceans -- lifecycle NOEC 0.047 EU 2005 ; 
Chapman et 
al.  1985 
(unpublished) 
Daphnia magna Crustaceans -- lifecycle NOEC 0.129 EU 2005 ; 
Chapman et 
al. 1985 
(unpublished) 
Daphnia magna Crustaceans 21 d Reproducti
on 
NOEC 3.4 EU 2005 ; 
Kuhn et al. 
1989; Dose 
1993 
Danio rerio Fish 30 d Time to 
hatch 
NOEC 0.018 ECHA 
disseminatio
n 
website 201
8b; Study 
report 1990 
Oncorhynchus 
mykiss 
Fish 72 d ELS NOEC 0.05 EU 2005 ; 
Stevens and 
Chapman 
1984 
Pimephales 
promelas 
Fish 5 d lifecycle NOEC 0.75 EU 2005 ; 
Pickering 
unpublished 
Marine water 
Neanthes 
arenaceodentat
a 
Annelid -- -- NOEC 
 
>50.1 
 
EU 2005 ; 
Oshida et al. 
1976 
Petrolisthes 
laevigatus 
Crustaceans 7 d Mortality NOEC 40 Urrutia et al. 
2008 
(Klimisch 2) 
* The reliability of the study was evaluated by using the LET tool in-house developed by the JRC, and based on 
the work of Kase et al. (2015) 
 
 
 
PNEC derivation (Cr(VI)) 
PNEC Endpoint Endpoint value (µg/L)  AF 
PNEC value 
(µg/L) 
PNECfw HC5-50% 6.0  3 (SSD) 2.06  
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PNECt+cw 
NOEC  
(Nereis 
arenaceodentata 
/ 2-week) 
6.0  10 0.6  
 
PNEC derivation (Cr(III)) 
PNEC Endpoint Endpoint value (µg/L)  AF 
PNEC value 
(µg/L) 
PNECfw 
NOEC 
(Danio rerio / 
30d) 
18  10 1.8  
 
 
Risk Quotient (MEC or PEC/PNEC) 
RQ Value 
RQfw (CrVI, dissolved) 
(for MEC(P(95) data from England and 
PNEC=2.06 µg/L) 
0.12 (Sc3) 
RQfw (Cr(total), dissolved) 
(for MEC(P(95) data from 24 countries 
for time period 2010-2018, and 
PNEC=1.8 µg/L) 
0.56 (Sc3) 
RQc+tw (Cr(total), dissolved) 
(for MEC(P(95) data from 6 countries 
and PNEC=0.6 µg/L) 
1.17 (Sc3) 
RQfw (PEC/PNEC) 102.94
a 
a PEC has been derived for the 1st WL  and it doesn’t consider the restricted use. (Carvalho, et al., 
WL report 2015) 
 
 
 
STE score (Sc3) 
 
1.099 (PNEC=2.06 µg/L) (Cr(VI) inland whole water; data from 4 countries). 
0.203 (PNEC=1.8 µg/L) (Cr(total) inland dissolved phase; data from 24 countries). 
0.564 (PNEC=0.6 µg/L) (Cr(total) coastal and transitional dissolved phase; data from 6 
countries). 
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Ciprofloxacin (CAS N. 85721-33-1) 
Substance identity 
EC name  
EC number  
CAS number 85721-33-1 
Molecular formula 
 
C17H18FN3O3 
 
Molecular weight 331.3 g/mol 
Structure 
  
SMILES  
 
Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa)   
Water solubility (mg/L) 30 
https://pubchem.ncbi.nlm.nih.gov/compound/ciprofloxac
in#section=Top 
Log Kow 
0.28 
 
https://pubchem.ncbi.nlm.nih.gov/compound/ciprofloxac
in#section=Top 
 
Environmental fate 
Although several studies have reported the presence of ciprofloxacin in wastewater 
effluent and surface water (see table below), the half-life of ciprofloxacin in surface water 
is expected to be short due to rapid bio- (Amorim et al., 2013) and photodegradation 
(Cardoza et al., 2005; Lam et al., 2003; Sturini et al., 2012) with reported half-lives in 
surface water between 10 days (Van Doorslaer et al., 2014) and 2 h (Lam et al., 2003; 
Cardoza et al., 2005). Ciprofloxacin also tends to adsorb to particles with a log Koc value 
of 4.8 l/kg for soil (Nowara et al., 1997) and log Koc values of 4.3–4.9 l/kg (dependent on 
pH) for fine particulate matter (Cardoza et al., 2005). In conclusion, both adsorption and 
photodegradation strongly influence ciprofloxacin fate in aquatic systems, although the 
dominant mechanism appears to depend upon the ambient SPM level (Cardoza et al., 
2005). 
Endpoint Value Source 
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Sorption potential log Koc   
Possible FQ removal 
mechanisms during 
wastewater treatment are 
biodegradation and 
sorption on activated 
sludge. 
4.3–4.9 l/kg (SPM) 
4.8 l/kg (soil) 
Van Doorslaer et al., 2014; 
Cardoza et al., 2005 
Nowara et al., 1997 
Partition coefficient solid-water in 
sediment Kpsed (L/kg) 
  
Biodegradability 
Half-life time in surface 
water: 2 h - 10.6 days 
Andreozzi et al., 2003; Cardoza et al., 
2005; Van Doorslaer et al., 2014. 
Bioaccumulation (BCF)   
 
Note that ciprofloxacin is a degradation product of enrofloxacin (Babic et al., 2013). 
Since enrofloxacin is used in animal health, also ciprofloxacin will be found in waste water 
streams of animal farms.  
 
Environmental exposure assessment 
Predicted Environmental Concentration 
 Description Source 
Tonnes/year   
   
Uses Human medicine   
   
Spatial usage (by MS) 
  
  
  
   
Banned uses   
ERC code   
PECfw (µg/L) 
Evaluation of the potential concentrations of 
four antibiotics (ciprofloxacin, 
sulfamethoxazole, trimethoprim, and 
erythromycin) throughout the rivers of Europe. 
This involved reviewing national consumption 
rates together with assessing excretion and 
Johnson et al. (2015) 
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sewage treatment removal rates. The modelled 
antibiotic concentrations were within the range 
of measurements reported previously in 
European effluents and rivers. With the 
expected scenario, the predicted annual-
average antibiotic concentrations ranged 
between 0 and 10 ng/l for 90% by length of 
surface waters. In the worst case scenario 
concentrations could reach between 0.1 and 1 
µg/l at the most exposed locations.  As both 
predicted and observed sewage effluent 
concentrations were below reported effect 
levels for the most sensitive aquatic wildlife, no 
direct toxicity in rivers is expected.   
PECfw (µg/L)  7.5 (EMEA; 2006). 
PECfw (µg/L) 0.139 (Besse and Garric, 2008) 
PECsed (mg/kg dw)   
PECbiota (mg/kg)   
 
 
Measured Environmental Concentration  
MS 
Source of 
monitoring data 
MEC values (µg/l) 
In Sc2 (inland whole water) 
data from 3 MS (54 sites) with 
842 samples are available.  
9% are quantified. 
Sc3 was not developed since 
data scarcity. 
Data quality is not good. 
Dataset of 
monitoring 
prioritisation 2014 
MEC(P95)= 0.037 (Sc2) 
 
France 
Canche River 
(urban impact) 
(Tlili et al., 2016) 
0.007 
Spain 
Ter River 
downstream WWTP 
in Girona 
(Rodriguez-Mozaz 
et al., 2015) 
0.072 (max) 
USA 
River in Maryland 
(He et al., 2015) 
0.010 (upstream WWTP) 
0.031 (max; downstream 
WWTP) 
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Worldwide monitoring data 
collected from 47 articles; in 
total 501 samples. 
Sum of 
fluoroquinolones in 
surface water (Van 
Doorslaer et al., 
2014) 
0.026 (median) 
China 
Wenyu River 
(Zhang et al., 
2014) 
0.066 (max) 
Poland 
Gościcina and Reda 
Rivers (Wagil et 
al., 2014) 
2.7 (max) 
90 samples from 18 European 
countries 
Ciprofloxacin in EU 
WWTP effluents 
(EU-wide 
monitoring survey) 
(Loos et al., 2013) 
0.096 (mean) 
0.264 (max) 
Spain 
Urban WWTP 
effluents in Girona 
(Gros et al., 2013) 
0.147 (max) 
France 
Seine River; 
Charmoise River, 
downstream WWTP  
(Dinh et al., 2011) 
0.017; 
0.135 
Italy 
Surface water, River Po 
(Zuccato et al., 2010) 
0.0088 (mean) 
Italy 
Surface water, River Arno 
(Zuccato et al., 2010) 
0.019 (mean) 
China 
Tonghui River (Xiao et al., 
2008) 
0.010 (median); 
0.020 (max) 
China 
Pearl River (Peng et al., 
2008) 
0.459 (max) 
USA 
Upper Tennessee River 
(Conley et al., 2008) 
0.007 (median); 
0.054 (max) 
Finland 
Vantaa River (Vieno et al., 
2007) 
0.025 (max) 
USA 
Streams downstream 
WWTPs (Batt et al., 2006) 
0.170 (median); 
0.360 (max) 
France, Greece, 
Italy and Sweden 
WWTP effluents 
(Andreozzi et al., 2003) 
0.060 (median) 
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Italy 
Po and Lambro River 
(Calamari et al., 2003) 
0.020 (median); 
0.026 (max) 
Switzerland 
WWTP effluent in Zuerich 
(Golet et al. 2002) 
0.071 (mean) 
USA 
Surface water (Kolpin et al., 
2002) 
0.030 (max) 
 
 
Analytical Methods    
 
Ciprofloxacin 
Method LOQ (µg/l) Description / Reference 
SPE-LC-MS-MS 0.005 Filtration of water in case of visible particles; the pH 
is adjusted to 2.0; addition of tetrasodium 
ethylenediamine-tetraacetate dehydrate (NA4EDTA 
2 H2O x 2 H2O). Internal standard: 
13C3 
15N-
Ciprofloxacin. 
Extraction of 1 L water with Oasis HLB (60 mg). 
Positive ionisation; mass transitions: 332.2 - 314.2 
(EPA, 2007) 
SPE-LC-MS-MS 0.002 Extraction of 500 ml water; positive ionisation; 
mass transitions 332 > 288, 231 (Gros et al. 
(2009). 
SPE-LC-MS-MS 0.018 Extraction of 100 ml water (Gros et al. (2012). 
SPE-LC-MS-MS 0.006 Extraction of 100 ml water; positive ionisation; 
mass transitions 332 > 288, 245 (Gros et al. 
(2013). 
SPE-LC-MS-MS 0.018 Extraction of 500 ml water; positive ionisation; 
mass transitions 332 > 288, 245 (Petrović et al. 
(2013). 
SPE-LC-MS-MS 0.001 After filtration, to 800 mL of river water Na2EDTA 
(0.5% w/v) was added, acidified to pH 3.0 with 
hydrochloric acid (HCl), and then spiked with the 
surrogate standards before being passed through 
the Oasis HLB cartridges (500 mg) at a flow rate of 
approximately 5−10 mL/min. Elution with 1 mL 
methanol, and this eluate was cleaned-up with 
Oasis MAX cartridges; Ciprofloxacin recovery: 63 
%; MRM transitions 332 > 288, 231   (Zhang et al., 
2014). 
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P, B, T, C, M, R, ED properties  
 
Substance Persistent (P) 
Bioaccumulative 
(B) Toxic (T) 
Carcinogenic (C) 
Mutagenic (M) 
Reproduction 
toxicity (R) 
Endocrine 
Disruptive 
(ED) 
Comment 
Ciprofloxacin T  
 
Not 
investigated   
 
 
The half-life time of fluoroquinolone antibiotics in surface water is approximately 10.6 
days (Andreozzi et al., 2003; Van Doorslaer et al., 2014).  
 
Hazard assessment 
Ecotoxicology data 
 
Source: ECOTOX 2013 (CH) 
 
Mammalian toxicology data 
PNEC derivation 
PNEC Endpoint Endpoint value AF PNEC 
Species Time-scale Endpoint Toxicity  
(µg/L) 
Algae 
Chlorella vulgaris 96 h, growth 
rate 
EC10 1800 
Cyanobacteria  
Anabaena flos-aquae 72 h, growth 
rate 
EC10 4.47 
Plants  
Lemna gibba 7 d, biomass EC10 149 
Myriophyllum spicatum 14 d NOEC 980 
Crustaceans 
Daphnia magna 21 d, 
reproduction  
NOEC 4670 
197 
(µg/l) value 
(µg/l) 
PNECfw 
72 h, EC10 
(Growth rate, Anabaena 
flos-aquae) 
4.47 50 0.089a 
PNECsed     
PNECbiota,sec 
pois 
    
PNECbiota, hh     
PNECdw, hh     
a Source: Ecotox 2013 (CH)  
 
Risk Quotient (MEC or PEC/PNEC) 
RQ Value 
RQfw(MEC(P(95))/PNEC) 0.4
b 
RQfw(PEC/PNEC)c 84.2 
c 
b RQ is not reliable due to the low quality of MEC value  
c PEC source from Initial assessment of eleven pharmaceuticals using the EMEA guideline 
in Norway (TA-2216/2006; ISBN 82-7655-295-1) 
 
STE score  
0.44 (Sc2; PNEC=0.089 µg/l) 
Not reliable value 
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Cyanide-Free (CAS N. 57-12-5)  
Substance identity 
EC name  
EC number  
CAS number 57-12-5 
Molecular formula HCN, CN
-
 
Molecular weight 27.03 
Structure 
 
SMILES C#N 
 
Physico-chemical Properties 
Endpoint Value Source 
Vapour 
Pressure  
620 mmHg at 20°C (as HCN) WFD – UK TAG Report, 2012
1
 
Water solubility 
(mg/L) 
1,000,000 at 25°C (as HCN) 
10.9 mol/L (predicted) 
WFD – UK TAG Report, 2012
1
 
https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8
=%E2%9C%93&search=Cyanide%2C+free 
logKow 0.35–1.07 (as HCN) WFD – UK TAG Report, 2012
1
 
 
 
Environmental fate 
Endpoint Value Source 
Biodegradability Biodegradation is an important 
transformation process for cyanide in 
natural surface waters and is 
dependent on such factors as cyanide 
concentrations, pH, temperature, 
availability of nutrients and acclimation 
of microbes. 
WFD – UK TAG Report, 2012
1
 
Bioaccumulation 
(BCF) 
Experimental BCF values for rainbow 
trout range from 1.69–4.12. 
WFD – UK TAG Report, 2012
1
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Environmental exposure assessment 
Predicted Environmental Concentration 
 Description Source 
Tonnes/year 11894 (2010) in CZ CZ 
Uses Cyanides are used extensively in 
industry and are also emitted from car 
exhaust fumes. They also occur 
ubiquitously in the environment and 
are found in a range of aquatic 
organisms such as arthropods, 
macrophytes, fungi and bacteria. 
Cyanide is used in the following MS: 
CZ, IRL 
WFD – UK TAG Report, 2012
1
 
 Electroplating CZ 
Spatial usage (by MS) Widespread use  
In Northern Ireland used in very small 
number of industrial processes. 
UK 
Banned uses -  
ERC code -  
Fraction of tonnage to 
region 
- 
 
PECfw (mg/L) -  
PECsed (mg/kg dw) -  
PECbiota (mg/kg) -  
 
 
Measured Environmental Concentrations 
 
MS 
Source of monitoring 
data 
MEC values RBSP 
CZ Waste water 2.5-11 µg/l (2015)  
UK 
Monitored at 35 sites 
quarterly in water body’s 
deemed at risk from 
Cyanide via permitted 
discharges.  
Results show 
concentrations 
above the EQS at 3 
sites. Results are 
limited by the LOD 
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limitations. 
14 (CZ, SI, 
EL, FR, DE, 
AT, ES, UK, 
IE, NL, PL, 
RO, SK, IT) 
Reported as  
cyanide in 
the 
databases 
NORMAN DB, 20142 
MEC95, whole: 1.07 
µg/L 
MEC95, dissolved: 5 
µg/L 
10 MS (RBSP EQS 
ECOSTAT – UBA 
report)5 
EQS set for cyanide 
ion and total (WRc, 
2012)6 
WATERBASE, 20143 
MEC95, whole: 20 
µg/L 
MEC95, dissolved: 20 
µg/L 
IPCheM4 MEC95: 14  µg/L 
 
No data found in the dataset of the monitoring prioritisation 2014 
 
 
Analytical Methods    
Method LOQ (µg/l) Description / Reference 
Free cyanide: 
CSN ISO 6703 
Total cyanides: 
CSN 757415, CSN 
EN ISO 14403-2 
Free cyanide: 
5 μg/l 
Total cyanides: 
1 – 5 μg/l 
CZ 
Spectrophotometric 
measure of total 
and free cyanide 
by molecular 
absorption  
LOD: 0.1 µg/l  
LOQ: 0.5 µg/l 
 
BE-Wallonia 
SPEK (CFA), SIST 
EN ISO 14403-
2:2013 
LOD: 0.1 µg/L 
LOQ: 0.5 µg/L 
Slovenia 
Continuous flow 
analysis (CFA) with 
photometric 
detection 
LOQ: 0.14 - 
0.30 µg/l 
Fraunhofer Institute (2017) 
n.a. LOD: 5 µg/l; 
Improved 
analytical 
capability would 
require 
significant 
investment and 
low prospect of 
UK 
204 
success. 
 
 
P, B, T, C, M, R, ED properties 
 
Substance Persistent (P) 
Bioaccumulative 
(B) Toxic (T) 
Carcinogenic (C) 
Mutagenic (M) 
Reproduction toxicity 
(R) 
Endocrine 
Disruptive 
(ED) 
Comment 
Cyanide-
free 
T - 
 
- - 
 
Volatilisation and biodegradation are important transformation processes for cyanide in 
ambient waters. Hydrogen cyanide can be biodegraded by acclimated microbial cultures, 
but is usually toxic to unacclimated microbial systems at high concentrations (WFD- UK 
TAG Report, 20121). 
 
Hazard assessment 
Ecotoxicology data 
 
Trophic level Endpoint Value Reference 
Fish 
Rainbow trout, 20 d, 
LOEC 
5 µg/L 
WFD- UK TAG 
Report (2012)1 
Fish 
Lepomis 
macrochirus, 289 
d, total inhibiotin 
of spawning, LOEC 
5.2 µg/L 
WFD- UK TAG 
Report (2012)1 
Fish 
Salvelinus fontinalis, 
egg production, 
NOEC 
5.7 µg/L 
WFD- UK TAG 
Report (2012)1 
Aquatic 
Invertebrates 
Moinodaphnia 
macleayi, 5 d, 
reproduction, NOEC 
9.6 µg/L 
WFD- UK TAG 
Report (2012)1 
Aquatic 
Invertebrates 
Gammarus 
pseudolimnaeus, 98 
d, growth, NOEC 
4 µg/L 
WFD- UK TAG 
Report (2012)1 
Aquatic 
Invertebrates 
Hydra viridissima, 6 
d, population growth, 
110 µg/L 
WFD- UK TAG 
Report (2012)1 
205 
NOEC 
Algae 
Pseudokirchneriella 
subcapitata, 72 
h,growth rate and 
biomass,  NOEC 
10 µg/L 
WFD- UK TAG 
Report (2012)1 
 
 
Mammalian toxicology data 
 
No information retrieved 
 
PNEC derivation 
PNEC Endpoint Endpoint value AF 
PNEC 
value 
PNECfw 
 
Lepomis 
macrochirus, 289 d, 
LOEC  
 
 
5.2 µg/L 20 0.26 (µg/L)a  
PNECsed - - - - 
PNECbiota,sec pois - - - - 
PNECbiota, hh - - - - 
PNECdw, hh - - - 50 (µg /L)
b 
N.R. Not required based on Koc and BCF values not reaching the trigger values required for sediment and biota 
assessment 
a Value retrieved from WFD- UK TAG Report (2012)1 . A more recent freshwater AA-EQS derivation 
of 5E-04 mg/l needs also to be considered. 
b EU Drinking Water QS7, refered to cyanide. 
 
Risk Quotient (PEC/PNEC) 
RQ Value 
RQfw  (MEC 5-20)
c and PNEC 0.5 10-40 
RQfw  (MEC 5-20)
c and PNEC 0.26 19.2-76.8 
RQsed - 
RQbiota,sec pois - 
RQbiota, hh - 
206 
RQdw, hh - 
c Dissolved fraction  
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Deltamethrin (CAS N. 52918-63-5) 
Substance identity 
EC name  
EC number  
CAS number 52918-63-5 
Molecular formula C22H19Br2NO3 
Molecular weight 505.21 g/mol 
Structure 
  
SMILES  
 
Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa)   
Water solubility (mg/L) 0.0002 
http://npic.orst.edu/factsheets/archive/Deltatech.
html 
Log Kow 
4.6 
6.1 
http://ceqg-rcqe.ccme.ca/download/en/170 
http://npic.orst.edu/factsheets/archive/Deltatech.
html 
 
Environmental fate 
Endpoint Value Source 
Sorption potential Koc   10240000 http://sitem.herts.ac.uk/aeru/ppdb/en/Reports/205.htm 
Partition coefficient solid-
water in sediment Kpsed 
(L/kg) 
  
Biodegradability   
Bioaccumulation (BCF) 1400 http://sitem.herts.ac.uk/aeru/ppdb/en/Reports/205.htm 
 
See under bifenthrin. 
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Environmental exposure assessment 
Predicted Environmental Concentration 
 Description Source 
Tonnes/year 
PUSG usage data for 2015 
noted 89097 hectares 
treated with 563 kg.  
UK 
   
Uses 
Deltamethrin is approved as 
PPP in the EU (in agriculture 
to protect crops or kill 
livestock parasites).  
Deltamethrin is authorised in 
28 MS’s (AT, BE, BG, CY, CZ, 
DE, DK, EE, EL, ES, FI, FR, HR, 
HU, IE, IT, LT, LU, LV, MT, NL, 
PL, PT, RO, SE, SI, SK, UK). 
http://ec.europa.eu/food/plant/pesticides/eu-pesticides-
database/public/?event=activesubstance.detail&language=EN
&selectedID=1197 
 
   
Spatial usage 
(by MS) 
  
Many products approved in 
UK re: PPP.  Approved on a 
range of crops eg grain, 
pulses, storage structures, 
fruit, vegetables, ornamental 
garden plants, herbs and 
amenity vegetation.  Also 
approved in relation to BPD 
in UK for use as an 
insecticide.  Approved 
products primarily for ants 
and mosquito nets.  Also 
some products approved 
under COPR for insecticide 
use.  VMD use as a pour-on 
and spot on for cattle & 
sheep and also spot on for 
dogs. 
Scotland: deltamethrin used  
in  fish farming for sea lice. 
Northern Ireland: used in 
agriculture. 
UK 
  
   
Banned uses   
209 
ERC code   
PECfw (mg/L)   
PECsed (mg/kg 
dw) 
  
PECbiota 
(mg/kg) 
  
 
 
 
Measured Environmental Concentrations  
MS 
Source of monitoring 
data 
MEC values 
In Sc2 (inland whole water) data 
from 7 MS (2766 sites) with 
28842 samples are available. 
Only 0.7% quantified samples. 
Sc3 was not developed since data 
scarcity. 
Data quality is not good. 
Dataset of monitoring 
prioritisation 2014 
MEC(P95)= 0.05 µg/l 
(Sc2) 
 
UK 
Monitored at approx. 
500 sites as part of 
national catchment 
sensitive farming (CSF) 
& watch list 
programmes and WFD 
national surveillance 
programme.   
Not detected in any 
samples. 
 
See under bifenthrin. 
 
 
 
Analytical Methods    
 
Method LOQ (µg/l) Description / Reference 
GC-NCI-MS 0.00038 Extraction by ultrasound-assisted 
emulsification-extraction of a water-
immiscible solvent (chloroform) in 20 mL 
water (Feo et al., 2010). 
210 
GC-NCI-MS 0.001 SPE of 1 L water (Elfman et al., 2011).  
GC-ECD/MS 0.00006–0.00098 
(LOD) 
SPE (Zheng et al., 2016). 
n.a. 0.005 Finland 
n.a. 0.001 – 0.02 CZ 
 
 
 
P, B, T, C, M, R, ED properties  
 
Substance Persistent (P) 
Bioaccumulative 
(B) Toxic (T) 
Carcinogenic (C) 
Mutagenic (M) 
Reproduction toxicity 
(R) 
Endocrine 
Disruptive 
(ED) 
Comment 
Deltamethrin B  ED  
 
Hazard assessment 
Ecotoxicology data 
Species Time-scale Endpoint Toxicity  
(µg/L) 
Algae 
Chlorella vulgaris  96 h NOEC 470 
Invertebrates 
Daphnia magna  21 d NOEC 0.0041 
Chironomus riparius  28 d   NOEC 0.010 
Chironomus riparius  28 d   NOEC 0.0035 
Gammarus pulex  21 d  NOEC 0.009 
Tisbe battagliai  6 d  EC10 0.0161 
Tisbe battagliai 6 d  EC10 0.0087 
Tisbe battagliai 6 d EC10 0.0281 
Tisbe battagliai 6 d LC10 0.0641 
Fish 
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Pimephales promelas  260 d NOEC 0.017 
 
 
Mammalian toxicology data 
 
 
PNEC derivation 
PNEC Endpoint 
Endpoint value 
(µg/l) 
AF 
PNEC 
value 
(µg/l) 
PNECfw 
28 d, NOEC  
(Chironomus riparius) 
 
0.0035 50 0.00007  
PNECsed     
PNECbiota,sec 
pois 
    
PNECbiota, hh     
PNECdw, hh     
 
 
Risk Quotient (MEC or PEC/PNEC) 
RQ Value 
RQfw (MEC(P(95))/PNEC) 714 (Sc2) 
RQfw (PEC/PNEC; PEC= 0.03 µg/l) 429 
RQfw  PEC/PNEC; PEC= 0.36 µg/l) 5143 
 
Note: PEC values are taken from Lettieri, T., Chirico, N., Carvalho, R.N., Napierska, D., 
Loos, R., Sanseverino, I., Marinov, D., Ceriani, L., Umlauf, G. 2016. Modelling-based 
strategy for the prioritisation exercise under the Water Framework Directive,  
https://circabc.europa.eu/w/browse/85b46283-9353-4e67-bf56-e4d18b32cbaf). 
 
 
STE score  
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2.69 (Sc2; PNEC= 0.00007 µg/l) 
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Diflubenzuron (CAS N. 35367-38-5) 
Substance identity 
EC name  
EC number  
CAS number 35367-38-5 
Molecular formula C14H9ClF2N2O2 
Molecular weight 310.68 g·mol
−1
 
Structure 
 
SMILES  
 
Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa)   
Water solubility (mg/L) 0.08 
http://pmep.cce.cornell.edu/profiles/extoxnet/dienochlor-
glyphosate/diflubenzuron-ext.html 
Log Kow 3.89 
http://www.fao.org/fileadmin/templates/agphome/documents/Pests_Pe
sticides/JMPR/Evaluation02/Diflubenzuron_EvA2jj.pdf 
 
Environmental fate 
Endpoint Value Source 
Sorption potential Koc   4609 ml/g Diflubenzuron assessment report, 2012 
Partition coefficient solid-water in 
sediment Kpsed (L/kg) 
65.2 Diflubenzuron assessment report, 2012 
Biodegradability 
Not readily 
biodegradable 
Diflubenzuron assessment report, 2012 
Bioaccumulation (BCF) 320 Diflubenzuron assessment report, 2012 
 
Environmental exposure assessment 
Predicted Environmental Concentration 
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 Description Source 
Tonnes/year 5715 kg a.i. in 2015. Romania 
 2265 kg a.s. sold in DK in 2015 (increasing). Denmark 
 100.8 kg sold in 2015. BE-Fl 
 
Pesticide usage data for 2015 for GB noted 
970 hectares treated with 112 kg. There is 
one product approved under COPR which is 
an insecticide for professional use. 
UK 
Uses 
Insecticide  
Authorised in 20 MS; in 16 MS as a PPP (BE, 
BG, CY, CZ, EL, ES, HR, HU, IT, LT, NL, PL, PT, 
RO, SK, UK), in 3 MS as a biocide (DK, FI, SE), 
in 1 MS as a PPP and as a biocide (FR) 
http://ec.europa.eu/food/plant/pesticides/eu-
pesticides-
database/public/?event=activesubstance.detail
&language=EN&selectedID=1236 
 
https://echa.europa.eu/it/information-on-
chemicals/biocidal-
products?p_p_id=echarevbiocidalproducts_WA
R_echarevbiocidalproductsportlet&p_p_lifecycl
e=0&p_p_col_id=column-
1&p_p_col_pos=1&p_p_col_count=2&_echarev
biocidalproducts_WAR_echarevbiocidalproduct
sportlet_approval_id=0062-18 
 
https://echa.europa.eu/it/information-on-
chemicals/biocidal-active-
substances?p_p_id=echarevbiocides_WAR_ech
arevbiocidesportlet&p_p_lifecycle=0&p_p_col_i
d=column-
1&p_p_col_pos=1&p_p_col_count=2&_echarev
biocides_WAR_echarevbiocidesportlet_rml_id=
100.047.740 
 
Spatial usage 
(by MS) 
Removed from the PPP register in 2013; 
before that sold minor amounts. 
Still in use as biocide / veterinary use 
(against ectoparasite of minks). 
Finland 
Larvae systemic insecticide Romania 
Only approved for use against lice in mink 
farms in SE 
Sweden 
Only approved for indoor use as biocide on 
lice in mink. 
Denmark 
Uses registered for apples, horse-chestnuts, Slovakia 
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oak tree, and forest trees. Quantity 
unknown. 
Admission for ornamental plants. BE-Fl 
Currently 3 products approved for use in UK 
as plant protection products.  Approved for 
use on a range of crops included amenity 
vegetation, fruit, vegetables, forestry, 
hedgerows, livestock housing, manure heap 
and refuse tips.   
In Scotland used as fish farm lice medicine. 
UK 
Banned uses   
ERC code   
PECfw (mg/L)   
PECsed 
(mg/kg dw) 
  
PECbiota 
(mg/kg) 
  
 
Measured Environmental Concentrations  
MS 
Source of monitoring 
data 
MEC values 
In Sc2 (inland whole water) data 
from 4 MS (415 sites) with 4725 
samples are available. Only 2 
samples are quantified. 
Sc3 was not developed since data 
scarcity. 
Data quality is not good. 
Dataset of monitoring 
prioritisation 2014 
MEC(P95)= 0.025 
µg/l (Sc2) 
 
England 
Monitored as part of 
national catchment 
sensitive farming (CSF) (2 
samples per week) & 
watch list programmes 
through LCMS samples at 
approx. 80 sites. 
0.0106 µg/l (mean 
based on 27 detect 
samples from 130 
samples) 
 
Analytical Methods    
Method LOD/LOQ 
(µg/l) 
Description / Reference 
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LC-MS/ MS 0.1 Determination of diflubenzuron and the relevant 
metabolites CPU and DFBA in surface water based 
on LC-MS/MS (one ion transition) (Diflubenzuron 
assessment report; 2012). 
n.a. 0.01 Finland 
LC-MS/MS 0.04 Arysta Life Science 
LC-MS/MS 0.005 UK 
 
 
P, B, T, C, M, R, ED properties  
 
Substance Persistent (P) 
Bioaccumulative 
(B) Toxic (T) 
Carcinogenic (C) 
Mutagenic (M) 
Reproduction toxicity 
(R) 
Endocrine 
Disruptive 
(ED) 
Comment 
Diflubenzuron T      
 
No degradation at pH 5 or 7. Degradation to CPU and DFBA at pH 9 with DT50 =32.5 d 
(25°C). DT50 = 80 days of sunlight (at 40 °N) (Diflubenzuron assessment report, 2012).  
 
Hazard assessment 
Ecotoxicology data 
  
Species Time-scale Endpoint Toxicity  
(µg/L) 
Fish 
Oncorhynchus mykiss 21 d NOEC 200 
Invertebrates 
Mercenaria mercenaria 48 h, static NOEC 320 
Daphnia magna 21 d NOEC 0.04 
Mysidopsis bahia 28 d NOEC 0.045 
Algae 
Selenastrum 
capricornutum 
72 h EC50 >200 
 
Data used for PNEC derivation 
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Source: EFSA 2012 and EU Report 2012 
 
 
Mammalian toxicology data 
 
 
PNEC derivation 
PNEC Endpoint 
Endpoint value 
(µg/L) 
AF 
PNEC 
value 
(µg/L) 
PNECfw 
21-d NOEC 
(Reproduction, Daphnia 
magna) 
0.04 50 0.0008  
PNECsed     
PNECbiota,sec 
pois 
    
PNECbiota, hh     
PNECdw, hh     
 
 
Risk Quotient (MEC or PEC/PNEC) 
RQ Value 
RQfw (MEC(P(95))/PNEC) 31.3 (Sc2) 
RQfw (PEC/PNEC; PEC=13.62µg/l) 17025 
 
STE score  
 
2.3 (Sc2; PNEC=0.0008µg/l)  
 
References 
 
Diflubenzuron assessment report under Directive 98/8/EC concerning the placing of 
biocidal products on the market; Product-type 18 (insecticides, acaricides and products 
to control other arthropods); 21 September 2012; Sweden. 
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Dimoxystrobin (CAS N. 149961-52-4) 
Substance identity 
EC name  
EC number  
CAS number 149961-52-4 
Molecular formula C19H22N2O3 
Molecular weight 326.39 g·mol
−1
 
Structure 
 
SMILES  
 
Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa)   
Water solubility (mg/L) 4.3 http://sitem.herts.ac.uk/aeru/iupac/Reports/246.htm 
Log Kow 3.6 http://sitem.herts.ac.uk/aeru/iupac/Reports/246.htm 
 
Environmental fate 
Endpoint Value Source 
Sorption potential Koc   486.2 ml/g EFSA, 2005 
Partition coefficient solid-water in 
sediment Kpsed (L/kg) 
Photolysis and partition to sediment was considered 
the main routes of dissipation of dimoxystrobin from 
the water phase in the outdoor water sediment 
study. A first order water phase DT
50water 
= 15.3 d was 
calculated using only 0-58 d data. 
EFSA, 2005 
Biodegradability Not readily biodegradable  EFSA, 2005 
Bioaccumulation (BCF) 48 EFSA, 2005 
 
Environmental exposure assessment 
Predicted Environmental Concentration 
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 Description Source 
Tonnes/year 
Use: 8.485 in 2016. CZ 
18.572 in 2015. RO 
The PUSG data indicates 17717 
hectares treated with 1797 kg for 
2015. 
GB 
Uses 
Dimoxistrobin is approved as PPP in 
EU (16 MS: AT, BE, BG, CZ, DE, EE, 
FR, HR, HU, LT, LU, LV, PL, RO, SK, 
UK) 
http://ec.europa.eu/food/plant/pesticides/eu-pesticides-
database/public/?event=activesubstance.detail&language=EN
&selectedID=1251 
 
Strobilurin funcicide with the main 
uses in oilseed rape. 
BASF, 2013 
Approval expiration date: 
31/01/2019. 
DG Sante 
Spatial usage 
(by MS) 
Not in PPP register, not sold as PPP 
in the 2000’s. In Finland the 
compound is not use. 
FI 
Uses registered for oil-seed rape, 
sunflower. 
SK 
Admission for rapeseed. BE-Fl 
Not approved in DK and SE. SE; DK 
Two PPP products approved in UK 
currently. Approved for use on 
oilseed rape, durum wheat and 
wheat.   
UK 
Banned uses   
ERC code   
PECfw (mg/L)   
PECsed (mg/kg 
dw) 
  
PECbiota 
(mg/kg) 
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Measured Environmental Concentrations  
MS Source of monitoring data MEC values 
In Sc2 (inland whole water) data 
from only 1 MS (720 sites) with 
6078 samples are available. 
2.8% quantified samples. 
Sc3 was not developed since 
data scarcity. 
Data quality is not good. 
Dataset of monitoring 
prioritisation 2014 
MEC(P95)= 0.025 
µg/l (Sc2) 
The MEC is 
unreliable due to the 
low quantity and 
quality of the 
monitoring data 
(see column on the 
left) 
UK 
Monitored as part of national 
catchment sensitive farming 
(CSF) (2 samples per week) & 
watch list programmes 
through LC-MS samples at 
approx. 80 sites. In addition 
monitored at an additional 
approx. 500 sites.   
Detects noted at 9 
of these sites but 
infrequently.   
Lowest minimum 
concentration 
0.0011 and highest 
max concentration 
1.5 µg/l. 
 
 
Analytical Methods    
Method LOQ (µg/l) Description / Reference 
SPE-LC-MS-MS 0.025 Extraction of 10 ml water; elution with methanol 
(BASF, 2013) 
LC-MS-MS 0.01 CZ 
SPE-LC-MS-MS 0.01 BE-Wallonia 
LC-MS-MS 0.001 England 
 
Dimoxystrobin has mainly been analysed in food products (Lozowicka et al., 2014; 
Schurek et al., 2008; Wang et al., 2012; 2017).  
Lozowicka et al. (2014) analysed pesticide residues (including dimoxystrobin) in grain 
(barley, oat, rye, and wheat) from Kazakhstan.  
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P, B, T, C, M, R, ED properties  
 
Substance Persistent 
(P)Bioaccumulative 
(B) Toxic (T) 
Carcinogenic (C) 
Mutagenic (M) 
Reproduction 
toxicity (R) 
Endocrine 
Disruptive 
(ED) 
Comment 
Dimoxystrobin P and T    
 
Dimoxystrobin is stable to hydrolysis at all environmental relevant pHs. Photolysis may 
moderately contribute to the degradation of dimoxystrobin in water. Degradation of 
dimoxystrobin in water/sediment systems was very limited. Only 10-15 % of the applied 
dimoxystrobin degrades after 100 d. Disappearance from the water phase is mainly 
attributed to partition with sediment.  Additionally an outdoor water sediment study and 
an outdoor mesocosm study in Germany were used to investigate the aquatic dissipation 
of dimoxystrobin. Photolysis and partition to sediment were considered the main routes 
of dissipation of dimoxystrobin from the water phase in the outdoor water sediment 
study. In the mesocosm study dimoxystrobin was applied in early May and a dissipation 
DT
50 
= 60 – 69 d was calculated for the water phase (EFSA, 2005).  
The hydrolytic stability of dimoxystrobin was studied in sterile aqueous buffer solutions 
(pH 4, 5, 7, and 9) at 25 ºC and 50 ºC. Dimoxystrobin is stable at all environmental 
relevant pHs. Photolysis in water was investigated in two different studies. Photolysis 
may moderately contribute to the degradation of dimoxystrobin in water. Measured half 
life under continuous irradiation under laboratory conditions was 14.1 d (pond water) and 
64.8 d (sterile buffer pH 7, extrapolated) (EFSA, 2005). 
 
Hazard assessment 
Ecotoxicology data 
Species Time-scale Endpoint Toxicity  
(µg/L) 
Algae & aquatic plants 
Pseudokirchneriella 
subcapitata 
96 h EC10 13.3 
Invertebrates 
Daphnia magna  21 d, reproduction NOEC 12.5 
Daphnia magna  10 d, growth NOEC 0.5 
Chironomus riparius 28 d, emergence 
rate 
NOEC 10 
Fish 
Oncorhynchus 
mykiss  
97 d, growth NOEC 0.316 
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Oncorhynchus 
mykiss 
97 d NOEC 1 
Acipenser ruthenus 
L. 
7 d NOEC (weight) 
NOEC (growth) 
0.1  
1  
Oncorhynchus 
mykiss 
28 d NOEC 10 
Pimephales 
promelas 
36 d NOEC 16 
Data used for PNEC derivation 
Source: UBA 2014 and EFSA 2005 
 
Mammalian toxicology data 
 
PNEC derivation 
PNEC Endpoint 
Endpoint value 
(µg/L) 
AF 
PNEC 
value 
(µg/L) 
PNECfw 
97-d NOEC 
(body length, ELS*, 
Oncorhynchus mykiss) 
0.316 10 0.0316  
PNECsed     
PNECbiota,sec 
pois 
    
PNECbiota, hh     
PNECdw, hh     
 
 
Risk Quotient (MEC or PEC/PNEC) 
RQ Value 
RQfw (MEC(P(95))/PNEC) 0.79 (Sc2) 
RQfw (PEC/PNEC; PEC=16.42 µg/l) 519.6 
 
Note: PEC value is taken from Lettieri, T., Chirico, N., Carvalho, R.N., Napierska, D., 
Loos, R., Sanseverino, I., Marinov, D., Ceriani, L., Umlauf, G. 2016. Modelling-based 
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strategy for the prioritisation exercise under the Water Framework Directive,  
https://circabc.europa.eu/w/browse/85b46283-9353-4e67-bf56-e4d18b32cbaf). 
 
 
STE score  
 
0 (Sc2; PNEC=0.0316 µg/l) 
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Esfenvalerate (CAS N. 66230-04-4) 
Substance identity 
EC name  
EC number  
CAS number 66230-04-4 
Molecular formula C25H22ClNO3 
Molecular weight 419.91 g/mol 
Structure 
  
SMILES  
 
Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa)   
Water solubility (mg/L) 
<0.001 at pH 5, 20 °C; 
nearly insoluble in water 
EFSA, 2014 
Log Kow 6.24 EFSA, 2014 
 
Environmental fate 
Endpoint Value Source 
Sorption potential Koc   251700 ml/g EFSA, 2014 
Partition coefficient 
solid-water in sediment 
Kpsed (L/kg) 
  
Biodegradability Not readily biodegradable  
Bioaccumulation (BCF) 3369 
http://www.rivm.nl/bibliotheek/rapporten/60171601
7.pdf 
EFSA, 2014 
 
See under bifenthrin. 
Environmental exposure assessment 
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Predicted Environmental Concentration 
 Description Source 
Tonnes/year 
PUSG usage data for 2015 
indicates 246807 hectares 
treated with 919 kg. 
GB 
   
Uses 
Esfenvalerate is approved as 
PPP in the EU (in agriculture 
to protect crops or kill 
livestock parasites).  
Esfenvalerate is authorised in 
25 MS (AT, BE, BG, CY, CZ, 
DE, DK, EL, ES, FI, FR, HR, HU, 
IE, IT, LT, LU, LV, NL, PL, PT, 
RO, SE, SK, UK). 
http://ec.europa.eu/food/plant/pesticides/eu-pesticides-
database/public/?event=activesubstance.detail&language=EN
&selectedID=1286 
 
 
Only uses as insecticide may 
be authorised.  
http://eur-lex.europa.eu/legal-
content/EN/TXT/HTML/?uri=CELEX:32011R0540&from=EN 
   
Spatial usage 
(by MS) 
  
10 products approved in the 
UK in relation to PPP.  
Approved for use on a wide 
range of crops including 
cereal, vegetables, turf, and 
grassland.   
UK 
  
   
Banned uses   
ERC code   
PECfw (mg/L)   
PECsed (mg/kg 
dw) 
  
PECbiota 
(mg/kg) 
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Measured Environmental Concentration  
MS 
Source of monitoring 
data 
MEC values 
In Sc2 (inland whole water) data 
from 4 MS (1152 sites) with 8661 
samples are available. Only 0.5% 
quantified samples. 
In Sc3 (inland whole water; 
PNEC=0.0001 µg/l) data from 
only 2 MS (26 sites) with 87 
samples are available. 52.9% 
quantified samples. 
Data quality is not good. 
Dataset of monitoring 
prioritisation 2014 
MEC(P95)= 0.05 µg/l 
(Sc2) 
MEC(P95)= 0.017 µg/l 
(Sc3) 
 
UK 
Monitored at approx. 
600 sites as part of 
national catchment 
sensitive farming (CSF) 
& watch list 
programmes and WFD 
national surveillance 
programme.   
Not detected in any 
samples. 
 
See under bifenthrin. 
 
Analytical Methods    
 
Method LOQ (µg/l) Description / Reference 
GC-NCI-MS 0.0001 Extraction by ultrasound-assisted 
emulsification-extraction of a water-
immiscible solvent (chloroform) in 20 mL 
water (Feo et al., 2010). 
GC-MS 0.06 SPE of water (Bereswill et al., 2013). 
GC-ECD 0.001 Surface water and drinking water analysis 
(EFSA, 2014). 
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P, B, T, C, M, R, ED properties  
 
Substance Persistent (P) 
Bioaccumulative 
(B) Toxic (T) 
Carcinogenic (C) 
Mutagenic (M) 
Reproduction toxicity 
(R) 
Endocrine 
Disruptive 
(ED) 
Comment 
Esfenvalerate  B and T    
 
Hazard assessment 
Ecotoxicology data 
Species Time-scale Endpoint Toxicity  
(µg/L) 
Algae 
Pseudokirchneriella 
subcapitata 
48 hr, growth 
rate  
NOEC 1.0 
Invertebrates 
Daphnia magna 21 d, 
reproduction 
                NOEC 0.052 
Daphnia magna  21 d, 
reproduction 
NOEC 0.056   
Chironomus riparius  28 d NOEC 0.16 
Fish 
Lepomis macrochirus 30 d, mortality NOEC 0.092 
Lepomis macrochirus 60 d, mortality NOEC 0.052 
Lepomis macrochirus 90 d, mortality NOEC 0.010 
Oncorhynchus mykiss 21 d, mortality                 NOEC 0.001 
Pimephales promelas 260 d, survival                 NOEC 0.090 
Salmo gairdneri 21 d                 NOEC 0.001 
Mesocosm study    
Aquatic insects - NOEC 0.001  
 
 
Mammalian toxicology data 
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PNEC derivation 
PNEC Endpoint 
Endpoint value 
(µg/L) 
AF 
PNEC 
value 
(µg/L) 
PNECfw 
21-day, mortality 
(Oncorhynchus mykiss) 
0.001 10 0.0001  
PNECsed     
PNECbiota,sec 
pois 
    
PNECbiota, hh     
PNECdw, hh     
 
 
Risk Quotient (MEC or PEC/PNEC) 
RQ Value 
RQfw (for MEC(P(95)) and PNEC=0.0001 
µg/l) 
500 (Sc2) 
170 (Sc3) 
RQfw (for PEC= 0.0634µg/l  and PNEC= 
0.0001 µg/l) 
634 
RQfw (for PEC= 0.0054µg/l  and PNEC= 
0.0001 µg/l) 
54 
 
Note: PEC values are taken from Lettieri, T., Chirico, N., Carvalho, R.N., Napierska, D., 
Loos, R., Sanseverino, I., Marinov, D., Ceriani, L., Umlauf, G. 2016. Modelling-based 
strategy for the prioritisation exercise under the Water Framework Directive,  
https://circabc.europa.eu/w/browse/85b46283-9353-4e67-bf56-e4d18b32cbaf). 
 
 
STE scores  
 
2.56 (Sc2) 
1.94 (Sc3) 
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Etofenprox (CAS N. 80844-07-1) 
Substance identity 
EC name  
EC number 407-980-2 
CAS number 80844-07-1 
Molecular formula C25H28O3 
Molecular weight 376.49 g/mol 
Structure 
 
SMILES  
 
Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa) 8.13 x 10
-7 
Etofenprox assessment report, 2013 
Water solubility (mg/L) 0.0225 Etofenprox assessment report, 2013 
logKow 6.9 Etofenprox assessment report, 2013 
 
Environmental fate 
Endpoint Value Source 
Sorption potential  Koc   28524 ml/g Etofenprox assessment report, 2013 
Partition coefficient solid-water 
in sediment Kpsed (L/kg) 
  
Biodegradability 
Not readily 
biodegradable 
Etofenprox assessment report, 2013 
Bioaccumulation (BCF) 3951 L/kg Etofenprox assessment report, 2013 
 
Hydrolysis of etofenprox was investigated in aqueous buffered solutions (pH: 4, 7 and 9) 
at 50 °C. Etofenprox was stable (< 10 % degradation) in all three experimental 
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conditions. Therefore, chemical hydrolysis is not expected to contribute to the 
environmental degradation of etofenprox. Aqueous photolysis of etofenprox under 
artificially simulated sunlight (Suntest CPS, Herareus, Xe lamp) was investigated in 
buffered solutions (pH 7) and in natural pond water at 25 °C. Photolysis of etofenprox is 
relatively rapid in both systems (DT50 buffered pH 7 = 4.7 days equivalent to DT50 35 °N = 10.4 
days; DT50 pond = 7.9 days equivalent to DT50 35 °N = 17.5 days). Major aqueous photolysis 
metabolites were α-CO (max 63.6 % at pH 7 and max. 37.8 % in pond water after 15 
days, end of the study) and PENA (max. 12 % at pH 7 and max. 14.4 % in pond water 
after 15 days, end of study)  (EFSA, 2008). 
Dissipation/ degradation of etofenprox in water/sediment systems was investigated in 
two systems (pHwater = 6.1 – 7.827; OC 5.1 – 7.3 %, clay 18.1 – 19.4 %). Rapid partition 
of etofenprox to the sediment occurs during the first seven days. The meeting of experts 
agreed on the half-lives calculated for etofenprox in the whole system (DT50 whole system = 
6.5 days – 20.1 days). Metabolite 4’- OH was identified as a major metabolite (max. 12.2 
– 21.4 %) in the sediment phase of both systems (EFSA, 2008). 
This metabolite degraded in the whole water/sediment system with a half-life of 21.8 - 
57 days (EFSA, 2008). 
The meeting of experts discussed the need to consider aqueous photolysis and photolysis 
metabolites for the EU risk assessment. From the results of the aqueous photolysis study 
and the mesocosm study the meeting concluded that photolysis could be a relevant 
process of etofenprox transformation in the environment. However, the results of the 
water/sediment study under light/dark cycles were considered inconclusive, possibly due 
to the strong sorption of the active substance to the sediment (EFSA, 2008). 
Additional information on pyrethroids: see under bifenthrin. 
 
Environmental exposure assessment 
Predicted Environmental Concentration 
 Description Source 
Tonnes/y
ear 
0.550 in 2015. RO 
Uses 
Etofenprox is authorised in 18 
MS; in 10 MS as a PPP (BG, CZ, 
EL, ES, HU, MT, PL, RO, SK, UK), 
in 4 MS as a PPP and as a biocide 
(AT, DE, FR, IT) and in 4 MS as a 
biocide (DK, LU, SE, SI) 
 
http://ec.europa.eu/food/plant/pesticides/eu-pesticides-
database/public/?event=activesubstance.detail&language=EN
&selectedID=1307 
 
https://echa.europa.eu/it/information-on-chemicals/biocidal-
active-
substances?p_p_id=echarevbiocides_WAR_echarevbiocidespo
rtlet&p_p_lifecycle=0&p_p_col_id=column-
1&p_p_col_pos=1&p_p_col_count=2&_echarevbiocides_WAR
_echarevbiocidesportlet_rml_id=100.100.942 
 
https://echa.europa.eu/it/information-on-chemicals/biocidal-
products?p_p_id=echarevbiocidalproducts_WAR_echarevbioci
dalproductsportlet&p_p_lifecycle=0&p_p_col_id=column-
1&p_p_col_pos=1&p_p_col_count=2&_echarevbiocidalproduc
ts_WAR_echarevbiocidalproductsportlet_approval_id=0030-18  
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 Insecticide.  
Spatial 
usage (by 
MS) 
Not in PPP register, not sold as 
PPP in the 2000’s. 
Still in use as biocide against ants 
(in outdoor close to buidings). In 
Finland the use is very limited 
and used amounts small => 
unlike to detect from water. 
FI 
Pyrethroid insecticide –.; 
moderate use in Romania 
RO 
Only approved against bed bugs 
in SE. 
SE 
No registered sale from 2012 to 
2015. It was approved as biocide 
for combatting ants outdoor in 
2012. Expect use as biocide in 
the future. 
DK 
Uses registered for forest trees, 
oak tree, pine, spruce, oil-seed 
rape. 
SK 
No use in BE. BE-Fl 
One product currently approved 
for use in UK as a PPP product.  
Approved for use on oilseed 
rape.  No data available on 
extent of usage. 
UK 
Banned 
uses 
  
ERC code   
PECfw 
(mg/L) 
  
PECsed 
(mg/kg 
dw) 
  
PECbiota 
(mg/kg) 
  
 
 
Measured Environmental Concentration  
MS Source of monitoring MEC values 
233 
data 
In Sc2 (inland whole water) data from 3 
MS (91 sites) with 1116 samples are 
available.  
Only 10 samples are quantified. 
Sc3 was not developed since data 
scarcity. 
Data quality is not good. 
Dataset of monitoring 
prioritisation 2014 
MEC(P95)= 
0.01 µg/l (Sc2) 
 
 
See under bifenthrin. 
 
Analytical Methods    
Albaseer et al. (2010) give an overview of sample preparation and extraction of synthetic 
pyrethroids from water, sediment and soil.  
Method LOQ (µg/l) Description / Reference 
SPE-GC-ECD/MS 
or GC-MS 
 
0.00006–0.00098 
(LOD) 
Investigation of the distribution and risk 
assessment of 82 pesticides in Jiulong River 
and estuary (surface waters) in South China. 
SPE with ENVI-Carb column and LC-NH2 
column. 
(Zheng et al., 2016).  
GC-MS 0.05 (drinking and 
ground water) 
0.01 (surface water) 
Monitoring of residues of etofenprox and α-
CO in water (EFSA, 2008; Etofenprox 
assessment report, 2013). 
 
 
P, B, T, C, M, R, ED properties  
 
Substance Persistent (P) 
Bioaccumulative 
(B) Toxic (T) 
Carcinogenic (C) 
Mutagenic (M) 
Reproduction toxicity 
(R) 
Endocrine 
Disruptive 
(ED) 
Comment 
Etofenprox B and T R   
 
 
Hazard assessment 
Ecotoxicology data 
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Species Time-scale Endpoint Toxicity  
(µg/L) 
Fish  
Oncorhynchus 
mykiss 
21d, semi-static Mortality and 
growth, NOEC 
2.1 
Brachydanio rerio 40 d, flow-through Mortality and 
development, NOEC 
25 
Invertebrates  
Daphnia magna 21 d, semi-static Reproduction, NOEC 0.054 
Algae  
Pseudokirchneriella 
subcapitata 
72 h, static Biomass, NOEC 56.25 
Sediment dwelling organisms  
Chironomus riparius 25 d, static water-
sediment 
system, 
spiked water 
Emergence, 
Development, NOEC 
3.8  
Data used for PNEC derivation 
Source: EU-RAR 2013 and EFSA 2008 
 
Mammalian toxicology data 
 
PNEC derivation 
PNEC Endpoint 
Endpoint value 
(µg/l) 
AF 
PNEC 
value 
(µg/l) 
PNECfw 
21 d, semi-static, 
reproduction 
 (Daphnia magna) 
0.054 50 0.001  
PNECsed     
PNECbiota,sec 
pois 
    
PNECbiota, hh     
235 
PNECdw, hh     
 
 
Risk Quotient (MEC or PEC/PNEC) 
RQ Value 
RQfw (MEC(P(95))/PNEC) 10 (Sc2) 
RQfw (PEC/PNEC) 8300 
 
Note: PEC value is taken from Lettieri, T., Chirico, N., Carvalho, R.N., Napierska, D., 
Loos, R., Sanseverino, I., Marinov, D., Ceriani, L., Umlauf, G. 2016. Modelling-based 
strategy for the prioritisation exercise under the Water Framework Directive,  
https://circabc.europa.eu/w/browse/85b46283-9353-4e67-bf56-e4d18b32cbaf). 
 
STE score 
 
2.2 (Sc2; PNEC=0.001 µg/l) 
 
References 
Albaseer, S.S., Nageswara Rao, R., Swamy, Y.V., Mukkanti, K. 2010. An overview of 
sample preparation and extraction of synthetic pyrethroids from water, sediment and 
soil; Journal of Chromatography A, 1217 (2010) 5537–5554. 
EFSA, 2008. Conclusion on pesticides peer review. Conclusion regarding the peer review 
of the pesticide risk assessment of the active substance etofenprox. 19 December 2008. 
http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2009.213r/epdf. 
Etofenprox assessment report under Regulation 528/2012/EU concerning the making 
available on the market and use of biocidal products; Product-type 18 (Insecticide); 
September 2013, Austria. 
Zheng, S., Chen, B., Qiu, Q., Chen, M., Ma, Z., Yu, X. 2016. Distribution and risk 
assessment of 82 pesticides in Jiulong River and estuary in South China. Chemosphere 
144 (2016) 1177–1192.  
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Fenpyroximate (CAS N. 134098-61-6) 
Substance identity 
EC name  
EC number  
CAS number 134098-61-6 
Molecular formula C24H27N3O4 
Molecular weight 421,49 g/mol 
Structure 
 
SMILES  
 
Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa)   
Water solubility (mg/L) 0.023 EFSA, 2013 
Log Kow 5.0 EFSA, 2013 
 
Environmental fate 
Endpoint Value Source 
Sorption potential Koc   52067  EFSA, 2013 
Partition coefficient solid-water in 
sediment Kpsed (L/kg) 
  
Biodegradability Not readily biodegradable EFSA, 2013 
Bioaccumulation (BCF) 1601 EFSA, 2013 
 
Environmental exposure assessment 
Predicted Environmental Concentration 
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 Description Source 
Tonnes/year 
0.235 in 2015. RO 
0.006 in 2015. DK 
Uses 
Fenpyroximate is authorised as PPP in 18 
MS (AT, BE, BG, CY, CZ, DE, DK, EL, ES, FR, 
HU, IT, PL, PT, RO, SE, SI, SK) 
http://ec.europa.eu/food/plant/pesticides/eu-
pesticides-
database/public/?event=activesubstance.detail&l
anguage=EN&selectedID=1352 
 
   
Spatial usage 
(by MS) 
Not in PPP register, not sold as PPP in the 
2000’s. In Finland the compound is not 
use. 
FI 
Approved for use on apple, pear and in 
green houses. 
SE 
Uses registered for strawberries, soya. SK 
Admission for fruit trees. BE-Fl 
   
Banned uses   
ERC code   
PECfw (mg/L)   
PECsed 
(mg/kg dw) 
  
PECbiota 
(mg/kg) 
  
 
 
Measured Environmental Concentrations  
MS 
Source of 
monitoring data 
MEC values 
In Sc2 (inland whole water) data from 
only 1 MS (35 sites) with 1506 samples 
are available. Only1 quantified sample. 
Sc3 was not developed since data 
scarcity. 
Data quality is not good. 
Dataset of 
monitoring 
prioritisation 2014 
MEC(P95)= 0.01 µg/l 
(Sc2) 
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UK 
Monitored as part 
of national 
catchment sensitive 
farming (CSF) (2 
samples per week) 
& watch list 
programmes 
through LC-MS 
samples at approx. 
80 sites.  
Not detected in any of 
the 1700 samples 
taken at these sites. 
 
 
Analytical Methods    
Fenpyroximate has mainly been analysed in food products (Banerjee et al., 2009; 
Herrera Lopez et al., 2016; Zhao et al., 2014).  
Method LOQ (µg/l) Description / Reference 
HPLC-MS SIM 0.1 (EFSA, 2013) 
LC-MS-MS 0.005 (LOD) England 
 
 
P, B, T, C, M, R, ED properties  
 
Substance Persistent (P) 
Bioaccumulative 
(B) Toxic (T) 
Carcinogenic (C) 
Mutagenic (M) 
Reproduction toxicity 
(R) 
Endocrine 
Disruptive 
(ED) 
Comment 
Fenpyroximate P and B and T    
 
In laboratory incubations in dark aerobic natural sediment water systems (only 
pyrazole ring 14C radiolabelled), fenpyroximate exhibited moderate persistence, 
forming the major metabolites M-3 (max. ca. 20.8 % AR in water), M-11 (max. 
21 % AR in sediment), and M-8 (max. 28 % AR in water). In satisfactory field 
dissipation studies carried out at four sites in Germany (spray application to the 
soil surface on bare soil plots in early summer) fenpyroximate exhibited low to 
moderate persistence (EFSA, 2013). 
 
Hazard assessment 
Ecotoxicology data 
Species Time-scale Endpoint Toxicity  
(µg/L) 
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Algae 
Scenedesmus 
subspicatus 
72 h, static NOEC 1 
Fish 
Oncorhynchus 
mykiss 
long-term, 21 d 
flow through 
NOEC 0.19 
Pimephales promelas long-term, 34 d, 
flow through 
NOEC 0.1 
Invertebrates 
Daphnia magna long-term, 21 d, 
semi-static 
NOEC 0.68 
Chironomus riparius long-term, 28 d, 
static 
NOEC 10 
Microcosm study 
Zooplancton 28 d  NOEC 1  
Data used for PNEC derivation 
Source: EFSA 2008 
 
 
Mammalian toxicology data 
 
PNEC derivation 
PNEC Endpoint 
Endpoint value 
(µg/L) 
AF 
PNEC 
value 
(µg/L) 
PNECfw 
34 d, NOEC  
(Pimephales promelas) 
0.1 10 0.01  
PNECsed     
PNECbiota,sec 
pois 
    
PNECbiota, hh     
PNECdw, hh     
 
240 
 
Risk Quotient (MEC or PEC/PNEC) 
RQ Value 
RQfw (MEC(P(95))/PNEC) 1 (Sc2)
 a 
RQfw (PEC/PNEC; PEC=4.4 µg/l) 440 
a RQ is not reliable due to the low quality of MEC value  
 
Note: PEC value is taken from Lettieri, T., Chirico, N., Carvalho, R.N., Napierska, D., 
Loos, R., Sanseverino, I., Marinov, D., Ceriani, L., Umlauf, G. 2016. Modelling-based 
strategy for the prioritisation exercise under the Water Framework Directive,  
https://circabc.europa.eu/w/browse/85b46283-9353-4e67-bf56-e4d18b32cbaf). 
 
 
STE score 
 
0 (Sc2; PNEC=0.01 µg/l) 
Not reliable value 
 
References 
 
EFSA, 2013. Conclusion on pesticides peer review. Conclusion on the peer review of the 
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Food Chem. 2009, 57, 4068–4078. 
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Metaflumizone (CAS N. 139968-49-3) 
Substance identity 
EC name  
EC number  
CAS number 139968-49-3 
Molecular formula C24H16F6N4O2 
Molecular weight 506.40 g/mol 
Structure 
 
SMILES  
 
Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa)   
Water solubility (mg/L) 0.00179 EFSA, 2013 
Log Kow 4.2-4.9 EFSA, 2013 
 
Environmental fate 
Endpoint Value Source 
Sorption potential Koc   30714 mL/g EFSA, 2013 
Partition coefficient solid-water in 
sediment Kpsed (L/kg) 
  
Biodegradability Not readily biodegradable EFSA, 2013 
Bioaccumulation (BCF) 7800 - 8100 EFSA, 2013 
 
Environmental exposure assessment 
Predicted Environmental Concentration 
 Description Source 
242 
Tonnes/yea
r 
0.054 in 2015. RO 
Uses 
Metaflumizone is approved as PPP in the EU 
(13 MS: AT, BG, CY, EL, ES, HR, HU, IT, LT, PL, 
PT, RO, SI). The approval is in progress for NL. 
http://ec.europa.eu/food/plant/pesticides/eu-
pesticides-
database/public/?event=activesubstance.detai
l&language=EN&selectedID=1553 
 
Spatial 
usage (by 
MS) 
Not in PPP register, not sold as PPP in the 
2000’s. In Finland the compound is not use. 
FI 
Previously used against fleas, ticks and 
demodex in spot-on product for dogs. The vet 
prod was de-registred 2015. No use as PPP or 
biocidal products. 
SE 
Not approved in DK.  DK 
Fleas and tick control in dogs. SK 
No use in BE. BE-Fl 
Used in livestock farming in Northern Ireland. UK 
Banned uses   
ERC code   
PECfw (mg/L)   
PECsed 
(mg/kg dw) 
  
PECbiota 
(mg/kg) 
  
 
 
Measured Environmental Concentration  
No data found in the dataset of the monitoring prioritisation 2014. 
MS Source of monitoring data MEC values 
UK 
Monitored as part of national 
catchment sensitive farming 
(CSF) (2 samples per week) & 
watch list programmes 
through LC-MS samples at 
approx. 80 sites.  
Only detected once out 
of the approx. 1700 
samples taken at these 
sites (0.14 µg/l). 
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Analytical Methods    
Method LOQ (µg/l) Description / Reference 
LC-MS/MS 0.025 Metaflumizone E-isomer and Z-isomer can be 
monitored in drinking water and surface water by 
LC-MS/MS. The validation was performed using the 
2nd mass transition 507>178 m/z as well as primary 
mass transition 507>287 m/z for quantitation 
(EFSA, 2013). 
LC-MS/MS 0.05 LLE from 50 ml water with dichloromethane; LC-
MS/MS transitions: 507> 287, 178 m/z (BASF, 
2003). 
EN ISO 1136925 
modif. 
0.01/0.02 Slovenia 
(SPE – solid-phase extraction) 
LC-MS 0.005 Water sample preconcentration by SPE followed bu Ultra-
High-Definition (UHD) Accurate-Mass Quadrupole Time-of-
Flight (Q-TOF) MS. 
England 
 
 
P, B, T, C, M, R, ED properties  
 
Substance Persistent (P) 
Bioaccumulative 
(B) Toxic (T) 
Carcinogenic (C) 
Mutagenic (M) 
Reproduction toxicity 
(R) 
Endocrine 
Disruptive 
(ED) 
Comment 
Metaflumizone  vP, vB and T 
 
   
 
Metaflumizone was hydrolysed in water at pH < 7 with first order DT50 values ranging 
from 5.37 to 5.95 d (pH 4) and from 27.2 to 27.5 d (pH 5) at 25°C. Metaflumizone was 
stable to hydrolysis at pH 7 and 9 under the same conditions. Metaflumizone was 
photolysed in sterile water at pH 9 following 15 days of artificial irradiation, with single 
first order DT50 values ranging from 2.4 and 4.1 days (EFSA, 2013). 
 
Hazard assessment 
Ecotoxicology data 
Species Time-scale Endpoint Toxicity  
                                           
25 EN ISO method 11369 “Determination of selected plant treatment agents in water by high performance liquid 
chromatography with UV detection after solid-liquid extraction” from 1997 uses SPE with RP-C18 sorbent 
followed by HPLC-UV detection.  
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(µg/L) 
Fish 
Oncorhynchus 
mykiss  
93 d (flow through) 
 
NOEC 1.47 
Danio rerio  148 d (static, with 
sediment) 
NOEC 15 
Invertebrates 
Daphnia magna 21 h (flowthrough) NOEC 1.47 
Americamysis bahia  28 d  (flowthrough) NOEC 
(survival/repro.) 
0.654 
Chironomus riparius  
 
28 d (static water 
sediment study, 
with 
spiked water) 
NOEC 
 
2.56 
Algae 
Pseudokirchneriella 
subcapitata  
72 h EC10 >313 
Data used for PNEC derivation 
Source: EFSA 2013 and CLH Report 2016 
 
 
Mammalian toxicology data 
 
 
PNEC derivation 
PNEC Endpoint 
Endpoint value 
(µg/L) 
AF 
PNEC 
value 
(µg/L) 
PNECfw 
28-d NOEC 
(Reproduction/survival 
for A. bahia) 
0.654 10 0.0654 
PNECsed     
PNECbiota,sec 
pois 
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PNECbiota, hh     
PNECdw, hh     
 
 
Risk Quotient (MEC or PEC/PNEC) 
RQ Value 
RQfw  n/a 
RQfw (PEC/PNEC; PEC=0.3 µg/l) 4.6  
 
 
 
STE scores  
 
n/a (since missing data) 
 
 
References 
 
BASF, 2003. Method for the determination of BAS 320 I (E- and Z-isomer) and its 
metabolites in tap- and surface water. BASF method 534/0.  
EFSA, 2013. Conclusion on pesticides peer review. Conclusion on the peer review of the 
pesticide risk assessment of the active substance metaflumizone. EFSA Journal 
2013;11(10):3373; http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2013.3373/epdf.  
EN ISO 11369, 1997. Determination of selected plant treatment agents in water by high 
performance liquid chromatography with UV detection after solid-liquid extraction (ISO 
11369; 1997). 
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Permethrin (CAS N. 52645-53-1) 
Substance identity 
EC name  
EC number  
CAS number 52645-53-1 
Molecular formula C21H20Cl2O3 
Molecular weight 391.28 g/mol 
Structure 
  
SMILES  
 
Physico-chemical Properties 
Endpoint Value Source 
Vapour Pressure (Pa)   
Water solubility (mg/L) 
0.006 - 0.2;  
nearly insoluble in water 
 
Log Kow 6.1  
 
Environmental fate 
Endpoint Value Source 
Sorption potential Koc     
Partition coefficient solid-water in 
sediment Kpsed (L/kg) 
  
Biodegradability Not readily biodegradable  
Bioaccumulation (BCF) 570  
 
See under bifenthrin. 
 
Environmental exposure assessment 
Predicted Environmental Concentration 
247 
 Description Source 
Tonnes/year   
Uses 
 
Permethrin is not approved 
anymore as PPP in the EU (in 
agriculture to protect crops 
or kill livestock parasites).  
http://ec.europa.eu/food/plant/pesticides/eu-pesticides-
database/public/?event=activesubstance.detail&language=EN
&selectedID=1687 
The authorisations for 
permethrin as a PPP were 
withdrawn by a Commission 
decision in 2000: 
http://eur-lex.europa.eu/legal-
content/EN/TXT/?uri=CELEX%3A32000D0817 
 
Permethrin is approved in IE 
for use in biocidal products, 
wood preservatives (Product 
Typ 8), insecticides, 
acaricides and products to 
control other arthropods 
(Product Typ 18). Substance 
explicitly approved as 
biocide only. 
http://eur-lex.europa.eu/legal-
content/EN/TXT/PDF/?uri=CELEX:32014R1090&from=EN 
 
 
https://echa.europa.eu/it/information-on-chemicals/biocidal-
active-
substances?p_p_id=echarevbiocides_WAR_echarevbiocidesp
ortlet&p_p_lifecycle=0&p_p_col_id=column-
1&p_p_col_pos=1&p_p_col_count=2&_echarevbiocides_WAR
_echarevbiocidesportlet_rml_id=100.052.771 
 
Spatial usage 
(by MS) 
  
No PPP products approved in 
the UK.  Several products 
approved under COPR in 
relation to biocide use as 
used as an insecticide. 
UK 
  
Banned uses   
ERC code   
PECfw (mg/L)   
PECsed (mg/kg 
dw) 
  
PECbiota 
(mg/kg) 
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Measured Environmental Concentrations  
MS 
Source of monitoring 
data 
MEC values 
In Sc2 (inland whole water) data 
from 7 MS (2431 sites) with 
29730 samples are available. 
Only 0.4% quantified samples. 
In Sc3 (inland whole water; 
PNEC=0.00047µg/l) data from 4 
MS (74 sites) included 117 
samples. 98.3% quantified 
samples. 
Data quality is not good. 
Dataset of monitoring 
prioritisation 2014 
MEC(P95)= 0.025 µg/l 
(Sc2) 
MEC(P95)= 0.09 µg/l 
(Sc3) 
 
 
UK 
Monitored at 77 sites 
quarterly in water 
body’s deemed at risk 
from permethrin via 
permitted discharges.  
At none of the sites 
assessed were the 
averages above the UK 
EQS.   
A few detects noted with 
the maximum 
concentration detected 
0.00756 µg/l 
 
See under bifenthrin. 
 
Analytical Methods    
 
Method LOQ (µg/l) Description / Reference 
LLE followed by 
HRGC/HRMS 
0.000044 (LOD) US EPA method 1699 (2007) 
LLE-GC-MS 0.0015 LLE of 1 L water; silica gel clean-up. 
(Kupper et al., 2006). 
n.a. 0.005 Finland 
n.a. 0.0001 England 
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P, B, T, C, M, R, ED properties  
 
Substance Persistent (P) 
Bioaccumulative 
(B) Toxic (T) 
Carcinogenic (C) 
Mutagenic (M) 
Reproduction toxicity 
(R) 
Endocrine 
Disruptive 
(ED) 
Comment 
Permethrin PT - 
 
- - 
 
Hazard assessment 
Ecotoxicology data 
Species Time-scale Endpoint Toxicity  
(µg/L) 
Algae 
Pseudokirchneriella 
subcapitata 
72 h, cell density NOEC < 3.1 
Invertebrates    
Daphnia magna  21 d, 
reproduction 
NOEC 0.0047 
Fish 
Zebrafish  35 d, survival NOEC 0.41 
Pimephales promelas 32 d, survival NOEC 0.66 
Cyprinodon variegatus 28 d, survival NOEC 10 
 
 
Mammalian toxicology data 
 
 
PNEC derivation 
PNEC Endpoint 
Endpoint value 
(µg/L) 
AF 
PNEC 
value 
(µg/L) 
PNECfw 
21 d, reproduction 
 (Daphnia magna) 
0.0047 10 0.00047 
PNECsed     
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PNECbiota,sec 
pois 
    
PNECbiota, hh     
PNECdw, hh     
 
 
Risk Quotient (MEC or PEC/PNEC) 
RQ Value 
RQfw (for MEC(P(95)) and PNEC= 
0.00047µg/l) 
53.2 (Sc2) 
191 (Sc3) 
RQfw (PEC/PNEC) n/a 
 
 
STE scores  
 
2.41 (Sc2)  
2.29 (Sc3) 
 
 
References 
 
EPA method 1699, 2007. Pesticides in Water, Soil, Sediment, Biosolids, and Tissue by 
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Proquinazid (CAS N. 189278-12-4) 
Substance identity 
EC name  
EC number  
CAS number 189278-12-4 
Molecular formula C14H17IN2O2 
Molecular weight 372,2 g/mol 
Structure 
 
SMILES  
 
Physico-chemical properties 
Endpoint Value Source 
Vapour Pressure (Pa)   
Water solubility (mg/L) 0.97 EFSA, 2009 
Log Kow 5.5 EFSA, 2009 
 
Environmental fate 
Endpoint Value Source 
Sorption potential Koc   12870 mL/g EFSA, 2013 
Partition coefficient solid-water in 
sediment Kpsed (L/kg) 
In water / sediment systems, proquinazid 
partitioned rapidly into the sediment (DissT50 < 1 
d). However, it is moderately to highly persistent 
in the total system (DT50 = 36.5 – 136 d). 
EFSA, 2013 
Biodegradability Not readily biodegradable EFSA, 2013 
Bioaccumulation (BCF) 821 EFSA, 2013 
 
Environmental exposure assessment 
Predicted Environmental Concentration 
 Description Source 
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Tonnes/yea
r 
5 in 2015. RO 
PUSG data for 2015 indicates 285376 hectares treated in 2015 
with 6405 kg. 
GB 
Uses 
Proquinazide is a local systemic fungicide that inhibits the 
pathway for appressinogenesis in fungi. The active substance is 
used to combat powdery mildew in agriculture, fruit growing 
and viticulture. 
 
Proquinazid is approved as PPP in the EU (24 MS: AT, BG, CY, 
CZ, DE, EE, EL, ES, FI, FR, HR, HU, IE, IT, LT, LU, LV, MT, PL, PT, 
RO, SI, SK, UK). The approval is in progress for SE 
http://ec.europa.eu/food/pla
nt/pesticides/eu-pesticides-
database/public/?event=activ
esubstance.detail&language=
EN&selectedID=1779 
 
Fungicide.  
Spatial 
usage (by 
MS) 
Use as plant protection chemical in Finland (one of the most 
used fungicides for cereals). 
FI 
Approved as PPP against mildew on cereal since 2017-03-30. SE 
Not approved in DK. DK 
Uses registered on wheat, barley. SK 
No use in BE. BE-Fl 
Seven products approved in UK as PPP product.   Approved for 
use on barley, wheat, oats, rye and triticale.   
UK 
Banned 
uses 
  
ERC code   
PECfw 
(mg/L) 
  
PECsed 
(mg/kg dw) 
  
PECbiota 
(mg/kg) 
  
 
 
Measured Environmental Concentration  
MS 
Source of monitoring 
data 
MEC values 
In Sc2 (inland whole water) data 
from only 1 MS (31 sites) with 1285 
samples are available. No quantified 
Dataset of monitoring 
prioritisation 2014 
MEC(P95)= 0.01 µg/l 
(Sc2) 
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samples. 
Sc3 was not developed since data 
scarcity. 
Data quality is not good. 
UK 
Monitored as part of 
national catchment 
sensitive farming (CSF) 
(2 samples per week) & 
watch list programmes 
through LC-MS samples 
at approx. 80 sites. 
Only detected once out 
of the approx. 1700 
samples taken at these 
sites (0.002 µg/l). 
 
 
Analytical Methods    
 
Method LOQ (µg/l) Description / Reference 
GC-MS 0.1 Proquinazid and also the metabolites IN-MM986, IN-
MM671 and IN-MM991 can be determined in surface, 
ground and drinking water by GC-MS. Quantification 
was on the m/z 288 ion for proquinazid and IN-
MM986, and m/z 162 for INMM671 and IN-MM991 
(EFSA, 2009). 
LC-MS-MS 0.001 England 
 
 
P, B, T, C, M, R, ED properties  
 
Substance Persistent 
(P)Bioaccumulative 
(B) Toxic (T) 
Carcinogenic (C) 
Mutagenic (M) 
Reproduction 
toxicity (R) 
Endocrine 
Disruptive 
(ED) 
Comment 
Proquinazid vP, B and T 
 
   
 
Proquinazid and all the metabolites investigated were stable to hydrolysis (pH 4, 7 and 
9). In the aqueous photolysis study proquinazid is rapidly photolysed (DT50 < 1 h) 
(EFSA, 2013). 
 
Hazard assessment 
Ecotoxicology data 
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Mammalian toxicology data 
 
PNEC derivation 
PNEC Endpoint Endpoint value AF 
PNEC 
value 
PNECfw    0.18 µg/l 
PNECsed     
PNECbiota,sec 
pois 
    
PNECbiota, hh     
PNECdw, hh     
 
 
Risk Quotient (MEC or PEC/PNEC) 
RQ Value 
RQfw (MEC(P(95))/PNEC) 0.05 (Sc2)
 a  
RQfw (PEC/PNEC) 7.28  
a RQ is not reliable due to the low quality of MEC value  
 
STE scores  
 
0 (Sc2; PNEC=0.18 µg/l) 
Not reliable value 
 
References 
 
EFSA, 2013. Conclusion on pesticides peer review. Conclusion on the peer review of the 
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Pyridaben (CAS N. 96489-71-3) 
Substance identity 
EC name  
EC number  
CAS number 96489-71-3 
Molecular formula C19H25ClN2OS 
Molecular weight 364,93 g/mol 
Structure 
 
SMILES  
 
Physico-chemical properties 
Endpoint Value Source 
Vapour Pressure (Pa)   
Water solubility (mg/L) 0.022 EFSA, 2010 
Log Kow 6.37 EFSA, 2010 
 
Environmental fate 
Endpoint Value Source 
Sorption potential Koc   66503 mL/g EFSA, 2010 
Partition coefficient solid-water in 
sediment Kpsed (L/kg) 
  
Biodegradability Not readily biodegradable EFSA, 2010 
Bioaccumulation (BCF) < 48 EFSA, 2010 
 
In soil laboratory incubations under aerobic conditions in the dark, pyridaben exhibits 
moderate to high persistence forming the minor (<10 % applied radioactivity (AR)) 
metabolites PB-4 (max. 7.6 % AR, persistence endpoints not available) and PB-7 (max. 
8.5 % AR, exhibiting low to moderate persistence). Under the conditions of a laboratory 
soil photolysis study, degradation of pyridaben was enhanced compared to that which 
occurred in the dark…Pyridaben is considered immobile in soil. (EFSA, 2010). 
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Field dissipation studies were available from two sites in Denmark and two sites in Spain 
(spray application to the soil surface on bare soil plots in April, except one of the Spanish 
trials where an October application was made). At the site with the October application 
date, pyridaben exhibited high persistence (single first order pattern of decline), i.e. a 
comparable pattern of persistence to that exhibited in the laboratory incubations. In the 
trials with the April applications, photolysis appears to be playing its part in the measured 
decline as a biphasic pattern of decline was observed. In these spring application trials 
pyridaben exhibited moderate persistence. (EFSA, 2010). 
In laboratory incubations in dark aerobic natural sediment water systems, pyridaben 
exhibited moderate persistence. Under the conditions of a laboratory aqueous photolysis 
study pyridaben was rapidly degraded (within hours) to form the major metabolites W-1 
and B-3 which were also rapidly degraded under the conditions of the test (EFSA, 2010).  
The potential for groundwater contamination consequent to these uses from pyridaben or 
its metabolites PB-22, PB-4 and PB-7 above the parametric drinking water limit of 
0.1μg/L was assessed as low (EFSA, 2010).  
 
Environmental exposure assessment 
Predicted Environmental Concentration 
 Description Source 
Tonnes/year 0.023 in 2015 RO 
   
Uses 
Pyridaben is authorised as a PPP in 11 MS: BE, BG, CZ, ES, 
FR, HU, IT, NL, PL, RO, SK 
http://ec.europa.eu/food/plant/
pesticides/eu-pesticides-
database/public/?event=activesu
bstance.detail&language=EN&sel
ectedID=1799 
 
Insecticide, acaricide.  
Spatial 
usage (by 
MS) 
Not in PPP register, not sold as PPP in the 2000’s. 
In Finland the compound is not use. 
FI 
Selective contact insecticide and myticide. RO 
Not approved in SE and DK. SE; DK 
Uses registered for woody ornamentals. SK 
Admission for ornamental plants. BE-FL 
   
Banned uses   
ERC code   
PECfw (mg/L)   
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PECsed 
(mg/kg dw) 
  
PECbiota 
(mg/kg) 
  
 
 
Measured Environmental Concentration  
MS Source of monitoring data MEC values 
In Sc2 (inland whole water) 
data from 2 MS (785 sites) 
with 5395 samples are 
available. All samples are non-
quantified. 
Sc3 was not developed since 
data scarcity. 
Data quality is not good. 
Dataset of monitoring 
prioritisation 2014 
MEC(P95)= 0.025 µg/l 
(Sc2) 
Please note the MEC is 
not reliable because of 
the low quantity and 
quality of monitoring 
data, and the absence 
of quantified samples 
(see column on the 
left) 
 
UK 
Monitored as part of national 
catchment sensitive farming 
(CSF) (2 samples per week) & 
watch list programmes 
through LC-MS samples at 
approx. 80 sites.  
Only detected once out 
of the approx. 1700 
samples taken at these 
sites (0.036 µg/l). 
 
 
Analytical Methods    
Pyridaben has been analysed in different food items (Boulaid et al., 2005; Hayward et 
al., 2015; Hengel and Shibamoto, 2002; Valverde et al., 2002; Zhang et al., 2012). 
Wang et al. (2012) analysed 51 pesticides (including pyridaben) and 16 polychlorinated 
biphenyls (PCBs) in selected fish and food items in Southeast China by gas 
chromatography tandem mass spectrometry (GC-MS/MS). The results showed that 
organochlorine pesticides such as DDTs, hexachlorocyclohexanes (HCHs), 
hexachlorobenzene (HCB) and mirex and other pesticides including chlorpyrifos, 
pyrethroid pesticides, metolachlor, pyridaben and trifluralin were frequently detected in 
the samples.  
Hakme et al. (2017) have analysed different contaminants (including pyridaben) in honey 
bees and pollen by gas chromatography time-of-flight mass spectrometry, and the 
following insecticides/acaricides were detected: chlorpyrifos, coumaphos, fluvalinate-tau, 
chlorfenvinphos, pyridaben, and propyl cresol. 
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Method LOQ (µg/l) Description / Reference 
LC-MS-MS 0.005 LC-MS-MS method for tap, ground and surface 
water (EFSA, 2010).  
LC-MS-MS 0.005 (LOD) England 
 
 
P, B, T, C, M, R, ED properties  
 
Substance Persistent (P) 
Bioaccumulative 
(B) Toxic (T) 
Carcinogenic (C) 
Mutagenic (M) 
Reproduction toxicity 
(R) 
Endocrine 
Disruptive 
(ED) 
Comment 
Pyridaben P and B and T    
 
 
 
Hazard assessment 
Ecotoxicology data 
Species Time-scale Endpoint Toxicity  
(µg/L) 
Fish 
Pimephales  
promelas 
301 d (flow-through) 
 
NOEC 0.28 
Algae 
Skeletonema 
costatum 
120 h (growth rate) NOEC 8 
Invertebrates 
Daphnia magna 21 d (flow-through) NOEC 0.086 
Mysidopsis bahia 35 d (flow-through) NOEC 0.047 
Chironomus riparius 28 d (static) NOEC 5.1 
Data used for PNEC derivation 
Source: DAR 2007, RIVM 2008, EFSA 2010 and CLH Report 2013 
 
 
Mammalian toxicology data 
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The risk to birds and mammals was assessed as low, after the refinement presented, 
except for the long-term risk to mammals arising from the use in citrus, where further 
information is required to address the risk. A high risk was identified for the aquatic 
environment arising from the use in citrus; no-spray buffer zones up to 30 m were 
insufficient to address the risk. A high risk was identified for bees for the use in citrus 
and further information is required. Risk mitigation measures such as 10 m no-spray 
buffer zones are required to protect non-target arthropods. The risk to earthworms, soil-
dwelling macro- and micro-organisms, non-target plants and biological methods of 
sewage treatment was assessed as low (EFSA, 2010).  
 
 
PNEC derivation 
PNEC Endpoint 
Endpoint value 
(µg/l) 
AF 
PNEC 
value 
(µg/l) 
PNECfw 
35-d Reproduction 
 (M. bahia) 
0.047 10 0.0047  
PNECsed     
PNECbiota,sec 
pois 
    
PNECbiota, hh     
PNECdw, hh     
 
 
Risk Quotient (MEC or PEC/PNEC) 
RQ Value 
RQfw (MEC(P(95))/PNEC) 
5.3 (Sc2) 
Please note the RQ(MEC) is highly 
unreliable because of the low quantity 
and quality of monitoring data. 
Exceedancies result from the use of 
LOQ/2 for the non-quantified samples 
 
RQfw (PEC/PNEC; PEC=10.4 µg/l) 2212 
 
Note: PEC value is taken from Lettieri, T., Chirico, N., Carvalho, R.N., Napierska, D., 
Loos, R., Sanseverino, I., Marinov, D., Ceriani, L., Umlauf, G. 2016. Modelling-based 
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strategy for the prioritisation exercise under the Water Framework Directive,  
https://circabc.europa.eu/w/browse/85b46283-9353-4e67-bf56-e4d18b32cbaf). 
 
 
STE score  
 
2.11 (Sc2; PNEC=0.0047 µg/l) 
Please note the STE score is highly unreliable because of the low quantity and quality of 
monitoring data. Exceedancies result from the use of LOQ/2 for the non-quantified 
samples 
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 Venlafaxine (CAS N. 93413-69-5) 
Substance identity 
EC name  
EC number  
CAS number 93413-69-5 
Molecular formula C17H27NO2 
Molecular weight 277.4 g/mol 
Structure 
 
SMILES  
 
Physico-chemical properties 
Endpoint Value Source 
Vapour Pressure (Pa)   
Water solubility (mg/L) 230 g/l https://www.drugbank.ca/salts/DBSALT000186 
logKow 0.43 http://datasheets.scbt.com/sc-201102.pdf 
 
Environmental fate 
Endpoint Value Source 
Sorption potential Koc     
Partition coefficient solid-water in 
sediment Kpsed (L/kg) 
  
Biodegradability   
Bioaccumulation (BCF)   
 
Environmental exposure assessment 
Predicted Environmental Concentration 
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 Description Source 
Tonnes/year 12 GB 
   
Uses 
Antidepressant drug 
Venlafaxine is used in the following MS: CZ, FI, 
IRL, RO, SK 
 
  
  
Spatial usage (by MS) Not known - 
Banned uses   
ERC code   
PECfw (mg/L)   
PECsed (mg/kg dw)   
PECbiota (mg/kg)   
 
 
Measured Environmental Concentrations  
MS Source of monitoring data MEC values 
Europe (90 samples 
from 18 countries) 
WWTP effluents 
Loos et al. (2013) 
0.119 µg/l (mean) 
0.548 µg/l (max.) 
DE 
WWTP effluents (Germany; DE) 
Schlüsener et al. (2015) 
0.225 µg/l (mean) 
DE 
Rhine River 
Schlüsener et al. (2015) 
0.014 µg/l (annual 
mean) 
DE 
Emscher River (small river) 
Schlüsener et al. (2015) 
0.180 µg/l (mean) 
SE 
Surface waters downstream WWTPs; 
also found in blood samples from otters 
(in 10/10 pooled samples). 
<LOQ (0.1 ng/l) 
up to 0.440 µg/l 
In Sc2 (inland whole 
water) data from 
only 1 MS (93 sites) 
with 1395 samples 
Dataset of monitoring prioritisation 
2014 
MEC(P95)= 0.19 µg/l 
(Sc2) 
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are available. 76.8% 
quantified samples. 
Sc3 was not 
developed since data 
scarcity. 
Data quality is 
acceptable. 
UK 
Monitored at approximately 80 sites 
(approx. 1700 samples). Detected at 19 
of these sites with 15 of these having > 
60% detection rate.  
0.024-0.49 µg/l (max.) 
0.009-0.228 µg/l 
(mean)  
 
 
Analytical Methods    
Method LOQ (µg/l) Description / Reference 
SPE-LC-MS-MS 0.0007 Extraction of 100 ml water (Gros et al. (2012) 
SPE-LC-MS-MS 0.0005 Extraction of 100 ml water (Loos et al. (2013) 
SPE-LC-MS-MS 0.0003 Extraction of 1 L water (Schlüsener et al.; 2015) 
LC-MS-MS 0.01 CZ 
n.a. 0.0001 SE 
n.a. 0.0005 BE-Wallonia 
LC-MS-MS 0.005 England 
 
 
P, B, T, C, M, R, ED properties  
 
Substance Persistent (P) 
Bioaccumulative 
(B) Toxic (T) 
Carcinogenic (C) 
Mutagenic (M) 
Reproduction toxicity 
(R) 
Endocrine 
Disruptive 
(ED) 
Comment 
Venlafaxine P and  T    
 
 
Hazard assessment 
Ecotoxicology data 
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Mammalian toxicology data 
 
PNEC derivation 
PNEC Endpoint 
Endpoint value 
(µg/L) 
AF 
PNEC 
value 
(µg/L) 
PNECfw    0.038 
PNECsed     
PNECbiota,sec 
pois 
    
PNECbiota, hh     
PNECdw, hh     
 
 
 
Risk Quotient (MEC or PEC/PNEC) 
RQ Value 
RQfw (MEC(P95)/PNEC)  
RQfw(PEC/PNEC;  PEC=0.2 µg/l)  
RQsed  
RQbiota,sec pois  
RQbiota, hh  
RQdw, hh  
 
 
STE score 
 
n.a. 
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